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ABSTRACT 
 
 
 
Insulin-Like Growth Factor Binding Proteins-1 and -3, and Hydroxysteroid (11-Beta) 
Dehydrogenase One: Potential Roles in Ruminant Conceptus Development and 
Endometrial Function. (December 2009) 
Rebecca Marie Simmons, B.S., Oregon State University 
Chair of Advisory Committee: Dr. Thomas E. Spencer 
 
 
 
 Maternal contributions from the uterine endometrial luminal (LE) and glandular 
(GE) epithelia are unequivocally required to support ruminant conceptus growth and 
development, elongation and implantation.  Therefore, studies were conducted to 
examine expression of endometrial genes hypothesized to regulate conceptus 
development. 
 The first study investigated two genes specifically expressed in the LE and 
superficial GE of the ovine uterus.  Insulin-like growth factor binding protein (IGFBP1) 
and (IGFBP3) expression was coordinate with ovine conceptus elongation.  Treatment 
with P4 induced and IFNT stimulated IGFBP1, but not IGFBP3; however, IFNT only 
moderately stimulated IGFBP1, indicating that another conceptus-derived factor 
stimulates endometrial IGFBP1 expression.  IGFBP1 did not affect proliferation of 
ovine trophectoderm (oTr) cells in vitro, but stimulated their migration and attachment.  
Results indicated that IGFBP1, but not IGFBP3 is a marker of conceptus elongation in 
ruminants and stimulates cell migration and attachment. 
 The second study evaluated the effects of pregnancy, P4 and IFNT on expression 
of hydroxysteroid (11-beta) dehydrogenases (HSD11B1 and HSD11B2), nuclear 
receptor subfamily 3, group C, member 1 (NR3C1), and prostaglandin-endoperoxide 
synthase 2 (PTGS2) in the ovine uterus.  Expression of HSD11B1 mRNA and PTGS2 
protein in endometrial LE and sGE were coordinate with conceptus elongation, while 
HSD11B2 mRNA was expressed primarily in the conceptus.  Further, P4 induced, but 
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IFNT only moderately stimulated HSD11B1.  Thus, HSD11B1 expression may be 
regulated by prostaglandins (PGs) during early pregnancy.  The presence of NR3C1 in 
the ovine uterus implicates cortisol, the main product of HSD11B1, in peri-implantation 
period events that include elongation of the ovine conceptus. 
 The third study determined in vivo effects of PGs on ovine conceptus elongation 
and endometrial gene expression.  Compared to control ewes, intrauterine infusions of a 
PTGS2 inhibitor, meloxicam, retarded elongation and decreased expression of 
elongation-related genes including IGFBP1, IGFBP3, HSD11B1, galectin 15 
(LGALS15), solute carrier family 2, member 1 (SLC2A1), gastrin-releasing peptide 
(GRP), cystatin C (CST3), radical S-adenosyl methionine domain containing 2 (RSAD2), 
and ISG15 ubiquitin-like modifer (ISG15). 
 Collectively, these studies assessed the effects of pregnancy, P4, IFNT, and PGs 
on endometrial genes implicated in conceptus growth.  These results indicate that 
IGFBP1 is a marker of conceptus elongation in ruminants and provide novel roles for 
both cortisol and PGs in endometrial gene expression and conceptus elongation. 
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CHAPTER I 
INTRODUCTION 
 
 
 
 In all species, early pregnancy is a critical period of time for conceptus 
(embryo/fetus and associated extraembryonic membranes) survival.  Extensive prenatal 
mortality has been observed in all mammals studied, although significant differences 
exist among species in the extent and timing of embryonic death (Wilmut et al. 1986).  
In particular, ruminants experience relatively high levels of pregnancy loss during the 
peri-implantation period.  Cattle, for example, have an estimated fertilization rate of 90% 
with an average calving rate of about 55%, and thus an approximate 35% 
embryonic/fetal mortality.  Further, embryonic loss is higher between Days 8 and 16 
after insemination which results in 70-80% of pregnancy failures (Diskin et al. 2006).  In 
mated ewes, as much as 20 to 40% of ova ovulated do not result in live births (Edey 
1979).  While fertilization failure accounts for the loss of 5-10% of ova in sheep, the 
greatest proportion of the remaining loss occurs during the first 3 weeks of gestation.  
Prenatal death contributes to economic loss, resulting in reduced litter size in pigs and 
prolific sheep.  Moreover, in animals with only one ovulation at each estrus, such as 
cattle and some breeds of sheep, early embryonic death leads to an increased interval 
between births (Wilmut et al. 1986). 
 To establish and maintain pregnancy, the conceptus must signal its presence to 
the mother, and, in turn, the uterus must respond accordingly.  Various hormones, such 
as progesterone (P4) secreted from the corpus luteum (CL) and interferon tau (IFNT) 
released from the conceptus, regulate the expression of numerous endometrial genes that 
ensure an optimal environment for implantation and placentation.  Genes in the endo-           
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metrium are both positively and negatively regulated by P4 (Hansen et al. 1999).  Both 
P4 and IFNT co-regulate numerous genes important during early pregnancy (Spencer & 
Bazer 2002, Spencer et al. 2008).  Inadequate levels of either P4 (Savio et al. 1993, 
Wehrman et al. 1993, Mann & Lamming 2001) and IFNT (Nephew et al. 1991, Mann & 
Lamming 2001) have been implicated in early embryonic loss. 
 Prostaglandins (PGs) from the uterus and/or conceptus may also interact with 
other factors to regulate gene expression during the peri-implantation period.  In many 
species, PGs regulate numerous physiologically important events and are key players in 
reproduction.  PGs can stimulate gene expression, and, in turn, increase the activity of 
enzymes such as hydroxysteroid (11-beta) dehydrogenase 1 (HSD11B1) to produce 
active cortisol.  Cortisol, a ligand for both the mineralocorticoid (MR) and 
glucocorticoid (NR3C1) receptors, can stimulate either water and ion transport or 
regulate gene transcription (Marver 1984, Michael et al. 2003). 
 Although the exact mechanisms behind pregnancy success are poorly 
understood, it is believed that pre- and post-ovulatory conditions as well as proper 
concentrations of hormones all play a role in establishment and maintenance of 
pregnancy (Inskeep 2004).  It is important to define causes of such loss due to the 
substantial economic loss that follows prenatal death in farm animals.  Understanding 
the temporal and spatial (cell-specific) expression of implantation-related genes and their 
secreted products provides important insight into conceptus survival and growth.  In 
addition, gene regulation by established hormones of pregnancy, such as P4 and IFNT, 
as well as novel regulatory hormones, offers a new area of exploration into pregnancy 
success.  Results from this research will facilitate the development of markers for 
conceptus elongation in ruminants, as well as contribute to a greater working knowledge 
of the uterine environment and its effects on pregnancy and conceptus elongation. 
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CHAPTER II 
LITERATURE REVIEW 
 
 
 
Uterine Development and Structure in Ruminants 
 In many species including livestock (cattle, swine, and sheep), development of 
the uterus occurs during both fetal and neonatal life.  Uterine adenogenesis is completed 
during the postnatal period in mammals with long gestation periods (Marion & Gier 
1971, Wiley et al. 1987, Bartol et al. 1993).  In all mammals, the mature uterine wall 
consists of two functional units, the endometrium and myometrium (Fig. 2.1).  The 
endometrium or the inner lining of the uterus is comprised of two epithelial cell types, 
luminal epithelium (LE) and glandular epithelium (GE), two stratified stromal 
compartments, a dense zone of fibroblasts (stratum compactum) and a more loosely 
organized zone in the deeper endometrium (stratum spongiosum), blood vessels and 
immune cells.  The myometrium includes an inner circular layer and outer longitudinal 
layer of smooth muscle (Wiley et al. 1987, Bartol et al. 1988, Bartol et al. 1993). 
 The uteri of sheep are dichotomous in nature because the endometrium consists 
of numerous raised aglandular caruncles and glandular intercaruncular areas (Wimsatt 
1950, Atkinson et al. 1984).  Caruncles serve as the site of superficial implantation and 
placentation and eventually fuse with placental cotyledons to form placentomes.  These 
placentomes are the major sites of fetal-maternal gas exchange and provide fetal access 
to micronutrients such as glucose and amino acids (Wimsatt 1950, Mossman 1987).  
Intercaruncular areas are filled with branched, coiled uterine glands which synthesize 
and secrete a complex mixture of substances termed histotroph that is absorbed by 
placental areolae (Bazer 1975).  
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Fig. 2.1. Schematic illustration of uterine histoarchitecture.  The uterus is divided into 
endometrial and myometrial compartments.  The myometrium consists of an inner circular and 
outer longitudinal smooth muscle layers.  The endometrium consists of luminal epithelial cells 
lining the lumen of the uterus, glandular epithelial cells lining the coiling, branching endometrial 
glands, and stromal cells subdivided into dense, stratum compactum and loose, stratum 
spongiosum.  The endometrium additionally contains a large population of immune cells and 
vasculature. (Graphic courtesy of Rodney Geisert and Larry Burdett, Oklahoma State University, 
Stillwater, USA).  Originally published by (Spencer et al. 2005). 
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Early Pregnancy Events in Ruminants 
 Establishment and maintenance of pregnancy in ruminants (sheep, cow, and 
goat) involves synchronization of key events.  It is imperative for the conceptus to signal 
its presence to the mother, and for the mother, in turn, to create an optimal environment 
for conceptus elongation, implantation and placentation (Geisert et al. 1992, Burghardt 
et al. 2002, Spencer & Bazer 2002, Spencer & Bazer 2004).  In sheep and cows, 
ovulation occurs approximately 30 hours after onset of estrus and the ovum enters the 
ampulla of the oviduct (Fig. 2.2).  Fertilization takes place at the ampullary-isthmic 
junction of the oviduct where the zygote then undergoes consecutive rounds of cleavage.  
By Day 4 (Day 0=estrus/mating), the embryo has reached the morula stage and enters 
the uterus where it forms a blastocyst by Day 6.  Blastocysts contain a blastocoele, or 
fluid-filled cavity, surrounded by a monolayer of trophectoderm and extra-embryonic 
endoderm (Guillomot 1995, Spencer et al. 2004, Spencer et al. 2007b).  The expanded 
blastocysts hatch from the zona pellucida on Days 8 or 9 (sheep) or Days 9 to 10 (cattle) 
and then become ovoid to tubular by Day 11 (sheep) or Day 13 (cattle) and are then 
termed conceptuses.  On Day 12 (sheep) and Day 14 (cattle), the conceptus begins to 
elongate to a filamentous form that can reach 25 cm or more in length within a few days 
(Wales & Cuneo 1989).  The entire uterine horn ipsilateral to the CL is occupied by 
Days 16 to 18 in sheep and Days 19 to 21 in cattle. 
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Fig. 2.2. Schematic of events occurring during early pregnancy in sheep.  Position of the 
conceptus in the female reproductive tract, stages of blastocyst development and circulating 
levels of estradiol and progesterone are illustrated.  Following ovulation, the oöcyte enters the 
oviduct, is fertilized at the ampullary-isthmic junction and the embryo enters into the uterus on 
Day 4 post-mating.  The zona pellucida (ZP) is shed on Days 8 to 9, after which the conceptus 
expands to a tubular form, followed by elongation to a filamentous conceptus by Day 15.  
Conceptus elongation coincides with the onset of implantation.  (Graphic courtesy of Dr. Greg 
Johnson, Texas A&M University, College Station, USA).  From (Spencer et al. 2004). 
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Conceptus Development and Elongation 
 
 Maternal recognition of pregnancy was first defined in 1969 by Roger Short as 
the physiological process by which the conceptus signals its presence to the maternal 
system and extends the lifespan of the CL (Short 1969).  In ruminants, this recognition 
process requires conceptus elongation from a spherical to a tubular and then filamentous 
form after hatching from the ZP (Spencer & Bazer 2004).  It is hypothesized that 
elongation occurs as cells proliferate and redistribute towards the ends of tubular 
blastocysts, resulting in the characteristic increase in length and decrease in diameter.  
Studies in the pig by Geisert and coworkers (Geisert et al. 1982) first documented the 
mechanisms involved in elongation.  Measurement of DNA and mitotic index indicated 
no significant changes during the transition from spherical to filamentous forms, 
supporting the notion that elongation is accomplished through cellular remodeling as 
well as cellular hyperplasia.  This idea of migration was further supported by scanning 
and transmission electron microscopy (Geisert et al. 1982).  Blastocyst elongation 
appears to result from surface and ultrastructural changes involving both the 
trophectoderm and endoderm.  Not only did the trophectoderm flatten, but there was also 
an increase in microvilli on the cell surface and the formation of large intercellular 
spaces between trophectoderm cells, possibly to allow for remodeling.  A dense band of 
cells composed of both migrating endoderm and trophectoderm cells comprised a region 
known as the elongation zone.  Filapodia formed between the endoderm and the 
basement membrane of trophectoderm, possibly to allow endodermal cells to migrate 
freely and rapidly across the trophectodermal surface. 
 A major event in conceptus elongation includes the differentiation of the 
extraembryonic membranes (Wooding & Flint 1994).  On Day 13 the embryonic disc is 
raised above the surface of the elongated trophoblast, and by Day 15 it has grown in size 
and is more elongated.  Both the neural groove and the beginning of the yolk sac are also 
evident.  By Day 17, the embryo has increased in length and the allantois is clearly 
discernible at the caudal end.  The embryo takes on a characteristic rounded shape by 
Day 19 when many more structural features can be identified (Wales & Cuneo 1989).   
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 Conceptus elongation in sheep involves an exponential increase in length and 
weight of the trophectoderm (Wales & Cuneo 1989).  While the conceptus almost 
doubles in length every two days, increases in width remain minimal between Days 13 
and 19 of pregnancy (Wales & Cuneo 1989).  The conceptus can reach 190 mm or more 
in length by Day 15, but the width remains at approximately 1 to 1.5 mm throughout 
elongation, resulting in a filamentous appearance (Chang & Rowson 1965, Bindon 1971, 
Wintenberger-Torres & Flechon 1974).  In addition, growth of the conceptus is reflected 
in its dry weight which increases 4- to 5-fold every two days (Wales & Cuneo 1989).  
The dry weights of both the trophoblast and yolk sac double between Days 17 and 19, 
while the allantois, just forming on Day 17, undergoes rapid growth to reach 2 mg by 
Day 19 (Wales & Cuneo 1989). 
 The onset of trophoblast giant binucleate cell (BNC) formation is also 
characteristic of elongation (Wooding & Flint 1994).  The BNC first appear on Day 14 
in the sheep (Wooding 1984) and are thought to arise from mononuclear trophectoderm 
cells by successive nuclear divisions without cytokinesis (Wooding 1992), also known 
as mitotic polyploidy.  By Day 16, BNC comprise 15-20% of trophectoderm cells and 
begin to migrate to the microvillar junction of the LE.  They fuse with individual uterine 
LE cells to produce trinucleate fetomaternal hybrid cells (Wooding 1984), eventually 
giving rise to multinucleated syncytial plaques that cover the caruncles.  The two main 
functions for BNC include: (1) formation of syncytia necessary for implantation and 
cotyledonary growth in the placentome; and (2) synthesis and secretion of protein and 
steroid hormones important during pregnancy (Wooding 1992). 
 Elongation of conceptus trophectoderm is required for the production of IFNT, 
which is the pregnancy recognition signal that inhibits development of the endometrial 
luteolytic mechanism (Spencer et al. 1996, Roberts et al. 1999, Spencer & Bazer 2002).  
IFNT is an exclusive product of the mononuclear cells of the conceptus trophectoderm 
and is synthesized and secreted from Days 10 to 21 of pregnancy, with maximal 
production on Days 14 to 16 (Bazer 1992, Roberts et al. 1999).  During 24 hours in 
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culture, a single Day 16 conceptus produces approximately 1 x 108 antiviral units of 
IFNT (Ashworth & Bazer 1989). 
 
Implantation 
 Conceptus elongation coincides with the onset of the highly coordinated events 
of implantation.  Implantation is common to all mammals, but the timing of implantation 
differs among species and can last anywhere from a few hours in rodents to days in 
humans and domestic animals (Guillomot et al. 1993).  In general, implantation involves 
shedding of the zona pellucida, precontact and blastocyst orientation, apposition, 
adhesion, and endometrial invasion (Guillomot et al. 1981, Guillomot et al. 1993, 
Guillomot 1995).  Endometrial invasion by the conceptus does not occur in domestic 
ruminants.  After hatching from the ZP, the blastocyst is positioned and immobilized 
within the uterus from Days 9 to 14 while elongation commences (Fig. 2.3).  By Day 14 
the trophectoderm is closely associated with the endometrial LE and will weakly adhere 
to the uterine epithelia.  In most species, apposition results in the reduction of apical 
microvilli covering the trophectoderm from Days 13 to 15 in sheep (Guillomot et al. 
1981, Guillomot et al. 1993).  While loss of apical microvilli does not occur on the 
uterine LE in sheep, apposition of the blastocyst is ensured by interdigitation of 
cytoplasmic projections of the trophectoderm cells and uterine epithelial microvilli.  
Furthermore, uterine glands also serve as sites of apposition in ruminants (Guillomot et 
al. 1981, Guillomot & Guay 1982, Guillomot et al. 1993).  On Day 16, firm adhesion of 
trophoblast to the LE begins and is completed around Day 22. 
 In sheep, it is proposed that elongation from a spherical blastocyst to a 
filamentous form requires transitory attachment and adhesion of conceptus 
trophectoderm to LE.  The LE may initially be nonadhesive, in part, due to the apical 
expression of mucin glycoprotein one (MUC1); however, as MUC1 expression 
decreases between Days 9 and 17 of early pregnancy, the process of implantation can 
begin (Johnson et al. 2001).  Loss of MUC1 is common to sheep (Johnson et al. 2001), 
cattle (Davies et al. 2008), rodents (McNeer et al. 1998), and pigs (Bowen et al. 1996), 
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Fig. 2.3. Schematic illustration of the pre-attachment, apposition, and adhesion stages of 
superficial implantation in sheep.  Pre-attachment (A) involves shedding of the zona pellucida, 
followed by conceptus expansion, as well as precontact and blastocyst orientation.  Mucin 1, cell 
surface associated (MUC1) expression prevents contact with integrin subunits and/or 
carbohydrate receptors.  Apposition (B) involves a decrease in MUC1 expression by the LE and 
infiltration of the necks of the uterine glands by trophoblast papillae to aid in elongation.  
Adhesion (C) between the apical surfaces of the conceptus trophectoderm and LE is mediated by 
uterine secretory proteins, such as secreted phosphoprotein 1 (SPP1) and glycosylation-
dependent cell adhesion molecule-1 (Gly-CAM-1), binding to receptors.  Trophoblast binucleate 
cells fuse with the luminal epithelial (LE) cells to form syncytial plaques, but are not invasive 
beyond this single cell layer.  (Graphic courtesy of Dr. Greg Johnson, Texas A&M University, 
College Station, USA).  From (Spencer et al. 2004). 
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but in rabbits and humans MUC1 increases overall but is locally reduced at points of 
conceptus attachment (Hoffman et al. 1998, Aplin 1999).  As MUC1 levels decline, 
various integrin subunits expressed by both the LE and conceptus trophectoderm can 
bind bridging molecules such as secreted phosphoprotein one (SPP1) and other 
extracellular matrix (ECM) ligands (Yoshinaga 1989, Burghardt et al. 1997, Johnson et 
al. 2001). 
 
Uterine Histotroph 
 Growth and development of the blastocyst into an elongated conceptus requires 
histotroph, transported or secreted predominantly by the endometrial LE and GE (Bazer 
1975, Bazer et al. 1979, Roberts RM 1988, Gray 2001a).  All mammalian uteri contain 
endometrial epithelia that synthesize and secrete or transport a rather undefined, 
complex mixture of serum proteins, transport, and adhesion proteins, protease inhibitors, 
cytokines, growth factors, hormones, amino acids, sugars, and ions termed ‘histotroph’ 
(Wimsatt 1950, Amoroso 1952, Bazer 1975).  Experiments by Flechon and coworkers 
(Flechon et al. 1986) demonstrated that Day 12 ovine blastocysts were unable to 
elongate in vitro until surgically transferred into the uterine horn ipsilateral to the CL of 
ewes on Day 12 of the estrous cycle.  When Day 4 ovine conceptuses were transferred 
into Day 7 recipient ewes, all conceptuses survived but were unable to elongate (Lawson 
et al. 1983); furthermore, these conceptuses stopped growing after Day 11.  Results of 
these experiments support the idea that the maternal uterine environment regulates 
conceptus survival and development.  In addition, uterine gland knockout (UGKO) 
ewes, which lack endometrial GE and have much reduced LE, experience recurrent early 
pregnancy loss between Days 12 and 14 post-mating (Gray 2001, Gray 2002).  
Collectively, these studies indicate that uterine-derived histotroph is required for 
conceptus survival and elongation in ruminants. 
 Research has provided insight into both the components of histotroph and 
patterns of gene expression during pregnancy in ruminants (Spencer et al. 2007b, 
Spencer et al. 2008).  Histotroph is the product of the selective transport of serum-
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derived substances by the endometrium (amino acids, glucose) as well as synthesis and 
secretion of factors by the endometrium (cytokines, growth factors, adhesion proteins).  
A comprehensive study by Gao et al. (Gao et al. 2009b) identified the following 
nutrients in uterine histotroph of sheep: glucose, arginine, glutamine, leucine, aspartic 
acid, glutamic acid, asparagine, histidine, beta-alanine, tyrosine, tryptophan, methionine, 
valine, phenylalanine, isoleucine, lysine, cysteine, proline, glutathione, calcium, and 
sodium.  While quantities of glucose, amino acids, glutathione, calcium, sodium, and 
potassium increase during early pregnancy, particular nutrients are hypothesized to play 
a more direct role in conceptus elongation.  Further, specific genes expressed by the 
endometrium function in transport of histotroph and encode for secreted proteins that 
govern conceptus elongation; however, these genes are dependent upon ovarian P4 and 
conceptus-derived IFNT for adequate expression. 
 
Hormonal Regulation of Endometrial Epithelial Functions 
 
Progesterone 
Often termed the hormone of pregnancy, P4 has long been known to act on the 
uterus and stimulate uterine functions required for histotroph production, and thus 
conceptus survival, growth, and development (Bazer 1975, Spencer et al. 2004).  Bred 
ewes treated with mifepristone (RU486), a PGR and NR3C1 antagonist (Baulieu 1989), 
from Days 8 to 12 post-mating lacked conceptuses on Day 12 (Satterfield et al. 2006).  
Hormone replacement studies in sheep confirmed that P4 induces endometrial LE/sGE 
gene expression of lectin, galactoside-binding, soluble, 15 (LGALS15), cathepsin L1 
(CTSL1), cystatin C (CST3), gastrin-releasing peptide (GRP), insulin-like growth factor 
binding protein 1 (IGFBP1), insulin-like growth factor binding protein 3 (IGFBP3), 
hydroxysteroid (11-beta) dehydrogenase 1 (HSD11B1), prostaglandin-endoperoxide 
synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (PTGS2), solute carrier 
family 2 (facilitated glucose transporter), member 1 (SLC2A1), solute carrier family 5 
(sodium/glucose cotransporter), member 1 (SLC5A1), solute carrier family 7 (cationic 
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amino acid transporter, y+ system), member 2 (SLC7A2), and GE gene expression of 
solute carrier family 5 (sodium/glucose cotransporter), member 11 (SLC5A11), and 
GRP, and SPP1 (see (Spencer et al. 2007a, Spencer et al. 2008) for reviews).  
Interestingly, the onset of expression of many genes by uterine LE/sGE that are 
associated with conceptus elongation is associated with loss of PGR between Days 10 
and 11 in the LE and between Days 12 and 13 in the GE post-mating (Wathes & Hamon 
1993, Spencer & Bazer 1995).  However, PGR expression does not decrease in the 
stroma or myometrium after 8 to 10 days of P4 exposure (Spencer & Bazer 2002).  
Immediately prior to implantation, loss of PGR in uterine epithelia is a common feature 
across mammals and allows for expression of key genes associated with implantation 
(Carson et al. 2000). 
 
Interferons and Interferon Tau 
 Interferons (IFNs) are cytokines that have potent antiviral and antiproliferative 
effects, and are important modulators of the immune system (Platanias 2005).  The IFN 
family includes numerous Type I IFNs, all of which share considerable structural 
homology, but only one Type II IFN, IFN gamma (IFNG) (Pestka et al. 1987, Pestka et 
al. 2004).  Type I IFNs include interferons alpha (IFNA), beta (IFNB), delta (IFND), tau 
(IFNT), and omega (IFNW1).  Some IFNs are species specific; for example, IFNT is 
unique to ruminants, while IFND is specific to pigs (Roberts et al. 1999, Roberts et al. 
2003, Pestka et al. 2004, Krause & Pestka 2005) and horses (Tayade C 2008; Abstract 
83, Cochet et al. 2009).  Although IFNT in ruminants is the only known IFN to be 
involved in pregnancy signaling, IFNs likely affect uterine receptivity, decidualization 
and placental growth and development in primates, ruminants, pigs and rodents (Austin 
et al. 2003, Pestka et al. 2004, Popovici et al. 2006, Hess et al. 2007, Spencer et al. 
2007a).  
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IFNT Signaling 
 All Type I IFNs bind a common receptor known as the Type I IFN receptor (Fig. 
2.4).  It consists of two subunits, IFNAR1 and IFNAR2, which are associated with the 
Janus-activated kinases (JAKs) tyrosine kinase 2 (TYK2) and JAK1, respectively 
(Darnell et al. 1994, Stark et al. 1998, Platanias 2005).  Type I IFNs induce 
homodimerization of signal transducer and activator of transcription (STAT1), which 
can then translocate to the nucleus and bind gamma-activation site elements (Bridges et 
al. 2008) in the promoter region of certain ISGs to initiate transcription (Leanza et al. 
2007).  IFN regulatory factor one (IRF1) is a GAS-regulated gene that intensifies the 
effects of IFNs by binding and activating interferon-response elements (ISREs) of many 
ISGs.  Type I IFNs act predominately through interferon-stimulated gene factor 3 
(ISGF3), which is a STAT1-STAT2-IRF9 (IFN-regulatory factor 9) complex, as 
opposed to exerting effects through the gamma activation factor (GAF) (Platanias 2005, 
Bazer et al. 2009). 
 Type II IFNG signaling involves activation of the JAK family due to a 
constitutive association between JAK1 and JAK2 with IFNGR1 and IFNGR2 subunits of 
Type II IFNR, respectively (Chard 1989, Bazer & Johnson 1991, Krause & Pestka 
2005).  Activation of the JAKs by IFNG results in their tyrosine phosphorylation and 
activation, leading to tyrosine phosphorylation and homo-dimerization of STAT1.  
STAT1 can then translocate to the nucleus and bind GAS elements in promoter regions 
of IFNG-regulated genes to initiate transcription (Leanza et al. 2007, Bazer et al. 2009).  
Action of IFNT 
 As the conceptus elongates, IFNT, the maternal recognition signal in ruminants, 
is synthesized and secreted by the mononuclear trophectoderm cells (Bazer 1975, Bazer 
et al. 1979, Spencer & Bazer 2004).  IFNT inhibits transcription of the estrogen receptor 
alpha (ESR1) gene and, therefore, estrogen-induced expression of the oxytocin receptor 
(OXTR) in the endometrial LE/sGE, which is required for the generation of oxytocin-
induced luteolytic pulses of PGF2α in cyclic or non-pregnant animals.  Moreover, IFNT 
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Fig. 2.4. Interferon tau (IFNT) signaling in the ovine endometrium. [A] In luminal and 
superficial glandular epithelia (LE/sGE), IRF-2, a transcriptional repressor, prevents IFNT 
induction of expression of IFN-stimulate genes (ISGs), including STAT1, STAT2, and 
interferon-stimulated gene factor 3 (ISGF3G). The LE/sGE also lack progesterone receptors; 
however, progesterone induces and IFNT stimulates novel cell signaling pathways to induce 
expression of WNT7A, CST3, CTSL, HIF2A, GLUT1, CAT2, and LGALS15 genes only in 
LE/sGE. [B] In stromal cells and GE, IFNT activates the classical Janus-activated kinase-signal 
transducer and activator of transcription 1-interferon regulatory factor 1 (JAK-STAT1-IRF-1) 
cell signaling pathway for formation of ISGF3 and gamma-activation factor (GAF) transcription 
factor complexes to induce ISG expression. Additional transcriptional regulators are likely 
involved in IFNT actions on stromal cells and GE (Bazer et al. 2009).   
 
 
[A] 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
[B] 
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inhibition of ESR1 expression prevents PGR reappearance in endometrial epithelia 
(Spencer et al. 1996).  The maintained CL produces an increasing amount of P4 that, 
along with IFNT, induces and/or stimulates a myriad of genes in the endometrium 
implicated in the events of early pregnancy (Spencer et al. 2008).  IFNT acts on the 
endometrium to induce or enhance expression of many genes believed to regulate 
conceptus development, known collectively as IFN-stimulated genes or ISGs.  Early 
embryonic losses and pregnancy failure are the result of inadequate reaction of the 
endometrium to progesterone and IFNT or insufficient secretion of IFNT by the 
conceptus (Hernandez-Ledezma et al. 1993).  The combined effects of P4 and IFNT 
have been attributed to stimulating a myriad of endometrial implantation-related genes 
important for conceptus survival and growth. 
Combinatorial Effects of P4 and IFNT 
 Uterine receptivity to implantation is P4 dependent; however, implantation 
events, endometrial gene expression, and selective transport of molecules into the uterine 
lumen that support conceptus development, all require loss of expression of PGR after 8-
10 days of exposure of the uterus to P4 (Bazer et al. 2009).  Loss of PGR by endometrial 
epithelia, but not by stromal or myometrial cells, is hypothesized to be required for 
uterine receptivity as well as blastocyst survival and growth, and is common among all 
studied mammals prior to implantation (Lessey et al. 1988, Press & Greene 1988, 
Geisert et al. 1994, Spencer & Bazer 1995, Tan et al. 1999, Spencer & Bazer 2002).  In 
addition, reduced expression of anti-adhesive genes such as MUC1 from uterine LE 
appears to be a prerequisite for uterine receptivity to implantation (Spencer & Bazer 
2002, Spencer et al. 2007b).  Thus, P4 likely acts on PGR-positive stromal cells in a 
classical manner to induce expression of progestamedins, including fibroblast growth 
factor -7 (FGF7) and -10 (FGF10) and hepatocyte growth factor (HGF) (Fig. 2.5).  In 
the ovine uterus, FGF10 and HGF are expressed in the endometrial stroma, and FGF7 is 
expressed in the tunica media of blood vessels within the endometrium (Chen et al. 
2000a, Chen et al. 2000b).  These progestamedins exert paracrine effects on uterine 
epithelia and conceptus trophectoderm that express receptors for FGF7 and FGF10  
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Fig. 2.5. Hypothesis on the roles of progesterone, progestamedins, and interferon tau on gene 
expression and secretory function by ovine uterine luminal and superficial glandular epithelia  
that lack both progesterone receptor and signal transducer and activator of transcription 1 (see 
Bazer et al. 2009). Ovine uterine LE/sGE lack detectable PGR and STAT1, indicating that P4 
and IFNT use nonclassical signaling pathways to regulate expression of P4-induced and IFNT-
stimulated genes. The stroma remains PGR positive. Results from preliminary studies indicate 
that P4 increases production of stromal-derived progestamedins in the ovine uterus that act on 
uterine LE/sGE and conceptus trophectoderm cells that express FGFR2(IIIb) and MET receptors 
for FGF7/FGF10 and HGF, respectively, to activate MAPK and PI3K cell signaling. 
Progestamedins and type I interferons (IFNs) activate the PI3K and AKT1 signaling pathways in 
other cell types (Platanias 2005). Unpublished results (J. Kim, G. Wu, G.A. Johnson, and F.W. 
Bazer) indicate that IFNT activates p38 MAPK and PI3K-AKT1-FRAP1 (mTOR) signaling 
pathways and that promoter/enhancer regions of novel P4-induced and IFNT-stimulated genes 
expressed in uterine LE/sGE have binding sites for transcription factors activated by MAPK and 
PI3K signaling pathways. 
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(FGFR2IIIb) and HGF (MET; proto-oncogene MET) (Chen et al. 2000a, Chen et al. 
2000b, Spencer & Bazer 2002, Spencer et al. 2007b).  The primary progestamedin 
responsive to P4 in ewes appears to be FGF10, which presumably mediates P4 actions 
on PGR-negative uterine epithelia that express their receptors (Satterfield et al. 2008).
 Because uterine LE/sGE of sheep express interferon regulatory factor 2 (IRF2), 
a potent inhibitor of gene transcription that silences expression of genes such as ESR1 
and STAT1, classical ISGs are limited to uterine GE and stromal cells (Choi et al. 2001).  
Lack of PGR, STAT1, STAT2, and IRFs in the ovine uterine LE/sGE renders IFNT 
unable to affect gene transcription through the canonical JAK-STAT cell signaling 
pathways.  It has been proposed that both P4-induced progestamedins and IFNT are 
working through nonclassical cell signaling pathways independent of PGR and STAT1, 
such as mitogen-activated protein kinases (MAPKs) and phosphoinositide-3 kinase 
(PI3K), to stimulate uterine gene expression (Platanias 2005, Spencer et al. 2007a, Bazer 
et al. 2009).  Progestamedins and Type I IFNs have been shown to activate to PI3K and 
AKT1 signaling pathways in other cells types, such as endothelial cells in the uterine 
artery (Bird et al. 2003).  Recent evidence suggests that P4 and IFNT work together to 
induce and/or enhance endometrial genes, many of which transfer nutrients or encode for 
secreted proteins that contribute to uterine histotroph and conceptus elongation. 
Transporters 
 Glucose serves as the primary energy source for ovine conceptuses during 
implantation and can be metabolized into glycogen, nucleic acids, proteins, and lipids 
(Wales & Waugh 1993).  Glucose levels increase in the uterine lumen during early 
pregnancy (Gao et al. 2009b) and, in turn, utilization of glucose progressively increases 
between Days 13 and 19 of pregnancy (Wales & Waugh 1993) to regulate trophoblast 
cell growth and proliferation through the glutamine fructose-6-phosphate 
amidotransferase (GFAT)-mediated FKBP12-rapamycin complex-associated protein 1 
(FRAP1) signaling pathway (Wen et al. 2005).  Because neither fetal nor maternal 
tissues can perform gluconeogenesis, transport of glucose from maternal circulation into 
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the uterine lumen requires glucose transporters (Leese & Barton 1984, Pantaleon & 
Kaye 1998). 
 Two distinct families of glucose transporters are responsible for transfer of 
glucose across the plasma membrane: facilitative transporters (solute carriers SLC2A) 
and sodium-dependent transporters (sodium/glucose cotransporters SLC5A) (Wood & 
Trayhurn 2003).  SLC2A1, SLC5A1 and SLC5A11 are three transporters that have been 
identified in the ovine endometrium as well as the conceptus trophectoderm and 
endoderm; SLC5A1 and SLC2A1 are specific to the LE and sGE, while SLC5A11 is 
predominately found in the endometrial GE, and SLC2A3 is expressed by trophectoderm 
cells (Gao et al. 2009).  During early pregnancy, P4 induces expression of SLC2A1, 
responsive to P4 in ewes appears to be FGF10, which presumably mediates P4 actions 
on PGR-negative uterine epithelia that express their receptors (Satterfield et al. 2008).  
SLC5A1, and SLC5A11, and IFNT further stimulates SLC2A1 and SLC5A11 (Gao et al. 
2009).  Thus, P4 and/or IFNT induce expression of transporters that move glucose across 
the endometrium and into the uterine lumen to support conceptus growth and 
development. 
 
Cathepsins 
 Cathepsins are a family of lysosomal proteinases responsible for degradation of 
extracellular matrix molecules and influencing catabolism of intracellular proteins and 
pro-hormone processing (Kirschke H 1998).  Two members of the family, CST3 and 
CTSL1, are necessary for normal embryonic development and uterine decidualization in 
mice (Afonso et al. 1997).  Recent studies by Song and coworkers (Song et al. 2005) 
identified both cathepsins in the ovine endometrium, with CTSL expression abundant in 
the endometrial epithelia and conceptus trophectoderm during early pregnancy.  CST3 is 
expressed coordinately in the same tissues and is thought to control cathepsin actions 
during the peri-implantation period (Afonso et al. 1997).  In addition, both CTSL and 
CST3 are induced by P4 and stimulated by IFNT in the endometrial LE and sGE (Song 
et al. 2005, Song et al. 2006).  Because both cathepsins and their inhibitor CTSB are 
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primarily in intercaruncular endometrial glands and intercotyledonary placenta during 
later pregnancy, they are hypothesized to be involved in endometrial remodeling and 
placentation in sheep (Song et al. 2007).  
 
Radical s-Adenosyl Methionine Domain Containing 2 (RSAD2) 
RSAD2 is a cytoplasmic antiviral protein induced by Type I IFNs with the ability 
to prevent cells from being infected with human cytomegalovirus (Chin & Cresswell 
2001).  Produced in response to IFNs during viral infections, RSAD2 limits viral 
replication and modifies subsequent adaptive immunity (Katze et al. 2002, Helbig et al. 
2005).  During early pregnancy an antiviral state in the endometrium may be 
advantageous by blocking sexually transmitted viruses as well as modulating local 
immune cells to ensure acceptance of the allogenic conceptus and support conceptus 
survival and growth by stimulating production of cytokines (Hansen 1995, Tekin & 
Hansen 2002, Croy et al. 2003).  Endometrial RSAD2 in sheep increases between days 
12 and 16 of pregnancy, but not of the estrous cycle, with primary expression being in 
endometrial glands, stroma, and immune cells (Song et al. 2007b). 
 
ISG15 Ubiquitin-Like Modifier (ISG15) 
 This ubiquitin homolog is one of many classical interferon stimulated genes 
expressed in the uteri of ruminants in response to conceptus-derived IFNT, and it can 
also be found in decidual cells of pregnant humans and baboons (Bebington et al. 1999), 
the decidualized stroma and surrounding GE of pregnant mice (Austin et al. 2003), and 
in the endometrial stroma of pigs during the peri-implantation period (Joyce et al. 2003).  
In sheep, steady state levels of ISG15 mRNA decrease after Day 25 of pregnancy; 
however, ISG15 persists in the endometrium through Day 120, but is restricted to the 
maternal-placental interface (Joyce et al. 2005).  In several different mammalian species, 
ISG15 activity increases in the uterine endometria during pregnancy; therefore, ISG15 
may be part of a critical temporal and spatial response of the stroma as it prepares for 
embryo implantation and placentation (Joyce et al. 2005).  Bovine ISG15 has also been 
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shown to conjugate to intracellular proteins during pregnancy, suggesting its 
involvement in protein regulation critical for establishment and maintenance of 
pregnancy (Johnson et al. 1998). 
 
Gastrin-Releasing Peptide (GRP) 
 GRP, another secreted protein, is widely expressed in various mammalian organs 
such as the lung, pancreas, hypothalamus, anterior pituitary, and gastrointestinal tract 
(Patel et al. 2006), as well as the uteri of pregnant sheep (Fraser et al. 1994, Giraud et al. 
1994), cattle (Budipitoj et al. 2001, Budipitojo et al. 2003), and humans (Whitley et al. 
1996, Xiao et al. 1996).  Previous studies have identified GRP in the ovine endometrial 
glands and have implicated GRP as a potential regulator of fetal kidney growth and 
development (Whitley et al. 1996, Fleischmann et al. 2005).  While the major known 
role of GRP is to elicit the release of gastrin, GRP also can stimulate various lines of 
cancer cells to induce carcinogenesis both in vitro and in vivo (Patel et al. 2006).  
Biological roles of GRP include effects on cell morphogenesis, migration, adhesion, and 
angiogenesis (Martinez et al. 2005, Patel et al. 2006). 
 
Galectin 15 (LGALS15) 
Galectins are proteins with a conserved carbohydrate recognition domain (CRD), 
allowing them to bind glycoproteins and glycolipid receptors on the surface of cells and 
initiate biological responses (Cooper 2002, Yang & Liu 2003, Liu & Rabinovich 2005).  
Galectins play a functional role in cell adhesion, chemoattraction, migration, growth, 
differentiation, and apoptosis (Hughes 2001, Wang et al. 2004), all biological roles 
necessary for early blastocyst growth and differentiation (Guillomot 1995, Spencer et al. 
2004).  In sheep, LGALS15 mRNA is present in the endometrial LE and sGE after Day 
10 of pregnancy and is a P4 induced, IFNT stimulated gene (Gray et al. 2004, Satterfield 
et al. 2006).  The ovine LGALS15 protein contains predicted CRD, leu-asp-val (LDV), 
and arg-gly-asp (RGD) recognition sequences, which can bind and activate integrins 
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(Ruoslahti 1996), leading to stimulation of trophectoderm cell migration and attachment 
(Farmer et al. 2008). 
 
Insulin-Like Growth Factors 
Background 
 The IGF system is comprised of a complex network of ligands (IGF1 and IGF2), 
receptors (Type 1 IGFR and Type 2 IGFR), high affinity insulin-like growth factor 
binding proteins (IGFBPs), and specific proteases that regulate their biological activities 
(Jones & Clemmons 1995, Rajaram et al. 1997).  The IGFs share significant structural 
homology with insulin; however, unlike insulin, IGFs circulate in plasma complexed to a 
family of binding proteins that influence IGF actions (Rajaram et al. 1997).  IGFs 
control many important biological functions, such as placental, embryonic, and fetal 
growth (Osgerby et al. 1999).  Both IGF1 and IGF2 are involved in early embryonic 
development (Schultz & Heyner 1993, Giudice & Saleh 1995), and in vitro studies have 
demonstrated that IGF1 can enhance glucose uptake, protein synthesis, cell proliferation, 
and conceptus development (Harvey & Kaye 1992, Pantaleon & Kaye 1996, Herrler et 
al. 1998).  Additionally, IGF1 acts as a survival factor by decreasing apoptosis in 
numerous cell types (Giudice et al. 1998, Herrler et al. 1998).   
 Actions of both IGF1 and IGF2 are primarily mediated by the Type 1 IGF 
receptor (IGF1R), which is structurally similar to the insulin receptor.  In contrast, the 
Type 2 IGF receptor (IGF2R) is structurally distinct, binds primarily IGF2, and serves as 
a receptor for other mannose-6-phosphate containing ligands (Nissley & Lopaczynski 
1991).  While binding of IGFs to IGF1R activates a tyrosine kinase cell signaling 
pathway (Jones & Clemmons 1995), IGF2R lacks a signaling function but, removes 
excess IGF2 from the circulation (Kornfeld 1992) which can interfere with normal 
development (Filson et al. 1993).  While the role of IGF2R in mediating IGF actions is 
less clear, IGF2 can stimulate extravillous trophoblast cell migration in vitro by 
signaling through IGF2R (McKinnon et al. 2001).  
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IGFs in the Ovine Uterus 
 In sheep, components of the IGF system are located throughout the reproductive 
tract and the developing conceptus.  Caruncular and intercaruncular stromal cells express 
IGF1, while the LE and GE predominately express IGF1R (Satterfield et al. 2008).  
Lower levels of IGF1R are also present in the caruncular stroma and myometrium of the 
uterus and conceptus trophectoderm (Stevenson et al. 1994, Kim et al. 2008).  IGF2 
mRNA is present in the endometrium during the preimplantation period, specifically in 
the caruncles and, to a lesser extent, the surrounding endometrial stroma.  IGF2 levels 
are unaffected by day of pregnancy and or P4 treatment (Satterfield et al. 2008).  During 
the first half of gestation, IGF2 expression decreases after fetal interdigitation, but low 
levels of expression continue in the maternal caruncles.  Interestingly, expression is 
higher at the base of the maternal caruncle and lower near the fetal membranes, 
suggesting that fetal tissue may inhibit maternal expression of IGF2 in sheep (Reynolds 
et al. 1997).  Intense expression of IGF2 mRNA is also present in mesodermal tissue of 
the allantochorion, particularly at the tips of the invading villi, and may be playing a role 
in stimulating proliferation within the developing placentome (Reynolds et al. 1997).  It 
has been suggested that these high levels of IGF2 might be responsible for the 
downregulation of IGF1R in caruncles at the fetal-maternal interface (Papa et al. 1991) 
and shift localization to the deep uterine glands, which could influence secretion of 
histotroph into the uterine lumen (Wathes et al. 1998).  
 IGF2 has also been identified in uterine flushes and, along with IGF1, may 
regulate blastocyst growth and development (Ko et al. 1991, Kim et al. 2008).  IGF2 
levels are elevated on Days 12 to 14 of pregnancy (Ko et al. 1991).  Studies by Kim and 
coworkers (Kim et al. 2008) demonstrated that IGF2 stimulated activation of ERK 1/2 
and MAPK p38 phosphorylation in ovine trophectoderm cells, two pathways important 
in embryonic and placental development in other species (Wang et al. 2004, Daoud et al. 
2005).  Further, IGF2 increased migration of trophectoderm cells (Kim et al. 2008) and a 
combination of IGF1 and IGF2 promoted IFNT secretion by ovine conceptuses in vitro 
(Ko et al. 1991).  IGF1, IGF2, and IGF1R mRNAs are present in ovine preimplantation 
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embryos (Watson et al. 1994), perhaps to produce IGFs and respond to IGFs released by 
the oviduct or uterus. 
 
IGFs in the Bovine Uterus 
 The temporal and cell-specific patterns of expression of IGF mRNAs are similar 
in uteri of cattle and sheep, i.e., IGF1 is abundant in subepithelial stroma of 
intercaruncular and caruncular endometria, and IGF2 and IGF1R are present in deep 
endometrial stroma, caruncular stroma and myometrium (Robinson et al. 2000, 
Llewellyn et al. 2008).  IGF1, IGF2 and the IGF1R and IGF2R mRNAs have also been 
identified at all stages of bovine preimplantation embryos from mature oocyte to 
blastocyst (Watson et al. 1992), and IGF1R is also present in Day 15 elongated bovine 
conceptuses (Sawai et al. 2007). 
 IGF1 is one of the most studied regulatory molecules for the bovine pre-
implantation embryo.  In cattle, IGF1 is secreted by the oviduct (Pushpakumara et al. 
2002), uterine endometrium (Geisert et al. 1991), and embryo (Lonergan et al. 2000), 
and has receptors in the ovary (Perks et al. 1999), oviduct (Pushpakumara et al. 2002), 
uterus (Robinson et al. 2000), preimplantation embryo (Watson et al. 1992), and 
elongated conceptus (Bertolini et al. 2002).  Numerous in vitro studies have 
demonstrated positive effects of IGF1 on bovine pre-implantation embryonic 
development through modification of cellular physiology and increased cell survival 
(Matsui et al. 1997, Palma et al. 1997, Prelle et al. 2001).  Interestingly, pre-
implantation bovine embryos cultured with IGF1 are protected from stress, as IGF1 
blocks the induction of apoptosis and inhibition of development caused by elevated 
temperature (Jousan & Hansen 2004, Jousan & Hansen 2007).  IGF1 can also stimulate 
P4 production, which is important for maintaining production of IFNT by the conceptus 
(Einspanier et al. 1990, Sauerwein et al. 1992). 
 While IGF2 is also present in uterine flushes, its maximal values are from Days 0 
to 5 of the cycle (Ko et al. 1991).  IGF2 protein is also present in bovine conceptus 
trophectoderm, but is less abundant in the inner cell mass (Wang et al. 2009).  
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Supplementation of maturation medium for bovine oocytes with 20 ng/mL IGF2 or 
development medium with 100 ng/mL IGF2 benefited bovine preimplantation embryo 
development; however, excess IGF2 decreased the number of embryos developing to 
blastocysts in vitro (Wang et al. 2009). 
 
IGFs in the Porcine Uterus 
 Maintenance of pregnancy in pigs is dependent upon rapid expansion and 
elongation of conceptuses throughout the two uterine horns; however, unlike ruminants, 
pig conceptuses release estrogen (E2) as the maternal recognition signal of pregnancy on 
Days 11-12 (Bazer & Thatcher 1977, Geisert & Yelich 1997).  IGF1 synthesis and 
release are tightly correlated with the time of conceptus elongation (Simmen et al. 1992, 
Persson et al. 1997) and are thought to increase E2 synthesis by stimulating aromatase 
gene expression in the conceptus (Green et al. 1995).  Levels of endometrial IGF1 
mRNA peak on Day 12, but are undetectable by midgestation.  Interestingly, IGF1 
levels in the myometrium are greater during the preimplantation period when compared 
to the endometrium, and myometrial IGF1 remains detectable in later pregnancy 
(Simmen et al. 1992).  In addition, conceptus tissues constitutively express low levels of 
IGF1 during early pregnancy (Dominguez et al. 2003).   
 Endometrial IGF2 and IGF1R remain low and relatively invariant during the 
estrous cycle and early pregnancy of pigs (Simmen et al. 1992).  These low levels of 
IGF2 mRNA expression are characteristic of the uterine endometrium of pigs during 
implantation as both E2 and/or P4 can induce the accumulation of IGF1 mRNA in the 
pig uterus without affecting IGF2 levels (Simmen et al. 1990).  IGF2 increases with 
stage of pregnancy, however, and placental IGF2 levels are greater than either 
endometrial or myometrial IGF2 (Simmen et al. 1992).  
 Differential expression patterns of endometrial IGF1 and IGF2 in the pig suggest 
a preferential role for IGF1 during the preimplantation period and for IGF2 during 
postimplantation stages of conceptus development.  The pregnant uterus is the major site 
of IGF1 biosynthesis in pigs (Tavakkol et al. 1988) and high levels are also produced by 
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the oviduct (Wiseman et al. 1992).  Only at the time of implantation is there a notable 
induction of IGF2 mRNA in the endometria of pigs.  Therefore, IGF1 may function 
more in endometrial remodeling during the estrous cycle and implantation, while IGF2 is 
perhaps regulating growth and differentiation of the endometrium and placenta during 
fetal development (Simmen et al. 1992). 
 
IGFs in the Primate Uterus 
 IGF1 mRNA is expressed in mid- to late-proliferative and early-secretory phase 
endometria in humans (Giudice et al. 1993, Zhou et al. 1994).  IGF2 mRNA is highest 
in mid- to late-secretory phase human endometria and is suggested to be a 
progestamedin (Zhou et al. 1994, Giudice & Irwin 1999), and additional studies have 
implicated P4 in IGF2 regulation (Rutanen et al. 1997).  Both IGF1R and IGF2R are 
highly expressed in endometrial epithelia and to a lesser degree in the stroma, but do not 
change during the cycle (Zhou et al. 1994).  Thus, IGF actions in the endometrium are 
more likely regulated by their binding proteins, and not by their receptors. 
 IGFs are important mediators of metabolic function because they influence 
nutrient transfer across the placenta.  In cultured human trophoblasts, IGF1 can stimulate 
transport of both glucose and amino acids (Kniss et al. 1994).  In the human placenta, all 
mRNAs of the IGF system except IGF2 are expressed in a similar spatial pattern and 
relative abundance throughout gestation.  Both IGF1 and IGF2 show comparable tissue 
distribution, but IGF2 is more abundant than IGF1 at all gestational stages (Han et al. 
1996).  Of note, IGF2 is found in the villous cytotrophoblasts only during the first 
trimester of pregnancy, and the greatest concentrations are in invading cytotrophoblasts 
that must gain access to maternal blood vessels (Han et al. 1996). 
 
IGFs in the Rodent Uterus 
 In rodents, Igf1 mRNA is intensely expressed in the mesometrial decidua on Day 
10 of pregnancy (Correia-da-Silva et al. 1999) and may participate in endometrial 
stromal cell decidualization.  While Igf1 mRNA increases during the estrous cycle in 
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rodents (Murphy & Ghahary 1990), low levels of Igf2 are expressed in the uterus with 
no distinctive changes (Norstedt et al. 1989).  In placentae of rodents, Igf2 mRNA is 
expressed in all cellular elements of the labyrinth (Correia-da-Silva et al. 1999), 
trophoblast invading the decidua (Zhou & Bondy 1992), endothelial cells of fetal 
capillaries, mesenchymal cores of trabeculae (Correia-da-Silva et al. 1999), and fetal 
vessels of the placenta (Zhou & Bondy 1992).  Thus, IGF2 may be associated with both 
trophoblast invasion and growth of the fetal vasculature. 
 In mice, IGF1 mRNA increases during the estrous cycle (Murphy & Ghahary 
1990) and is expressed diffusely throughout decidua during implantation, with highest 
expression in the primary decidual zone (Kapur et al. 1992).  IGF2 is found in primitive 
endoderm and extra-embryonic mesoderm (Lee et al. 1990).  On Day 9.5 and 12.5, the 
spongiotrophoblast, which is homologous to the cytotrophoblast columns and shell in 
early human pregnancy, strongly expresses IGF2 (Redline et al. 1993).  IGF1R mRNA 
is present in endometrial epithelial cells of mice (Henemyre & Markoff 1999). 
 The preimplantation mouse embryo also expresses IGFs and their receptors.  
IGF2 and IGF2R mRNA are present in 2-cell mouse embryos, and the IGF1R in 8-cell 
embryos (Rappolee et al. 1992).  IGF1 mRNA is not expressed in preimplantation 
mouse blastocysts; however, maternally derived IGF1 within reproductive tract fluids 
may compensate for lack of this receptor (Smith et al. 1993).  This idea is supported by 
in vitro experiments in which IGF1 stimulated growth of mouse preimplantation 
embryos (Harvey & Kaye 1992) as well as proliferation and migration of ectoplacental 
cone cells (Kanai-Azuma et al. 1993).  
 Various gene knockout studies in mice have demonstrated the importance of 
IGFs and their receptors.  Igf1 (-/-) null mutant mice experience embryonic and postnatal 
growth restriction, with pups exhibiting a 40% reduction in birth weight (Baker et al. 
1993).  Igf2 (p-) null (paternally derived heterozygous) mutants are growth restricted at 
birth, but grow postnatally at a normal rate (Baker et al. 1993).  Mutagenesis of the 
Igf1R (-/-) results in more severely growth restricted fetuses because of loss of both 
IGF1 and IGF2 signaling (Liu et al. 1993).  Placental growth is impaired in Igf2 (p-) 
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mutant mice, but not until Day 13.5, suggesting its significance in placental growth 
(DeChiara et al. 1990, Baker et al. 1993).  Further, mice lacking Igf2R, which 
contributes to IGF2 turnover, but is not essential for IGF2 signal transduction, exhibit a 
25% increase in placental mass (DeChiara et al. 1990). 
 
The Insulin-Like Growth Factor Binding Protein Family 
Background 
 The IGFBP family consists of seven members that can modulate actions of IGFs, 
facilitate storage of IGFs in extracellular matrices, and/or exert IGF-independent effects 
(Rosenfeld et al. 1990, Shimasaki & Ling 1991, Rechler 1993) (Table 2.1).  The 
majority of circulating IGF1 and IGF2 are complexed to IGFBPs due to a higher affinity 
for these binding proteins than the IGF1R, thus preventing receptor association 
(Clemmons 1997).  Although IGFBPs limit IGF interactions with their receptors, 
IGFBPs can enhance IGF effects by slowly releasing IGFs for receptor interactions 
(Conover & Powell 1991) or targeting IGFs to specific tissues (Bar et al. 1990).  Post-
translational modifications of the IGFBPs can alter their affinity for IGFs and help 
maintain a large, stable reservoir of IGFs in a more favorable equilibrium with their 
receptors (Clemmons et al. 1995, Jones & Clemmons 1995).  For example, IGFBP 
phosphorylation increases its affinity for the IGFs, while proteolysis and glycosylation 
of IGFBPs decreases IGFBP binding to IGFs (Clemmons 1997). 
 The nomenclature used to distinguish the IGFBPs was developed from the 
historical order in which their sequences were identified.  IGFBP1 was the first to be 
purified and sequenced because of its abundance in amniotic fluid (Drop et al. 1984, 
Povoa et al. 1984), followed by the cloning and sequencing of rat IGFBP2 (Brown et al. 
1989).  IGFBP3 was next to be cloned and sequenced, and purified to homogeneity from 
human serum (Martin & Baxter 1986), with Shimasaki and coworkers (Shimasaki & 
Ling 1991) identifying the sequences of IGFBP4, -5 and -6.  Recently a new member of 
the family, IGFBP7, was identified and is under investigation for its roles in early 
pregnancy (Oh et al. 1996).  While all cells that have been examined synthesize at least 
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one form of IGFBP, patterns and combinations of synthesis vary among tissues and cell 
types.  Expression of IGFBPs changes significantly in many tissues during the transition 
from fetal life to adulthood (Clemmons 1997). 
 Binding proteins are components of uterine histotroph in ruminants (Bazer 1975), 
pigs (Bazer et al. 1991), and humans (Giudice et al. 1991).  IGFBPs 1-6 have previously 
been reported during early pregnancy in the ovine uterus (Stevenson et al. 1994, 
Reynolds et al. 1997, Wathes et al. 1998, Osgerby et al. 1999, Gadd et al. 2000, Gadd et 
al. 2002).  In sheep, Satterfield and coworkers (Satterfield et al. 2008) found mRNAs for 
IGFBPs 2, 4, 5, 6, and 7 in uterine stroma, most of which increased in ewes receiving 
RU486, a PGR antagonist, suggesting that P4 decreases expression of those stromal 
IGFBPs.  In contrast, IGFBP1 and IGFBP3 mRNA were upregulated in the ovine 
endometrial LE/sGE in the presence of P4, coincident with loss of PGR in the uterine 
LE/sGE (Spencer & Bazer 1995, Satterfield et al. 2008).  These results suggest that, 
unlike other binding proteins, epithelial-derived IGFBP1 and IGFBP3 have a biological 
role in the ovine uterus during the peri-implantation period of pregnancy and may be 
important for the events of conceptus elongation. 
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 Special features and Post- 
Translational Modifications 
IGF affinity Modulation of  
IGF action 
Biological Roles in Mammalsb 
IGFBP1 RGD sequencec, specifically 
binds α5β1 integrin 
Phosphorylation 
I = II Inhibition and/or 
potentiation 
Stimulates cell migration, limits trophoblast 
invasion 
 
IGFBP2 
 
RGD sequence 
Heparin binding if IGFs present, 
proteolysis 
 
II > I 
 
Inhibition and/or 
potentiation 
 
Pituitary development and transfer of IGFII to 
CSF, stimulates glucose transport 
 
IGFBP3 
 
Complexed to ALSc subunit to 
retain IGFs in serum 
N glycosylation, heparin binding, 
proteolysis 
 
I = II 
 
Inhibition and/or 
potentiation 
 
Prolongs half-life of IGFs, alters their 
interaction with cell surface receptors  
IGF independent actions 
 
IGFBP4 
 
2 extra cysteine residues 
N glycosylation, proteolysis 
 
I = II 
 
Inhibition 
 
Inhibits IGF-stimulated cell proliferation, 
Inhibitory effect relieved by proteolysis 
 
IGFBP5 
 
Protected from proteolysis when 
bound to IGFs 
O glycosylation, heparin binding 
 
 
II > I 
 
Inhibition and/or 
potentiation 
 
Localizes IGFI and IGFII in ECM, stimulates 
mitogenesis, inhibits cell growth in  
    ovary and kidney 
IGFBP6 2 fewer cysteine residues 
O glycosylation 
II > I Inhibition Regulates cell proliferation, differentiation,  
and transformation 
 
IGFBP7d 
 
Low affinity for IGFs 
 
I = II 
 
Inhibition 
 
Regulates cell proliferation, adhesion, 
angiogenesis 
aTable adapted from Rajaram et al. 1997 and Clemmons et al. 1997 
bBiological roles of IGFBPs 1-6 from Kelley et al. 1996 
cRGD, Arg-Gly-Asp; ALS, acid-labile α-subunit d 
IGFBP7 data obtained from Kim et al. 1997 and Tamura et al. 2007
Table 2.1. General characteristics of the insulin-like growth factor binding proteins and their biological roles in mammals a 
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Insulin-Like Growth Factor Binding Protein One 
Background 
 IGFBP1 is present in many biological fluids, including amniotic and seminal 
fluid, milk, urine, and serum, and also in many tissues including placentae (Kelley et al. 
1996).  It is synthesized most abundantly in the liver, but has been detected in uteri of 
cows, cats, rats, primates, and humans (Lee et al. 1997, Osgerby et al. 1999).  In serum, 
IGFBP1 is often phosphorylated (Fowler et al. 2000), which increases its affinity for 
IGF1 six-fold (Jones et al. 1991); thus, IGFBP1 can influence the ability of IGFs to bind 
IGF1R and either inhibit or potentiate IGF actions.  In experiments designed to mimic 
the normal physiological ratio of IGF1 to IGFBP1, IGFBP1 potentiates actions of IGF1.  
For example, when non-phosphorylated forms are added with a molar excess of IGF1, 
DNA synthesis is enhanced (Koistinen et al. 1990) as is wound healing (Jyung et al. 
1994, Tsuboi et al. 1995).  Conversely, addition of exogenous IGFBP1 decreases cell 
growth and/or inhibits differentiation of cells (Jones & Clemmons 1995). 
 
Interactions of IGFBP1 with Integrins 
 Unlike other IGFBPs, IGFBP1 contains an RGD sequence in the C-terminus that 
binds the α5β1 integrin heterodimer (Irwin & Giudice 1998, Gleeson et al. 2001).  
Integrins are dominant glycoproteins composed of non-covalently linked α and β 
subunits that bind to various ECM components and cell adhesion molecules (Giancotti & 
Ruoslahti 1999).  They play a central role in mediating adhesion, stabilizing adhesion 
through cytoskeletal reorganization, and transducing cellular signals through various 
signaling intermediates during implantation (Yoshinaga 1989, Burghardt et al. 1997, 
Giancotti & Ruoslahti 1999, Johnson et al. 2001).  Because integrins lack endogenous 
activity, they must interact with other catalytic molecules to initiate signaling to the cell 
interior (Juliano & Haskill 1993, Clark & Brugge 1995).  Binding of integrins to ligands 
leads to formation of focal adhesions in vitro (Kornberg et al. 1992) and to activation of 
members of the MAPK pathway, especially extracellular-regulated protein kinase (ERK) 
(Morino et al. 1995), as well as focal adhesion kinase (FAK) (Guan & Shalloway 1992).  
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The binding of IGFBP1 to the α5β1 integrin stimulates trophoblast cell migration in a 
RGD-dependent manner that is independent of effects of IGF1 (Irving & Lala 1995, 
Gleeson et al. 2001).  Various studies have demonstrated that cell migration is abrogated 
by mutation of the RGD domain in IGFBP1, as well as inhibition of the FAK and 
MAPK pathways (Jones et al. 1993, Gleeson et al. 2001). 
 
Integrins in Sheep 
 Both conceptus trophectoderm and endometrial LE in sheep express integrins 
(Johnson et al. 2001), which are essential for conceptus development and implantation 
(Burghardt et al. 2002).  Recent studies in sheep identified the presence of αv, α4, α5, β1, 
β3, and β5 mRNAs and proteins in endometria of both cyclic and pregnant ewes, and 
conceptus trophectoderm (Johnson et al. 2001).  These integrins are constitutively 
expressed on the apical portion of the LE, GE and conceptus trophectoderm, and do not 
increase during the peri-implantation period.  Unlike primates, in which integrins frame 
the window of implantation (Lessey et al. 1994), sheep may be more dependent on 
integrin access through downregulation of MUC1 (Johnson et al. 2001).  After MUC1 
declines, exposed integrins on the LE are hypothesized to bind RGD and non-RGD 
amino-acid sequences of proteins to participate in cytoskeletal reorganization events of 
conceptus elongation and migration (Burghardt et al. 2002). 
 
IGFBP1 Regulation 
 The IGFBP1 gene contains specialized regions that allow for regulation of 
IGFBP1 production, including a binding site for hepatic nuclear factor 1 (HNF1), 
glucocorticoid response elements (GREs) 1 and 2, a 3'-5'-cyclic adenosine 
monophosphate (cAMP) response element (CRE), and a steroid hormone response 
element (HRE) (Lee et al. 1997).  The effects of insulin, which can both inhibit and 
stimulate IGFBP1 secretion, are mediated through an insulin response element 
(Suwanichkul et al. 1994).  In the presence of insulin, IGFBP1 mRNA and protein 
production in human endometrial stromal cells is downregulated in a dose-dependent 
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manner (Powell et al. 1991).  Further, both insulin and IGF1 block a relaxin-mediated 
increase in decidual IGFBP1, possibly via a negative feedback mechanism to control 
cellular growth (Thraikill et al. 1990).  Insulin is also inhibitory in Hep G2 cultures but 
can stimulate the release of IGFBP1 in myocytes (McCusker & Clemmons 1988, 
Conover et al. 1989), suggesting cell type-specific regulation of IGFBP1 secretion.  
Conversely, IGFBP1 is stimulated by glucocorticoids (GCs) (Lee et al. 1993) and 
hypoxia (Tazuke et al. 1998) in hepatic cells, and by human chorionic gonadotropin 
(hCG) (Tang & Gurpide 1993) and interleukin 1 beta (IL1B) (Strakova et al. 2000) in 
endometrial stromal cells.  In vitro, IGFBP1 secretion is stimulated by IGF1 in liver 
explants (Binoux et al. 1984), myocytes (McCusker & Clemmons 1988), and human 
fibroblasts (Hill et al. 1989). 
 
IGFBP1 in the Ovine Uterus 
 IGFBP1 is abundant in the ovine uterus during both the estrous cycle and 
pregnancy (Wathes et al. 1998) and is localized to endometrial LE/sGE (Waites et al. 
1990) during the period of conceptus elongation.  IGFBP1 is highest during early 
pregnancy (Waites et al. 1990, Osgerby et al. 1999) and expression increases 
considerably between Days 9 and 12 of pregnancy.  In sheep, early P4 treatment 
beginning on Day 1.5 of pregnancy increases endometrial expression of IGFBP1 and 
blastocyst growth on Day 9, and advances the transformation from a spherical blastocyst 
to an elongated filamentous conceptus on Day 12 (Satterfield et al. 2008).  However, 
RU486 blocks these effects of P4 (Satterfield et al. 2008) and blastocysts do not survive 
(Satterfield et al. 2006).  Thus, IGFBP1 may mediate effects of P4 on blastocyst growth 
and development (Reynolds et al. 1997, Satterfield et al. 2008).  Interestingly, IGFBP1 
mRNA levels are higher in the gravid horn of unilaterally pregnant ewes (Osgerby et al. 
1999), suggesting a local effect of the conceptus and P4 on gene regulation. 
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IGFBP1 in the Bovine Uterus 
 Similar to sheep, IGFBP1 is expressed exclusively in the endometrial LE/sGE of 
cattle (Wathes et al. 1998, Robinson et al. 2000).  Expression increases between Days 8 
to 12 and peaks on Day 14, consistent with the early period of conceptus elongation 
(Robinson et al. 2000).  Increased expression of bovine endometrial IGFBP1 occurs 
when P4 levels are high.  Since the human IGFBP1 gene contains a P4 response element 
and ovine endometrial IGFBP1 is stimulated by P4, it is hypothesized that P4 increases 
IGFBP1 expression in the bovine endometrium (Lee et al. 1997, Tseng et al. 1997).  
However, low levels of IGFBP1 are also detectable during estrus when P4 is minimal 
(Robinson et al. 2000), suggesting that P4 is not the sole regulator of endometrial 
IGFBP1 expression. 
 
IGFBP1 in the Porcine Uterus 
 While IGFBP 2-6 are expressed in the pig endometrium, IGFBP1 is undetectable 
(Song et al. 1996, Robinson et al. 2000).  IGFBP2 is the most abundant binding protein 
in porcine endometria (Robinson et al. 2000) and, along with IGF2, increases with 
advancing stages of pregnancy (Simmen et al. 1992).  This variation suggests 
differences in either importance or functions of IGFBP1 among species. 
 
IGFBP1 in the Primate Uterus 
 Unlike ruminants, successful implantation, placental development and 
subsequent fetal growth in primates and rodents requires adequate invasion of the 
intermediate trophoblasts into the maternal decidua to gain access to maternal blood 
vessels (Nayak & Giudice 2003).  Differentiation of the uterine endometrial stromal cells 
to decidual cells occurs after establishment of pregnancy.  These decidual cells are 
imperative for proper implantation and nutritional support for the embryo, as they 
produce factors that promote trophoblast invasion and modulate the maternal immune 
system to prevent rejection of the conceptus allograft (Bell 1983, Hunt et al. 2000). 
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 IGFBP1 is present in human decidua, placenta, and fetal membranes (Hill et al. 
1993), as well as in uterine epithelia and a small population of stromal cells during the 
late secretory phase (Zhou et al. 1994).  During implantation in primates, IGFBP1 is the 
most prevalent IGF binding protein in the uterus and is thought to facilitate trophoblast 
penetration at the maternal interface (Tarantino et al. 1992, Han et al. 1996).  IGFBP1 is 
secreted primarily by decidualized endometrial cells (Koistinen et al. 1986) and its 
concentration increases in maternal circulation during pregnancy (Drop et al. 1984b).  
High levels of IGFBP1 are also present in amniotic fluid (Drop et al. 1984a), and fetal 
plasma (Drop et al. 1984b).  In non-human primates, endogenous E2 and P4 act 
synergistically to increase concentrations of IGFBP1 in blood and results of in vitro 
studies demonstrated that P4 is required for endometrial stromal cells to synthesize and 
secrete IGFBP1 (Richards et al. 1995).  
 Human implantation is a complex process that is similar to tumor invasion, as it 
involves proteolysis of the ECM, cellular attachment and migration, as well as inhibition 
of these processes (Stetler-Stevenson et al. 1993).  IGFBP1 is proposed to mediate the 
events of implantation because it has both pro- and anti-invasive roles in terms of human 
cytotrophoblast invasion.  IGFBP1 may act independently of IGFs via binding of its 
RGD sequence to the α5β1 integrin heterodimer, which is uniquely expressed by the 
invading trophoblast (Fisher & Damsky 1993).  It is hypothesized that when IGFBP1 
binds this specific integrin heterodimers it inhibits fibronectin (FN), another RGD ligand 
in the placenta that favors the α5β1 integrin.  Inhibition of FN leads to improved cell 
detachment and potentiates invasion (Irwin & Giudice 1998).  In addition, binding of the 
RGD sequence to the α5β1 integrin stimulates human trophoblast cell migration (Jones 
et al. 1993, Irving & Lala 1995) via the MAPK pathway (Gleeson et al. 2001). 
IGFBP1 binding to the α5β1 integrin heterodimer is conducive to trophoblast 
invasion in humans.  However, maternal IGFBP1 can also inhibit cytotrophoblast 
invasion.  Metalloproteinases (MMPs), which digest the ECM of maternal tissue and 
favor invasiveness of tumor cells, are expressed by human cytotrophoblasts in vivo 
(Polette et al. 1994) and in vitro (Fisher et al. 1989).  In contrast, tissue inhibitor of 
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metalloproteinases (TIMPs) inhibit the invasiveness of cytotrophoblast cells (Librach et 
al. 1991).  IGFBP1 can stimulate TIMP1 secretion by cytotrophoblasts (Bischof et al. 
1998), thus providing a maternal restraint on invasion.  IGFBP1 may also restrict 
trophoblast migration and invasion by preventing IGF interactions with cell surface 
receptors (Lee et al. 1997).  Cytotrophoblast invasion is limited when co-cultured with 
human endometrial stromal cells, which produce inordinate amounts of IGFBP1 when 
decidualized in vitro (Irwin & Giudice 1998).  Moreover, excessive concentrations of 
IGFBP1 in human maternal and fetal serum have been implicated in shallow 
cytotrophoblast invasion, resulting in preeclampsia and underweight offspring (Giudice 
et al. 1997). 
 
IGFBP1 in the Rodent Uterus 
 The preimplantation rat uterus expresses Igfbp1 in the deep GE on Day 3.5, but 
only minimal expression in LE and sGE (Cerro & Pintar 1997).  By Day 7 the LE and 
GE express Igfbp1, and as decidualization proceeds, Igfbp1 mRNA expression remains 
high in uterine epithelia of inter-implantation sites, but is undetectable in epithelia 
surrounding the decidua (Cerro & Pintar 1997).  Decidualization, however, is a 
progressive process that begins at the LE and moves to the myometrium (Krehbiel 
1937).  Since Igfbp1 follows an opposite pattern of expression, it may be more involved 
in pre-decidual transformation of the rat uterus (Cerro & Pintar 1997). 
 In the mouse uterus, Damario and coworkers (Damario et al. 1998) first detected 
IGFBP1 on Day 1.5 postcoitum in LE, GE and decidual stroma, with greater staining in 
GE compared to LE (Damario et al. 1998).  By Day 7.5 to 8.5, moderate staining was 
present in decidualized stromal cells at implantation sites, with lighter staining 
throughout the non-implantation decidua.  Intense decidual stromal staining was 
localized immediately adjacent to the conceptus and implantation site, and by Day 9.5 to 
10.5 a dense band of IGFBP1 comprised of maternal placenta and the adjacent decidua 
was evident (Damario et al. 1998).  Presence of an embryo increased IGFBP1 protein in 
murine uterine epithelia (Damario et al. 1998), as well as IGFBP1 mRNA expression in 
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endometrial stromal cells on Days 3, 5, and 8 of culture (Soong et al. 1998).  Thus 
IGFBP1 is likely playing a role in decidualization and regulation of implantation in mice 
and is stimulated by factors from the conceptus (Soong et al. 1998). 
 Transgenic mice overexpressing Igfbp1 have reduced brain size, somatic growth 
retardation, alterations in glucose homeostasis, and decreased reproductive performance 
including impaired fertility, implantation, and interrupted or prolonged pregnancies that 
result in fetal and neonatal death (Gay et al. 1997).  Interestingly, Igfbp1 -/- mice are 
phenotypically indistinguishable from wild-type or heterozygous littermates, with no 
embryonic lethality or significant developmental defects.  Adult mice of both sexes are 
fertile, produce a normal litter size, and females can lactate (Leu et al. 2003a).  
However, Igfbp1 knockout mice suffer from massive hepatic apoptosis, indicating that 
Igfbp1 may function as a critical survival factor in the liver via its regulation of integrin-
mediated signaling (Leu et al. 2003b). 
 
Insulin-Like Growth Factor Binding Protein Three 
Background 
 IGFBP3, the most abundant binding protein in human serum, exists in various 
glycosylated forms between 40 and 44 kDa (Butt & Williams 2001).  Circulating 
IGFBP3 originates mainly from hepatic nonparenchymal cells, with insulin being 
responsible for increased gene transcription (Kelley et al. 1996).  Concentrations of 
IGFBP3 in blood are regulated by age, nutrition, and various hormones, primarily 
growth hormone (Rechler 1993).  Approximately 75% of the IGFs in blood are bound to 
IGFBP3 in a high molecular weight ternary complex that includes an acid-labile subunit 
(ALS) responsible for prolonging the half-lives of IGFs (Baxter & Martin 1989).  While 
free IGFBP3 is cleared from serum, the ALS/IGFBP3/IGF complex is present at high 
levels in serum (Clemmons 1997). 
 IGFBP3 binds both IGF1 and IGF2 with high affinity (Cubbage et al. 1990) and 
must be degraded by serine and/or metal dependent enzymes, such as plasmin, cathepsin 
D (CTSD), matrix metalloproteinases (MMPs), and prostate specific antigen, to increase 
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IGF availability (Giudice 1995, Maile et al. 1998).  Recent studies have identified an 
interaction between IGFBP3 and numerous molecules that may bind IGFBP3, thus 
regulating its action on cells.  These include transferrin (Weinzimer et al. 1999), type 1 
alpha collagen (Liu et al. 1999), heparin (Yang et al. 1996b), and the latent TGFB 
binding protein (LTBP1) (Xu & Murphy 1998). 
 
IGFBP3 Action 
 IGFBP3, which contains a nuclear localization sequence, can translocate to the 
nucleus and either directly control gene expression or exert IGF-independent actions 
(Jaques et al. 1997, Schedlich et al. 1998).  In addition, IGFBP3 has the ability to both 
potentiate and inhibit IGF actions.  Demello and Baxter (De Mellow & Baxter 1988) 
first reported that IGFBP3 associated with cell surfaces could stimulate DNA synthesis 
in human fibroblasts; however, pre-incubation of the cultures with IGFBP3 prior to 
addition of IGF1 was required.  Thus, it was hypothesized that IGFBP3 induced 
modifications in IGF1R activity since IGF1R downregulation was prevented by pre-
incubation with IGFBP3 (Conover 1992), which is a possible mechanism whereby 
IGFBP3 enhances the effects of IGF1 (Clemmons 1997).  Further, co-incubation of 
IGF1 and IGFBP3 potentiates the effect of IGF1 on alpha-aminoisobutyric acid (AIB) 
uptake in rat osteoblasts (Ernst & Rodan 1990) and increases DNA synthesis by 90% in 
baby hamster kidney (BHK) fibroblast cells (Blum et al. 1989).  IGFBP3 and IGF1 also 
accelerate wound healing in rats (Sommer et al. 1991) and stimulate growth and an 
increase in bone mineral density in ovariectomized rats (Bagi et al. 1994). 
 IGFBP3 can also inhibit growth and induce apoptosis through its ability to bind 
IGFs. When bound to IGF1, IGFBP3 modulates the amount of IGF1 available for 
receptor binding (McCusker et al. 1991).  The addition of excess IGFBP3 inhibits IGF1-
stimulated DNA synthesis in cultured fibroblasts (Blat et al. 1989, Villaudy et al. 1991), 
as well as IGF1-stimulated steroidogenesis and cAMP generation in rat granulosa cells 
(Bicsak et al. 1990).  Studies by Lee and Cohen (Lee & Cohen 2002) demonstrated that 
IGFBP3 forms a complex with the retinoid X-receptor (RXR) homodimer that induced 
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gene transcription, leading to apoptosis in cancer cells.  In the prostate carcinoma cell 
line PC-3, Rajah et al. (Rajah et al. 1997) verified both a dose-dependent induction of 
apoptosis in response to the addition of recombinant IGFBP3 that was independent of 
effects of IGFs.  
 While IGFBP3 affects cell growth and DNA synthesis in the presence of IGF1, 
IGFBP3 also has direct effects in the absence of IGF1.  IGFBP3 cDNA inhibited DNA 
synthesis independent of IGF1 after it was transfected into Balb/c3T3 cells (Cohen et al. 
1993).  Effects of FSH on granulosa cell functions were attenuated by IGFBP3 directly, 
thus negating a response of mouse embryo fibroblasts to either serum or fibroblast 
growth factor (Blat et al. 1989, Liu et al. 1992).  Further, the inhibitory effects of 
TGFB1 on breast carcinoma cell division is mediated through induction of IGFBP3 (Oh 
et al. 1993a), and these actions may be controlled by a cell-surface receptor specific for 
IGFBP3 (Oh et al. 1993b). 
 The local microenvironment can also affect actions of IGFBP3.  In a neutral 
environment, IGFBP3 blocks IGF1-stimulated [3H]-aminobutyric acid uptake, but in an 
acidic environment IGFBP3 stimulates effects of IGF1 (Conover et al. 1996).  Because 
cell membranes of conceptuses are acidic due to high levels of sialic acid (Denker & 
Gerdes 1979, Oriol et al. 1993), IGFBP3 may attract maternal IGF1 to the conceptus and 
potentiate its actions.  Studies in the horse and rabbit identified IGFBP3 in close 
proximity to the extraembryonic matrices where it may accumulate maternal IGFs to 
promote development of the conceptus by controlled release of IGFs (Herrler et al. 1997, 
Herrler & Beier 2000, Herrler et al. 2002).  IGFBP3 may also contribute to early 
embryonic development, since human embryos co-cultured with the high levels of 
IGFBP3 and Vero cells (derived from kidney epithelial cells of the African Green 
Monkey) were the most developed (Menezo et al. 1990, Lai et al. 1996).  
 
Proteolysis of IGFBP3  
 A large number of IGFBP3 fragments have been found in close association with 
the conceptus in ovine uterine luminal fluid.  Studies in sheep determined this 
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fragmentation to result from actions of maternal IGFBP proteases (Peterson et al. 1998b) 
that release IGFs into the environment.  Two types of fragments have been identified; 
one has a weak affinity for IGF1 and is thus a weak antagonist of IGF action, and the 
other lacks affinity for IGFs but inhibits IGF-stimulated mitogenesis through an IGF-
independent mechanism (Lalou et al. 1996).  Others have demonstrated that IGFBP3 
fragments, but not intact IGFBP3, bind and block insulin action (Yamanaka et al. 1997, 
Vorwerk et al. 1998).  While IGFBP3 has many well-established roles in IGF regulation, 
potential functions in conceptus elongation require further study. 
 
IGFBP3 in the Ovine Uterus 
 IGFBP3 is expressed in endometria of sheep (Reynolds et al. 1997, Peterson et 
al. 1998a) and is the predominant IGFBP in the uterine lumen (Peterson et al. 1998b).  
While high levels of IGFBP3 mRNA are found in specific regions of the LE during the 
preimplantation period and increase in the caruncular stroma following fetal villi 
penetration, the majority of expression is in the wall of maternal blood vessels (Reynolds 
et al. 1997).  Further work by Satterfield and colleagues (Satterfield et al. 2008) 
localized IGFBP3 mRNA to ovine uterine LE and sGE and found that expression 
increased substantially between Days 9 and 12 of pregnancy, and further on Day 9 in 
response to early P4 beginning on Day 1.5 post-mating; however, IGFBP3 decreased on 
Day 12 in ewes receiving a combination of P4 and RU486.  Further, early P4 treatment 
increased blastocyst growth on Day 9 and advanced the transformation from a spherical 
blastocyst to an elongated filamentous conceptus on Day 12 (Satterfield et al. 2008), 
implicating IGFBP3 in stimulation of conceptus elongation. 
 Similar to IGFBP1, ovine IGFBP3 may mediate effects of P4 on blastocyst 
growth and development (Reynolds et al. 1997, Satterfield et al. 2008).  Within the 
uterine lumen, IGFBP3 exists primarily in a fragmented form between Days 12 and 15 
of pregnancy, perhaps to increase availability of IGFs for actions on the elongating 
conceptus.  Interestingly, ovariectomized ewes treated with P4 for 10 days exhibited 
increased proteolytic activity; however, by Day 15 of P4 treatment, proteolytic activity 
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decreased in uterine luminal fluid, suggesting upregulation of an unidentified inhibitor 
(Peterson et al. 1998b).  Treatment of ewes with estradiol down-regulated IGFBP3 
expression in the endometrium; therefore, low levels of IGFBP3 in the uterine lumen 
early in the estrous cycle may be due to high levels of estradiol in plasma during this 
period (Peterson et al. 1998a). 
 
IGFBP3 in the Bovine Uterus 
 Robinson and coworkers (Robinson et al. 2000) evaluated IGFBP3 mRNA 
expression during the bovine estrous cycle and pregnancy.  Expression was detected 
specifically in the sub-epithelial stroma, LE and GE (Robinson et al. 2000).  There was 
no significant change in endometrial IGFBP3 mRNA during the estrous cycle, indicating 
that ovarian steroid hormones do not regulate expression of IGFBP3 (Robinson et al. 
2000).  IGFBP3 mRNA was also moderately expressed in the caruncular stroma on Day 
16 of pregnancy and may modulate effects of IGF2 on caruncular development 
(Robinson et al. 2000).  Similar to results of Keller and coworkers (Keller et al. 1998), 
IGFBP3 mRNA was lower on Day 16 of pregnancy and not different from values for 
inseminated non-pregnant cows (Robinson et al. 2000).  Lower IGFBP3 expression in 
pregnant heifers led to the hypothesis that a factor(s) from bovine conceptuses may 
reduce IGFBP3 expression, thus increasing mitogenic action of IGFs on the endometrial 
stroma (Cerro & Pintar 1997).  IGFBP3 has also been identified in vascular endothelial 
cells (Keller et al. 1998), myometrium and oviduct (Kirby et al. 1996), as well as the 
pre-implantation bovine conceptus (Winger et al. 1997), and is the most abundant 
IGFBP in the uterine lumen during early pregnancy (Keller et al. 1998). 
 
IGFBP3 in the Porcine Uterus 
 In pigs, IGFBP3 is the most prevalent IGF binding protein within the uterine 
lumen during the estrous cycle and pregnancy in pigs (Geisert et al. 2001).  IGFBPs are 
first detected on Day 10, but are very low to undetectable by Day 12, coinciding with the 
morphological transition of conceptuses from spherical to filamentous forms (Lee et al. 
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1998).  Further, proteolytic activity is detected in the uterine luminal fluid of 
filamentous, but not spherical conceptuses, indicating the importance of IGFs during 
elongation of porcine conceptuses (Lee et al. 1998).  While IGFBP3 is undetectable by 
Day 12, IGFBP3 mRNA remains constitutive in the uterine endometrium, indicating that 
loss of IGFBP3 in uterine luminal fluid is most likely due to IGFBP-specific proteolysis 
or activity of estrogens secreted by conceptuses (Lee et al. 1998). 
 
IGFBP3 in the Primate Uterus 
 IGFBP3 is found in endometria of humans (Giudice et al. 1991) in a small 
population of decidual cells, as well as in certain intermediate trophoblast cells of the 
basal plate, anchoring villi of placenta, mesodermal core, amnion and chorion (Han et al. 
1996).  In humans, IGFBP3 levels decrease as gestation progresses and by eight weeks 
of gestation it is barely detectable (Giudice et al. 1990).  Because IGF distribution does 
not change during human pregnancy but IGFBP3 levels decrease, it is thought that 
altered IGFBPs carry IGFs, but with a lower affinity, thus allowing the developing 
conceptus access to IGFs (Davies et al. 1991a).   
 Proteolytic activity of IGFBP3 was first identified in plasma and serum of 
pregnant women (Giudice et al. 1990, Hossenlopp et al. 1990), and in patients in various 
catabolic states including post-operative recovery after major surgery, severe illness, 
growth hormone-resistant and -deficient states, malignancies and malnutrition (Davies et 
al. 1991b, Davenport et al. 1992a, Fielder et al. 1992, Muller et al. 1993).  In humans, 
IGFBP3 proteolysis is evident at six weeks of gestation and persists through pregnancy, 
but is undetectable by Day 5 postpartum, consistent with the notion that proteolysis 
requires the presence of trophoblast (Giudice et al. 1990).  The placenta is hypothesized 
to regulate proteolysis (Wiesli et al. 2006) since isolated human placental trophoblasts 
produce a neutral IGFBP3 protease with characteristics similar to activity in pregnancy 
serum (Irwin et al. 2000).  Both syncytiotrophoblast and extravillous trophoblast may be 
sources of IGFBP3 protease, as both are in direct contact with maternal blood and 
secrete products into the maternal circulation.  Further, IGFBP3 protease activity 
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increases with both gestational age and fetal number, indicating a direct correlation 
between placental tissue mass and protease activity in maternal serum (Irwin et al. 
2000).  However, IGFBP3 protease activity is absent from fetal serum (Bang et al. 1994, 
Giudice et al. 1995). 
 
IGFBP3 in the Rodent Uterus 
 In the rat uterus, Igfbp3 is detected on Day 3.5 in scattered stromal cells, but as 
decidualization proceeds, expression shifts to the LE (Cerro & Pintar 1997).  After 
implantation, Igfbp3 is found in non-decidualized stromal cells adjacent to the LE with 
very strong expression in sub-luminal stromal cells near the decidua.  By Day 7 an 
intense ring is detectable throughout non-decidualized stromal cells surrounding the anti-
mesometrial decidua; expression extends mesometrially by Day 11.5, possibly to buffer 
effects of IGF on LE and decidua (Cerro & Pintar 1997). 
 As pregnancy proceeds and the decidua cells proliferate, the uterine vasculature 
undergoes remodeling.  Igfbp3 mRNA is abundant in the capillary plexus, which 
surrounds the primary decidual zone.  By Day 11.5, expression is strong in cells that line 
sinusoids in decidua (Cerro & Pintar 1997), indicating that Igfbp3 is associated with 
development of the uterine vasculature.  IGFBP3 is the most abundant binding protein in 
the placenta and uterus on Day 12 of pregnancy, but is undetectable by Day 18 
(Davenport et al. 1992).  Proteolytic activity has been detected in rat serum between 
Days 12 and 15 of pregnancy, corresponding with the dramatic decrease in serum 
IGFBP3 (Davenport et al. 1990).   
 In mice, Igfbp3 mRNA expression is strong in the LE, weaker and more diffuse 
in the stroma, but greater on the anti-mesometrial side where the blastocyst attaches.  
This expression is similar but less intense in pseudopregnant animals (Sherwin et al. 
2004).  After implantation, Igfbp3 mRNA is strong in the primary zone of 
decidualization immediately surrounding the implanting blastocyst and in the LE, and is 
possibly mediated by local embryo-derived factors (Sherwin et al. 2004). 
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 Igfbp3 expression decreases in response to both E2 and P4, but increases in 
response to leukemia-inhibitory factor (LIF), a cytokine important for murine 
implantation (Sherwin et al. 2004).  Igfbp3 mRNA is first observed on Day 3 of 
pregnancy before endogenous LIF on Day 4, which may represent actions of nuclear 
receptor subfamily 3, group C, member 1 (glucocorticoid receptor) (NR3C1) (Cheon et 
al. 2003).  Thus, the intense expression of Igfbp3 on Day 4 in the LE may require a 
combination of LIF and P4 (Sherwin et al. 2004). 
 While Igfbp3 protein is not detected on Day 3.5 postcoitum in mice, by Day 7.5-
8.5 moderate staining is present in decidualized stromal cells at the implantation site 
(Damario et al. 1998).  By Day 9.5-10.5, a thick band of immunostaining is evident in 
the maternal surface of the placenta and adjacent decidua (Damario et al. 1998).  As in 
other primates, proteolytic activity has been detected in the mouse uterus (Fielder et al. 
1990).  Igfbp3 levels gradually decrease during gestation and are undetectable in serum 
by Day 10 (Fielder et al. 1990).  Inactivation of Igfbp3 in mice does not result in a 
phenotype different from control mice (Schneider et al. 2000), but ALS null mice 
experience a post-natal growth defect after three weeks with a 62 to 88% reduction in 
Igfbp3 concentrations in plasma (Ueki et al. 2000). 
 
Hydroxysteroid (11-Beta) Dehydrogenases -1 and -2 
Background 
 HSD11B1 is a member of the short-chain dehydrogenase/reductase (SDR) family 
of oxidoreductases (Oppermann et al. 2001) that generally catalyze NADPH-dependent 
reactions with substrates including polyols, retinoids, steroids, and xenobiotics (Bray et 
al. 2008).  The presence of one or more amino-terminal transmembrane domains makes 
the HSD11Bs unique from other HSD family members (Tomlinson et al. 2004).  Both 
HSD11B1 and HSD11B2 are responsible for the interconversion of active cortisol 
(humans) or corticosterone (mice and rats) and inactive cortisone (Stewart & Krozowski 
1999).  HSD11B1 activity is bidirectional; however, it has a higher affinity for cortisone 
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than for cortisol, causing it to act primarily as a reductase to generate active cortisol 
(Alfaidy et al. 2003). 
The expression of HSD11B1 is widespread throughout the body, with the liver being 
the major site of enzyme production (Agarwal et al. 1989, Yang et al. 1992).  HSD11B2, 
an exclusive oxidase, is localized to the placenta to protect the fetus from excess 
glucocorticoids (GCs) (Sun et al. 1999).  HSD11B2 activity is thought to regulate both 
the transplacental passage of maternal GCs to the fetus (Yang 1997) and access of GCs 
to their intracellular receptors (Burton & Waddell 1999), since both excessive and 
inadequate GC exposure in utero are detrimental to fetal development (Reinisch et al. 
1978, Mosier et al. 1982). 
 While HSD11B2 serves as a protective enzyme to regulate corisol levels, the 
significance of HSD11B1 and cortisol production in early pregnancy is a more recent 
area of interest.  Cortisol regulates many of the processes required for successful 
implantation of blastocysts, as well as subsequent growth and development of the 
conceptus; however, actions of GCs are balanced between positive effects promote 
pregnancy versus adverse effects that compromise the pregnancy (see (Michael & 
Papageorghiou 2008) for review).  In later pregnancy, prostaglandins (PGs) increase the 
activity of HSD11B1 and subsequent cortisol production (Challis et al. 1997).  As a 
result, the relationships between HSD11B1, cortisol, and PGs in the induction of 
HSD11B1 expression during early pregnancy are being evaluated in primates and 
livestock (Klemcke et al. 2003, Tomlinson et al. 2004, Draper & Stewart 2005). 
 
HSD11B1 and HSD11B2 in the Ovine Uterus 
 In sheep, HSD11B1 is expressed in the endometrium during both the estrous 
cycle and pregnancy (Yang et al. 1996), as well as in the endometrium and, to a lesser 
extent, in myometrium of pregnant sheep at term (Yang et al. 1995).  HSD11B1 
expression is localized exclusively to the LE throughout pregnancy (Yang et al. 1996a) 
and may regulate GCs which, in turn, could impact local PG and peptide production as 
well as fetal growth and maturation (Liggins 1976). 
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 In late pregnancy, fetal cortisol acts at levels of intrauterine tissues to alter 
steroidogenesis and induce upregulation of prostaglandin-endoperoxide synthase 2 
(prostaglandin G/H synthase and cyclooxygenase) (PTGS2) expression within 
trophoblast cells, leading to increased PG production (Challis et al. 1997) (Fig. 2.6).  
PGs can then stimulate HSD11B1-induced cortisol production which leads to a decline 
in P4 and an increase in E2.  Higher E2 levels initiate specific contraction-associated 
proteins (CAPs) within the myometrium that permit myometrial contractions in response 
to PG and oxytocin (Lye 1994), allowing for induction of labor.  Progesterone is 
hypothesized to regulate HSD11B1 mRNA expression throughout gestation and after 
parturition.  HSD11B1 mRNA in the endometrium is undetectable in cycling ewes until 
Day 10 of the late luteal phase, when circulating levels of P4 are elevated.  Further, 
HSD11B1 mRNA is undetectable in either myometrial or endometrial tissue at three 
months postpartum, possibly due to low P4 levels (Challis et al. 1997).  Induction of 
HSD11B1 when P4 levels increase supports the idea of HSD11B1 persisting through 
pregnancy. 
 
HSD11B1 and HSD11B2 in the Bovine Uterus 
 HSD11B1 and HSD11B2 mRNAs have also been identified during early 
pregnancy in endometria of cattle (Lee et al. 2007, Komiyama et al. 2008), which 
suggests a role for GCs in endometrial and conceptus development.  Endometrial 
HSD11B1 mRNA is low during the estrous cycle and luteal phase, but increases during 
the follicular phase; however, HSD11B2 mRNA is lowest during the follicular phase 
(Lee et al. 2007).   
 Increased levels of HSD11B1 mRNA and bioactivity are temporally coincident 
with an increase in basal release of PGF2α, but not PGE2, during the estrous cycle 
(Miyamoto et al. 2000, Murakami et al. 2001).  Using cultured bovine endometrial cells, 
Lee and coworkers (Lee et al. 2008) found that PGF2α stimulated HSD11B1 bioactivity 
and protein expression in a dose-dependent manner.  When cultured with indomethacin, 
a non-specific inhibitor of PTGS1 and PTGS2, HSD11B1 bioactivity and PGF2α levels 
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Fig. 2.6. Endocrine events at the onset of ovine parturition. Fetal cortisol increases placental 
trophoblast expression and activity of PTGS2 leading to PGE2 production. Placental PGE2 in 
turn mediates an autocrine/paracrine increase in placental P450C17 expression/activity resulting 
in a surge in placental estrogen production that is superimposed on a gestation-dependent 
increase in estrogen output. Placental PGE2 is also secreted into the fetal compartment where it 
acts to sustain fetal HPA axis activation. Estrogen upregulates the expression of maternal 
endometrial PTGS2, leading to increased PGF2α output and also induces the expression of 
CAPs. Consequently, myometrial contractility is stimulated and labor and delivery of the fetus 
ensues (Whittle et al. 2001). 
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decreased.  HSD11B1 bioactivity was restored, however, when co-cultured with PGF2α, 
indicating a suppressive effect of indomethacin on HSD11B1 activity was mediated by 
the decrease in endogenous PG production (Lee et al. 2008).  Thus, PGF2α may be 
exerting direct stimulatory effects on HSD11B1 bioactivity. 
 Because high levels of PGF2α are believed to cause premature luteolysis and 
early embryonic loss (Adams et al. 1987), the authors suggest that activation of 
HSD11B1 by PGF2α and subsequent cortisol production may be a protective 
mechanism against excessive PGF2α production (Lee et al. 2008).  In the non-pregnant 
bovine endometrium, cortisol suppresses basal PGF2α production and tumor necrosis 
factor-stimulates both PGE2 and PGF2α production by endometrial stromal cells, thus 
initiating a negative feedback loop between local PG production and cortisol synthesis 
(Lee et al. 2007).  The inhibitory effect of cortisol on PGF2α production in bovine 
endometrial stromal cells, as well as the stimulatory effect of GCs during pregnancy, 
suggests that reproductive status alters the interaction of GCs and PGs in the uterus 
(Alfaidy et al. 2001, Lee et al. 2008). 
 
HSD11B1 and HSD11B2 in the Porcine Uterus 
 At Day 75 of gestation, Klemcke and coworkers (Klemcke 2000) first identified 
both HSD11B oxoreductase and dehydrogenase activities, with dehydrogenase activity 
5-fold greater than oxoreductase activity.  They also noted a significant positive linear 
association between net dehydrogenase activity and fetal/placental size.  HSD11B1 and 
HSD11B2 mRNAs were also identified during early pregnancy in porcine placentae 
(Klemcke et al. 2003).  While HSD11B2 mRNA and enzymatic activity were present in 
porcine placentae as early as Day 24 of gestation, placental HSD11B1 mRNA was 
absent on Day 24.  Both isoforms increased during gestation, as did dehydrogenase 
activity (Klemcke & Christenson 1996, Klemcke et al. 2003).   
 Since HSD11B2 is proposed to act as a placental barrier, levels of fetal cortisol 
were analyzed and, as expected, the percentage of fetal cortisol contributed by the 
maternal compartment decreased from 22.8% at Day 50 of gestation to 5.9% at Day 100 
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in piglets (Klemcke 1995).  HSD11B2 activity was greater in crowded than in a roomy 
uterine environment, and placental activity from male fetuses was sometimes greater 
than in female fetuses, indicating a fetal influence on HSD11B2 activity (Klemcke & 
Christenson 1996).  Cortisol was also detected in the porcine embryo as early as Day 25, 
and levels increased 8-fold by Day 35 (Klemcke et al. 1999). 
 
HSD11B1 and HSD11B2 in the Primate Uterus 
 HSD11B1 mRNA is expressed at low, invariable levels between the proliferative 
and secretory phases, but is significantly higher in endometrium during the menstrual 
period (McDonald et al. 2006).  HSD11B1 is also present in the human decidua 
(Albiston et al. 1995) and levels increase in the first trimester of pregnancy.  Greater 
expression is also seen in uterine natural killer cells, a group of phenotypically unique 
cells that increase in number prior to pregnancy (McDonald et al. 2006).  HSD11B2 
mRNA is expressed in normal endometria throughout the menstrual cycle at higher 
levels than HSD11B1, but there was no increase in HSD11B2 mRNA in the 
endometrium during the menstrual phase or in uterine NK cells (McDonald et al. 2006).  
 HSD11B1 and HSD11B2 mRNA are also present in human placenta, vascular 
endothelium, and more abundantly in trophoblast cells of the chorion, amnion, and 
decidua (Sun et al. 1997).  The placental syncytiotrophoblast of both humans and 
baboons also express HSD11B1 (Pepe et al. 1999).  However, HSD11B1 protein is not 
detectable by immunohistochemistry (Sun et al. 1997) or western blot analyses (Ricketts 
et al. 1998) in humans.  Therefore, unlike the baboon, HSD11B2 is the primary 
dehydrogenase in the human placentae (Ricketts et al. 1998). 
 Additional research with human placentae supports evidence for HSD11B1 and 
PGs working together to induce labor as demonstrated in sheep at parturition.  In this 
model, locally produced PGs stimulate HSD11B1 reductase activity in fetal membranes 
to increase local production of cortisol (Alfaidy et al. 2001).  Accumulation of cortisol 
stimulates PG synthesis and decreases metabolism of PGs by 15-hydroxyprostaglandin 
dehydrogenase (HPGD), allowing PGs to further stimulate HSD11B1 activity.  
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Increased PGs, cortisol, and HSD11B1 create and then accelerate a feed-forward loop 
within trophoblast cells of the chorion responsible for human labor (Alfaidy et al. 2003). 
 
HSD11B1 and HSD11B2 in the Rodent Uterus 
 In the rat, HSD11B1 mRNA is evident in trophoblast cells within the basal zone 
on Day 16, and is undetectable by Day 22.  However, expression increases in trophoblast 
cells in the labyrinth zone as gestation progresses (Waddell et al. 1998), which may be 
the result of decreasing levels of P4 at parturition (Mark et al. 2009).  Conversely, 
HSD11B2 mRNA is highest in trophoblast cells within the labyrinth zone on Day 16 
(Waddell et al. 1998).  In rodents, as for humans, there is no detectable HSD11B1 
bioactivity, but HSD11B2 is detectable in both placental zones and varies with changes 
in the abundance of mRNA (Waddell et al. 1998). 
 In the mouse endometrium, HSD11B1 mRNA is localized to the LE, while 
HSD11B2 is only expressed in the stroma and inner circular layer of the myometrium 
from Days 12.5 to 18.5 (Thompson et al. 2002).  HSD11B1 mRNA is highly expressed 
in the decidualized stroma above and below the compact decidua from Days 12.5 to 
18.5.  Expression of HSD11B2 mirrors that of HSD11B1, but expression is only present 
below the compact decidua.  Both isoforms are undetectable in the compact decidualized 
region (Thompson et al. 2002). 
 In mice, the labyrinthine zone serves as the major site of maternal and fetal 
exchange of nutrients (Cross 2000).  HSD11B2 mRNA is found in both the labyrinthine 
zone of the placenta and extra-embryonic membranes on Day 15.5, but is undetectable in 
both the labyrinth trophoblast (Brown et al. 1996) and the yolk sac (Thompson et al. 
2002) by Day 16.5.  The onset of HSD11B1 expression in the placenta coincides with 
silencing of HSD11B2 and the corticosterone surge during late gestation, which peaks on 
Day 16.5 of gestation (Barlow et al. 1974).  This switch may allow for increased fetal 
exposure to maternal GCs, which are essential for final GC-dependent maturation of 
fetal organ systems (Venihaki et al. 2000). 
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 Hsd11b1 null mice are fertile, have unaltered birth weight and litter size, and 
appear generally normal; however, they lack reductase activity (Holmes et al. 2001).  A 
null mutation of Hsd11b2 results in a 50% increase in mortality of pups within 48 hours 
after birth, and death is preceded by motor weakness and reduced suckling.  However, 
the remaining mice develop normally to adulthood (Holmes et al. 2001). 
 
Corticosteroid Hormones and Receptors 
Background 
 Mineralocorticoids (MCs) and GCs are the two major classes of corticosteroid 
hormones that bind intracellular receptors, specifically the glucocorticoid and 
mineralocorticoid receptors (NR3C1 and MR), and thereby stimulate or silence gene 
transcription (Tomlinson et al. 2004).  NR3C1 and MR are members of the 
steroid/thyroid hormone receptor superfamily of ligand-inducible transcription factors 
(Pippal & Fuller 2008) and are homologous both in structure and function.  In humans, 
for example, NR3C1 and MR are approximately 56% identical in the steroid-binding 
domain (Arriza et al. 1987).  Despite acting through closely related receptors and a 
common DNA response element, GCs and MCs induce considerably different 
physiological responses in a tissue-specific manner (Pippal & Fuller 2008). 
 
Mineralocorticoids 
 The synthesis of MCs occurs in the zona glomerulosa of the adrenal cortex, 
where there is no 17-hydroxylase (Baulieu & Kelly 1990).  Progesterone is hydroxylated 
at 21 and 11β, producing corticosterone.  A hydroxylation at 18 (18-
hydroxycorticosterone) occurs, followed by an oxidation of the alcohol function to 
aldehyde, leading to aldosterone production (Baulieu & Kelly 1990).  MCs are 
imperative for maintaining sodium homeostasis and primarily stimulate sodium transport 
by epithelial cells when bound to the MR (Marver 1984).  MR is a physiologically 
important receptor for two classes of hormones, the MCs, aldosterone and 
deoxycorticosterone (Penning et al. 1997) and the GCs, cortisol (in humans) and 
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corticosterone (in rodents), making it unique among the steroid receptors (Pippal & 
Fuller 2008).  As with all nuclear receptors, the activated MR binds to response elements 
that enhance the promoter activity of target genes.  Although the MR predominantly acts 
as a transcription factor, it may also mediate non-nuclear activation of second messenger 
pathways (Fuller & Young 2005).  Furthermore, some actions of aldosterone may 
involve a receptor other than the MR that mediate rapid, nongenomic responses that have 
been reported for other steroid hormones such as E2 and P4 (Luconi et al. 2004). 
 
Glucocorticoids 
 Synthesis of GCs occurs primarily in cells of the zona fasciculata of the adrenal 
cortex where pregnenolone is oxidized at C3, resulting in a ketone function (Baulieu & 
Kelly 1990).  Isomerization of the double bond occurs to produce progesterone, which 
then undergoes a series of hydroxylations at C17 (17-hydroxyprogesterone), at C21 (11-
deoxycortisol), and then at C11β, terminating in cortisol (Baulieu & Kelly 1990).  GCs, 
such as cortisol and corticosterone, are important for their physiological roles in the 
regulation of carbohydrate and amino acid metabolism, maintenance of blood pressure, 
and modulation of stress and inflammatory responses (Michael et al. 2003).  In most 
tissues, GCs exert anti-inflammatory effects by decreasing the expression and/or activity 
of phospholipase A2, group IB (PLA2G1B), thus limiting synthesis of prostaglandins 
(PGs) and thromboxanes (TBXs) (Bailey 1991, Flower & Rothwell 1994, Barnes 1998); 
however, in the placenta and fetal membranes, GCs paradoxically increase PG synthesis 
(Sun & Myatt 2003, Zhang et al. 2006), possibly to facilitate parturition.  GCs can also 
directly alter uterine physiology (Brann & Mahesh 1991) by altering decidual gene 
expression in humans (Gellersen et al. 1994), modifying uterine blood flow and inducing 
labor in sheep (Monheit & Resnik 1981, Gupta et al. 2003), regulating prostaglandin 
biosynthesis in cows (Lee et al. 2007), and inhibiting fetal growth in pigs (Klemcke & 
Christenson 1997).  While GCs have been evaluated in late pregnancy and at parturition, 
the significance of GCs during early pregnancy in livestock remains relatively unknown.  
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 GCs have been studied extensively in humans during early pregnancy; however, 
the majority of the women evaluated were undergoing assisted reproduction (Quenby et 
al. 2005, Boomsma et al. 2007).  During the peri-implantation period, secretion of hCG 
from the trophoblast of early human blastocysts is pivotal in maintaining P4 secretion 
from the CL and may act locally to promote implantation and differentiation of the 
conceptus (Fazleabas et al. 1999, Islami et al. 2001, Licht et al. 2001).  Treatment with 
synthetic GCs can stimulate the secretion of hCG in vitro from human term trophoblast 
cells or from first trimester cytotrophoblast cells (Guller et al. 1994).  GCs can also 
suppress the expression of trophoblast integrins and modulate blastocyst attachment 
(Ryu et al. 1999).  During implantation, GCs may have a role in improving the intra-
uterine environment and facilitate implantation of blastocysts, possibly by correcting 
imbalances in growth factors, cytokines, and uterine NK cells (Quenby et al. 2005).  
Interestingly, GCs can either suppress fibronectin expression in term human 
cytotrophoblast cells and amnion, or act in synergy with TGFB to upregulate fibronectin 
in chorion and placental mesenchymal cells (Guller et al. 1995). 
 While GCs are involved in many facets of reproduction, it is well documented in 
humans that overexposure of the fetus to GCs in mid- to late pregnancy may result in 
adverse outcomes, such as intra-uterine growth restriction (Reinisch et al. 1978), 
increased risk of preterm labor (Shams et al. 1998), programming of post-natal 
hypertension (Tangalakis et al. 1992), programming of increased activity in the 
hypothalamo-pituitary-adrenal axis (Uno et al. 1994), or effects on fetal brain 
development (Muneoka et al. 1997).  Thus, tight regulation of GC production and 
degradation throughout gestation is critical for successful growth of the conceptus, as 
well as postnatal development of the neonate (Michael & Papageorghiou 2008). 
 
Mechanism of Glucocorticoid Signaling 
 While cortisol and corticosterone can activate both NR3C1 and MR, they 
primarily serve as ligands for NR3C1.  Two isoforms of NR3C1 have been identified, 
both of which originate from the same gene by alternative splicing of the NR3C1 
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primary transcript and are thus termed NR3C1α and NR3C1β (Hollenberg et al. 1985, 
Giguere et al. 1986, Funder 1993).  The ligand-dependent NR3C1α stimulates gene 
transcription in target tissues, while NR3C1β is unable to bind GCs due to an altered 
ligand-binding domain (Lu & Cidlowski 2004); therefore, NR3C1α is thought to be the 
active receptor (Hollenberg et al. 1985). 
 Residing primarily in the cytoplasm of cells, NR3C1 interacts with a chaperone 
complex that holds the receptor in an inactive state ready to bind its ligand.  This 
complex consists of various heat-shock proteins (hsp), including hsp40, hsp70, hsp90, in 
addition to p23 and p60 (Morishima et al. 2000).  When no ligand is present, the 
receptor is phosphorylated and becomes hyper-phosphorylated upon cortisol binding 
(Bodwell et al. 1998).  This induces the translocation of NR3C1 to the nucleus, were it 
can act as a ligand-dependent transcription factor.  Phosphorylated NR3C1 dimers can 
then recruit either co-activator proteins to increase target gene expression, or co-
repressor proteins to decrease gene expression.  NR3C1 dimers can modulate gene 
expression by controlling histone acetylation (Li et al. 2003, Hayashi et al. 2004) and 
permanently alter cellular functions (Michael & Papageorghiou 2008). 
 Once in the nucleus, NR3C1 can alter the level of gene expression by interacting 
with the regulatory regions of responsive genes.  Four types of binding sites have been 
identified: GC response elements (Prasit et al. 1999) and GC response element half-sites 
(GRE1/2s) which activate gene expression; negative GC response elements (nGREs) 
that suppress gene activity; and tethering GC response elements, which can both inhibit 
and stimulate gene expression (Schoneveld et al. 2004).  In many genes, the GC 
response depends both on NR3C1 binding to a GRE, but also requires the binding of 
other transcription factors to binding sites in close proximity.  Since these response 
elements are both spatially and functionally clustered, they are referred to as GC 
response units (GRUs) (Schoneveld et al. 2004).  
 Alternatively, NR3C1 can associate with other transcription factors and form 
protein-protein interactions (McKay & Cidlowski 1999), a mode referred to as crosstalk.  
This process involves the association of the NR3C1 complex with the AP-1 transcription 
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factor family; interactions can be direct through protein-protein interaction, indirect 
through bridging proteins, or through competition for a limiting cofactor (Gottlicher et 
al. 1998, McKay & Cidlowski 1999).  Crosstalk results in either transcription factor 
synergism or negative interference of gene expression, and is dependent on specific cell 
conditions (Whittle et al. 2001).  Thus, GCs can exert a wide array of effects on gene 
transcription independent of a GRE site (Bamberger et al. 1996, Gottlicher et al. 1998).   
 
MR and NR3C1 in the Ovine Uterus 
 Neither MR nor NR3C1 have been reported for the ovine uterus during early 
pregnancy, but NR3C1 protein has been identified in intrauterine tissues (Gupta et al. 
2003).  NR3C1 is present in trophoblast cells, but not maternal tissue of the placentome.  
NR3C1α is specific to the nuclei of trophoblast cells, while NR3C1β resides in the 
cytosol (Gupta et al. 2003).  Both isoforms are also present in epithelial cells of the 
amnion and chorionic epithelium, as well as the maternal endometrial epithelium.  
NR3C1α protein is also present in mesenchymal cells of the amnion and uterine GE.  
While NR3C1α levels are elevated during labor, NR3C1β levels remain unchanged 
(Gupta et al. 2003).  In sheep, NR3C1 is also expressed on Days 80 and 140 in 
placentomes, and increase throughout gestation (Gnanalingham et al. 2007).  In 
moderately nutrient restricted ewes, however, the increase in NR3C1 is much lower by 
mid-gestation when compared to adequately fed ewes (Gnanalingham et al. 2007).  
NR3C1 has also been identified in the uninucleate trophoblast cells of the placentome, 
but not in maternal stroma or BNC, and can be stimulated by infusion of cortisol into the 
fetus (Whittle et al. 2006).  
 
MR and NR3C1 in the Bovine Uterus 
 NR3C1 mRNA is present in endometria of non-pregnant cattle, as well as in the 
bovine corpus luteum during the luteal stage (Lee et al. 2007, Komiyama et al. 2008).  
Endometrial NR3C1 mRNA was greater in the mid-luteal stage compared to other stages 
of the estrous cycle (Lee et al. 2007), and levels were inversely correlated with PGF2α 
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output from the bovine endometrium (Miyamoto et al. 2000).  Because concentrations of 
cortisol in plasma were low during the luteal phase, differential expression of NR3C1 
during the estrous cycle may allow GCs to control endometrial PG production (Lee et al. 
2007).  Schäubli and coworkers (Schaubli et al. 2008) evaluated NR3C1 in cows at 8 
and 9 months of pregnancy and in cows undergoing a premature Caesarean section with 
or without induction of birth with a PGF2α agonist, or receiving a Caesarean section due 
to severe dystocia.  They noted a cell type- and location-specific pattern of NR3C1, with 
greater NR3C1 staining in endometrial stromal cells in cows undergoing premature 
Caesarean section after induction of birth compared to cows that were slaughtered 
during month 8 or 9 of pregnancy or cows receiving Caesarean section following 
dystocia (Schaubli et al. 2008).  During late pregnancy and at term NR3C1 protein was 
detectable in nuclei of LE (Schaubli et al. 2008), as in ewes (Gupta et al. 2003).  The LE 
express enzymes necessary for endometrial PG synthesis during pregnancy; thus, GCs 
may be directly stimulating PGF2α synthesis and secretion leading to luteolysis and 
labor or even premature birth (Schaubli et al. 2008). 
 
MR and NR3C1 in the Porcine Uterus 
 While MR have not been identified in pig reproductive tissues, NR3C1 mRNA is 
present during early pregnancy in porcine placentae, with expression first noted on Day 
24 of gestation.  Both NR3C1 mRNA and dehydrogenase activity increased by Day 40 of 
gestation (Klemcke et al. 2003).  Klemcke and coworkers (Klemcke et al. 2006) also 
evaluated effects of maternal cortisol on porcine conceptuses following treatment with 
metyrapone, a cortisol and aldosterone synthesis inhibitor, or metyrapone plus cortisol.  
NR3C1 mRNA was detectable in porcine conceptuses, embryonic tissue, and allantoic 
tissue with no treatment effects on NR3C1 mRNA expression.  But in trophectoderm, 
NR3C1 mRNA expression was reduced in metyrapone, and in metyrapone plus cortisol 
injected pigs when compared to controls.  These results suggest that NR3C1 mRNA in 
porcine conceptuses during early gestation may be capable of responding to cortisol in 
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the uterine environment.  Tissue aldosterone may also be regulating NR3C1 expression 
(Klemcke et al. 2006). 
 
MR and NR3C1 in the Primate Uterus 
  McDonald and coworkers (McDonald et al. 2006) extensively studied both the 
MR and NR3C1 in the cyclic and early pregnant human endometrium.  They identified 
MR expression in non-pregnant endometria throughout the menstrual cycle, in first-
trimester decidua, and in an isolated population of uterine NK cells.  MR was higher in 
mid-secretory phase endometria compared to proliferative phase endometria, and MR 
expression decreased significantly in the late secretory phase when P4 levels decreased; 
thus, MR is likely regulated by circulating P4 (McDonald et al. 2006).  NR3C1 mRNA 
was present at low levels in cyclic endometria, but was more abundant in endometria 
during the menstrual period and in uterine NK cells (Henderson et al. 2003, McDonald 
et al. 2006).  NR3C1 protein was present in stromal cells and was minimal in uterine LE 
during the proliferative and early secretory phases, but NR3C1 protein increased in the 
late secretory phase (McDonald et al. 2006). 
  In pregnant tissues, MR protein was highly expressed in first trimester decidua 
and increased coordinately, but not significantly, with increases in circulating levels of 
P4.  Both NR3C1 and HSD11B1 mRNA were upregulated in first trimester decidua and 
may be involved in eliciting an anti-inflammatory response to tissue remodeling 
(McDonald et al. 2006).  NR3C1 mRNA is abundant in decidua, chorion, amnion, 
stromal fibroblasts, vascular smooth muscle cells and endothelial cells from term human 
placental villi, and is moderately expressed in term cytotrophoblasts with negligible 
expression in term syncytiotrophoblast (Kossmann et al. 1982, Lopez Bernal et al. 1984, 
Sun et al. 1996, Weisbart & Huntley 1997, Driver et al. 2001, Chan et al. 2007, Yang et 
al. 2007).   
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MR and NR3C1 in the Rodent Uterus 
  Both Mr and Nr3c1 mRNAs have been identified in the rat ovary (Schreiber et 
al. 1982) and uterus (Panko et al. 1981), but Mr expression in these tissues is very low to 
undetectable.  In the rat uterus, NR3C1 protein is present in all uterine cell populations 
except for GE (Korgun et al. 2003).  Major sites of expression are LE and decidual cells 
in the stroma, similar to Nr3c1 distribution in the human uterus.  The subcellular 
localization of Nr3c1 protein differs in fetal and maternal tissues; in embryonic tissues it 
is in the cytoplasm, while in maternal tissues it is in the nucleus (Korgun et al. 2003). 
  Ho and coworkers (Ho et al. 1999) investigated effects of sex steroids on Nr3c1 
mRNA using a rat model.  Nr3c1 was downregulated in rats treated with equine 
chorionic gonadotrophin (eCG), but gradually recovered after treatment with human 
gonadotrophin (hCG) injection.  This downregulation may result from increases in E2 in 
blood after eCG injection that either directly or indirectly suppresses Nr3c1 gene 
transcription.  Further, at 24 hours after hCG injection, both Hsd11b1 and Nr3c1 
mRNAs were abundant (Ho et al. 1999).  Perhaps Hsd11b1 supplies more cortisol than 
its receptor can accommodate, thus preparing the uterus for implantation. 
  Similar to Hsd11b1, Nr3c1 is abundant in endometrial epithelia but not stromal 
cells of murine uteri.  While Nr3c1 mRNA is readily detectable in myometrium 
throughout late gestation, Nr3c1 protein is relatively unchanged in the myometrium 
between Days 12.5 to 18.5 of gestation (Thompson et al. 2002).  In uteri of mice, Nr3c1 
mRNA is absent from the compact decidua between Days 12.5 and 16.5, but is localized 
to the decidualized stroma both above and below the compact decidua (Thompson et al. 
2002).  More Nr3c1 mRNA is detected in the labyrinth layer and yolk sac of placentae, 
and is abundant in spongiotrophoblast and giant cells (Thompson et al. 2002).  Because 
Hsd11b1 and Hsd11b2 mRNA are co-expressed with Nr3c1 protein, they may regulate 
placental growth and function in an autocrine fashion by influencing synthesis of 
glucose transporters (Shin et al. 1997), growth factors, and their binding proteins (Han & 
Carter 2000). 
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  Null mutations of Mr and Nr3c1 in mice are lethal.  In Mr knockout mice, pups 
undergo normal prenatal development, but by week 1 the neonates begin to show signs 
of pseudohypoaldosteronism (Wintermantel et al. 2004).  By Day 8, pups exhibit high 
levels of circulating potassium, decreased levels of sodium, and a significant increase in 
rennin, angiotensin II, and aldosterone plasma concentrations.  Pups lose weight and 
suffer from impaired renal sodium reabsorption and water loss, leading to death in the 
second week of life (Wintermantel et al. 2004). 
  Nr3c1 knockout mice die shortly after birth from atelectasis of the lungs.  The 
induction of gluconeogenic enzymes is impaired and T-cell apoptosis is abolished.  Lack 
of Nr3c1 also impairs the ability of red blood progenitor cells to proliferate and renew 
erythrocytes (Tronche et al. 1998).  Further, negative feedback mediated by Nr3c1 is 
absent.  Although the hypothalamic-pituitary-adrenal axis is not fully functional at birth, 
GCs and ACTH levels are greater compared to wild type mice (Tronche et al. 1998) due 
to an increase in transcription of the corticotropin-releasing hormone (CRH) and 
proopiomelanocortin (POMC) genes (Reichardt & Schutz 1996). 
 
Prostaglandins 
Background  
  PGs mediate responses to pain and have been implicated in pathological 
conditions such as hypertension, cancer, and inflammation; thus, their production has 
been a target for pharmacological therapy with non steroidal anti-inflammatory drugs 
(NSAIDs) for more than a century (Fortier et al. 2008).  Normal functions of the female 
reproductive system also require presence of PGs to regulate numerous reproductive 
events including ovulation, implantation, parturition, luteolysis, and they may play a 
secondary role in pregnancy recognition (Poyser 1995, Dubois et al. 1998).  Apart from 
sex steroids, PGs are probably the most critical regulators of female reproductive 
function and associated pathologies (Lindstrom & Bennett 2004). 
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Synthesis and Receptors 
  PGs are ubiquitously expressed and exert their effects in a paracrine or autocrine 
fashion (Kudo & Murakami 2002).  The primary precursor of PGs is arachidonic acid, 
an essential fatty acid stored in membrane phospholipids (Bergstroem et al. 1964, Smith 
& Lands 1972) (Fig. 2.7).  Arachidonic acid is converted into prostaglandin H2 (PGH2) 
via the cyclooxygenase PTGS1 and PTGS2 pathway, making PTGS the rate-limiting 
enzyme in PG production (Smith et al. 2000, Parent et al. 2003).  Cell-specific 
isomerases and synthases then convert PGH2 into various PGs, including PGE2, PGF2α, 
PGD2, prostacyclin (PGI2), and thromboxane A2 (TXA2) (Smith et al. 1996). 
  PGs exert a wide array of effects governed by specific receptors, some of which 
exist in multiple isoforms to bind a single PG (Sales & Jabbour 2003b, Bos et al. 2004).  
Each class of PG acts through its cognitive G-protein coupled receptor, a family of 
rhodopsin-like seven transmembrane spanning receptors. The prostanoid receptor 
subfamily consists of eight members (PTGER1–4, PTGDR, PTGFR, PTGIR and 
TBXA2R), each named for the prostanoid ligand for which individual receptors have the 
greatest affinity (Breyer et al. 2001).  PGF2α, for example, acts through PTGFR 
receptors coupled to Gq, PLC and calcium release, whereas PGE2 acts through four 
subtypes of receptors, PTGER1 coupled to Gi and calcium channels, PTGER2 and 
PTGER4 coupled to Gs and cAMP generation, and PTGER3 coupled primarily to the 
inhibitory Gi system (Hata & Breyer 2004).  PTGDR, PTGIR and TBXA2R serve as 
receptors for PGD2, PGI2, and TBXA2, respectively (Kennedy et al. 2007). 
 
Peroxisome Proliferators-Activated Receptors (PPARs)  
 Though not part of the traditional family of PG receptors, peroxisome 
proliferators-activated receptors (PPAR A,G,D) have been linked to reproductive events 
in numerous animal models (Berger & Moller 2002).  PPARs are a family of nuclear 
transcription factors thought to act as receptors for polyunsaturated fatty acids and to 
reduce production of PGs responsible for swelling and inflammation, also referred to as 
series 2 PGs (Desvergne & Wahli 1999).  Activation of PPAR receptors may be ligand 
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dependent or independent, and cross-talk often occurs with other nuclear receptors, their 
response elements, as well as several transcription factors (Nunez et al. 1997).   
 While infamous for their roles in lipid metabolism, PPARs are also involved in 
reproduction (Berger & Moller 2002).  PPARs have been proposed as nuclear receptors 
for PGD2 and PGI2 (Desvergne & Wahli 1999), and, more recently, for PGE2 after the 
discovery of functional PTGER3 and PTGER4 in nuclear membranes, as well as in 
primary and transfected cells of human embryonic kidney (HEK) 293 cells, porcine 
microvascular endothelial cells, brain of newborn piglets and liver of adult rats 
(Bhattacharya et al. 1999).  
 
Prostaglandin Production in Ruminants 
  Studies in the 1970s and 1980s found that both conceptuses and endometria of 
sheep and cattle synthesize numerous PGs during early pregnancy (Lewis 1989).  PGI2, 
PGE2, PGF2α, TBXA2, and PGD2 are all synthesized and secreted by ovine 
conceptuses, and Day 16 conceptuses produce a larger amount of these PGs than Day 14 
conceptuses (Lewis & Waterman 1985).  Similarly, bovine conceptuses synthesize and 
secrete PGE2 and PGF2α, and Day 19 conceptuses produce more of those PGs than Day 
16 conceptuses (Lewis et al. 1982).  The Day 14 ovine conceptus produces 251 ng PGE2 
per day and 409 ng PGF2α per day, while the endometrium produces 50 ng and 281 ng 
of PGE2 and PGF2α per day, respectively (Lewis & Waterman 1985).  Levels of PGE2 
and PGF2α are thus higher in the lumen of pregnant compared to cyclic ewes (Days 14 
and 16) and cattle (Days 16 and 19), despite the fact that IFNT from the elongating 
conceptus inhibits expression of oxytocin receptors by endometrial cells and, therefore, 
oxytocin-induced pulses of PGF2α. 
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Fig. 2.7. Schematic representation of prostaglandin biosynthesis.  Arachidonic acid is liberated 
from the cell membrane by PLA2 and converted into PGH2 by the rate-limiting enzymes, 
cyclooxygenases (PTGS1 and PTGS2).  PGH2 is then converted into primary PGs, including 
PGE2, PGF2α, PGD2, PGI2, and thromboxane (TXA2), by cell-specific isomerases and 
synthases that exert their effects through G protein-coupled receptors, designated prostaglandin 
E receptors (PTGERs), PTGFR, PTGDR, PTGIR, and thromboxane A2 receptor (TBXA2R), 
respectively.  PTGER1 is coupled to phospholipase C (PLC), generating two second messengers, 
inositol trisphosphate (IP3), which liberates intracellular calcium (Ca2+), and diacylglycerol 
(DAG).  PTGER2 and PTGER4 are coupled to adenylate cyclase (AC) and generate cAMP.  The 
signaling of PTGER3 is more complex with four subtypes, A, B, C, and D, having a wide range 
of actions from inhibition of cAMP production to increases in Ca2++ and IP3.  Nuclear 
peroxisome proliferator-activating receptors (PPARs) PPARD and PPARG are also activated by 
PGI2 and a product of PGD2, 15-deoxy-Δ12,14-PGJ2, respectively. 
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Biological Roles of Prostaglandins 
  The two PGs most pertinent to reproduction, PGF2α and PGE2, have been 
evaluated for their roles in early pregnancy in many species.  It is well established that 
oxytocin-induced pulsatile release of PGF2α from the endometrium is responsible for 
luteolysis and subsequent return to estrus in ruminants (McCracken et al. 1999).  Actions 
of PGE2, while more controversial, are believed to favor establishment of pregnancy 
through luteotrophic or antiluteolytic mechanisms (Pratt et al. 1977, Magness et al. 
1981).  Less studied PGs such as PGI2 may also have supportive roles in implantation 
and pregnancy. 
 
PGE2 and PGF2α 
  In the reproductive system, PGF2α and PGE2 work in opposition to one another 
(Vincent & Inskeep 1986).  In the presence of oxytocin, endometrial release of PGF2α 
initiates luteolysis in animals and ovarian PGF2α in primates contributes to the 
luteolytic process (Nagle et al. 2005).  When a viable conceptus is present, however, an 
antiluteolytic or luteotrophic signal or a combination of both counteracts the default 
luteolytic mechanism to allow maintenance of a functional CL for continued production 
of P4.  IFNT from the conceptus inhibits the expression of uterine ESR1 and OXTR via 
paracrine mechanisms, blocks oxytocin-induced pulsatile secretion of PGF2α, and 
inhibits luteolysis (Spencer et al. 1999).  PGF2α has been suggested to constrict the 
myometrial and uterine blood vessels (Olson 2005), inhibiting CL function, leading to a 
decline in P4 production and an eventual return to estrus. 
  PGE2, on the other hand, is a vasodilator that exerts a strong luteotrophic action 
in humans (Hagstrom et al. 1996).  In species such as sheep and pigs, uterine PGE2 
production increases in early pregnancy, and intrauterine infusions of PGE2 can 
transiently protect the CL from the luteolytic effects of PGF2α, but non-physiological 
amounts of PGE2 are required (McCracken et al. 1999).  Moreover, PGE2 has been 
reported to counteract the effects of PGF2α when given simultaneously to cycling ewes 
via the uterine artery (Henderson et al. 1977) or into the uterine lumen (Magness et al. 
     
 
64
1978).  In addition, secreted factors from the conceptus such as estrogen in pigs and 
IFNT in ruminants are thought to increase the endometrial PGE2:PGF2α production 
ratio (Asselin et al. 1997, Ziecik 2002).  PGE2 synthesis may therefore be important 
during maternal recognition of pregnancy. 
  In terms of early pregnancy, PGs are hypothesized to modulate the uterine 
environment to prepare for pregnancy.  PGE2 and PGI2 are critical regulators of 
blastocyst implantation, decidualization, and uterine angiogenesis during pregnancy in 
mice, rats, and likely humans (Dey et al. 2004, Wang & Dey 2006, Kennedy et al. 
2007).  PGs also prevent rejection of the conceptus allograft by modulating the immune 
system to suppress activity of maternal natural killer cells (Lala 1990).  In primates, 
PGE2 binds to its specific receptor (PTGER2 or PTGER4) and activates adenyl cyclase, 
resulting in increased intracellular levels of cAMP that upregulate IGFBP1 gene 
transcription in stromal fibroblasts (Fazleabas et al. 1999).  Thus, PGs facilitate the 
events of early pregnancy by protecting the developing blastocyst and upregulating 
genes that are potentially important for blastocyst growth and development. 
 
Prostacyclin 
  Along with PGE2 and PGF2α, PGI2 is produced by the ruminant endometrium 
and trophoblast (Charpigny et al. 1997a, Charpigny et al. 1999).  PGI2, generated in the 
presence of its specific isomerase PTGIS, acts through the PTGIR to stimulate various G 
proteins, leading to an increase in cAMP generation and phosphatidylinositol responses 
(Narumiya et al. 1999).   
  Cammas and colleagues (Cammas et al. 2006) identified strong expression of 
PTGIS in the ovine endometrium before Day 12.  Expression decreased thereafter, 
coincident with the rise in circulating estradiol that occurs after Day 12 (Cox et al. 
1973).  Conversely, PTGIS was nearly undetectable before Day 12 in the trophoblast and 
expression was upregulated thereafter.  At the time of implantation, PTGIS protein was 
10 times more abundant in trophoblast than in endometrium.  Thus, PGI2 is constantly 
present during conceptus elongation, first as a product of the endometrium from Days 7 
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to 9, then the conceptus from Day 12 and beyond (Cammas et al. 2006).  PTGIR was 
also present in the endometrium and conceptus (Cammas et al. 2006), further 
implicating PGI2 in the events of early pregnancy. 
  PGI2 is hypothesized to activate the PPARD/RXRA heterodimer and control 
implantation in mice (Lim et al. 1999) and trophoblast invasion in humans (Tarrade et 
al. 2001).  Similarly, transcripts for all PPAR and their RXR heterodimerization partners 
are expressed in the ovine endometrium, with PPARD and PPARG proteins present in 
the LE after Day 12 (Cammas et al. 2006).  In addition, PPARD, PPARG, RXRA, and 
RXRG were simultaneously upregulated in the trophoblast after Day 12 (Cammas et al. 
2006), indicating that ovine PGI2 signaling in sheep involves both the uterus and the 
trophoblast.  More recently, PGI2 was found to improve the developmental competency 
of embryos via regulation of the cAMP and PTGS2-signaling pathways in cattle (Song et 
al. 2009).  Thus, PGI2, along with PGE2 and PGF2α, may mediate the establishment of 
pregnancy and the initiation of implantation in ruminants as in other species. 
 
Prostaglandin Receptor Knockout Models 
  Deletions of various PG receptors have demonstrated physiological functions of 
PGs in the murine model.  All four PTGERs are expressed in uteri of nice during the 
peri-implantation period (Yang et al. 1997); however, knockout models have shown that 
Ptger1- and Ptger3-deficient female mice are fertile, suggesting that these receptors are 
nonessential for ovulation, fertilization, and implantation (Ushikubi et al. 1998).  In 
contrast, Ptger4 deficiency results in embryonic perinatal lethality (Nguyen et al. 1997), 
while Ptger2 null mutants develop normally but produce small litters and exhibit 
ovulation and peri-implantation defects (Kennedy et al. 1999, Tilley et al. 1999).  Ptgfr 
null mice develop normally but are unable to successfully deliver pups (Sugimoto et al. 
1997).  While these mice exhibit normal estrous cycles, ovulation, fertilization, and 
implantation, they fail to respond to exogenous oxytocin (Sugimoto et al. 1997).  No 
reproductive effects have been demonstrated in Ptgdr null mice, yet they suffer from 
ataxia, abnormal astrocyte morphology, and premature death (Matsuoka et al. 2000, 
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Mohri et al. 2006).  Ptgir null mice exhibit normal implantation potential, but have 
fewer hatched blastocysts compared to wild type mice, approximately half of which fail 
to reach the expanded blastocyst stage within 48 hours after hatching from the zona 
pellucida (Huang et al. 2007). 
  Null mutations of the PPARs further implicate PGs in normal reproductive 
functions.  Ppara null mice experience a 20% increase in abortion rate, increased 
neonatal mortality, and downregulation of interleukin 4 (Il4) mRNA (Yessoufou et al. 
2006).  These mice experience greater weight gain, higher adiposity and lipidemia, as 
well as a reduced capacity to metabolize long-chain fatty acids (Kroetz et al. 1998).  
Homozygous Ppard-null mice exhibit placental defects and reduced birth weight (Peters 
et al. 2000), implicating this nuclear receptor in murine placental function and fetal 
development.  Pparg deficiency results in death by Day 10 of gestation (Barak et al. 
1999) due to various placental defects.  Placentae of Pparg mutant mice fail to form the 
vascular labyrinth, and the labyrinthine trophoblast fails to undergo typical 
morphological and cellular changes, such as compaction and syncytium formation 
(Barak et al. 1999). 
 
Prostaglandin-Endoperoxide Synthases 
Background 
  PGs are synthesized in the presence of one or more isoforms of the rate-limiting 
enzyme PTGS (PTGS1, PTGS2, and PTGS3) (Chandrasekharan et al. 2002, Morita 
2002).  PTGS1 is constitutively expressed in a variety of cell types (Kim et al. 2003) and 
is generally necessary for normal physiological functions (Sales & Jabbour 2003), but 
only responds to levels of AA above 10 μM (Parent et al. 2003).  Conversely, PTGS2 
can be rapidly induced by growth factors, oncogenes, carcinogens and tumor-promoting 
esters, and has been implicated in rheumatic disease, inflammation and tumorigenesis 
(Morita 2002).  In addition, PTGS2 supports sustained production of PGs from very low 
levels of AA, i.e., 2.5 μM or lower (Parent et al. 2003).  PTGS2 has been linked to 
reproductive events such as ovulation, implantation of blastocysts, and parturition 
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(Parent et al. 2003).  PTGS3 mRNA, a third variant transcript of the PTGS1 gene, retains 
intron 1 in its mRNA and shares all the structural and catalytic features of PTGS1 and 
PTGS2, but it is sensitive to drugs that that have low anti-inflammatory properties (Sales 
& Jabbour 2003).  PTGS3 has been identified primarily in the cerebral cortex of dogs 
and humans, as well as human heart, but has no known function in reproduction 
(Chandrasekharan et al. 2002). 
 
PTGS1 and PTGS2 in the Ovine Uterus 
  Charpigny and coworkers (Charpigny et al. 1997b) identified both PTGS1 and 
PTGS2 proteins in the ovine endometrium, and PTGS2 protein in the ovine conceptus 
(Charpigny et al. 1997a).  While PTGS1 is present at steady state levels during both the 
estrous cycle and pregnancy, PTGS2 was abundant and transiently expressed in uterine 
endometria between Days 12 and 15 of the estrous cycle and Days 12 and 17 of 
pregnancy (Charpigny et al. 1997b).  Further studies localized PTGS2 mRNA and 
protein in endometrial LE and sGE of cyclic and pregnant ewes.  Similar to findings by 
Charpigny, PTGS2 mRNA was also found to increase between Days 10 and 12 post-
mating and then decline in another study (Kim et al. 2003). 
  In the ovine conceptus, PTGS2 protein is abundant from Days 8 to 17 of 
pregnancy, while PTGS1 is undetectable during that time (Charpigny et al. 1997a).  In 
addition, PTGS2 levels are maximal between Days 14 and 16 and are specific to 
trophoblast cells, but not the inner cell mass (Charpigny et al. 1997a).  Furthermore, in 
the second half of pregnancy, PTGS2 mRNA is abundant in placentae of ewes while 
PTGS1 is constitutively expressed throughout pregnancy and at parturition (Wimsatt et 
al. 1993, Rice et al. 1995, Zhang et al. 1996). 
  Similar to sheep, PTGS2 is the predominant enzyme expressed in the bovine 
uterus (Arosh et al. 2002) and uterine LE and sGE, and is required for production of 
luteolytic pulses of PGF2α.  Endometrial PTGS2 mRNA is transiently induced during 
late diestrus around the expected time of luteolysis, but PTGS1 expression is 
undetectable in cows throughout the estrous cycle (Arosh et al. 2004a, Emond et al. 
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2004).  PTGS2 mRNA and protein are low from Days 1 to 12 of the estrous cycle, and 
higher on Days 13 to 21 (Arosh et al. 2002).  PTGS2 has also been identified during the 
early stages of bovine embryonic development (Gurevich & Shemesh 1994, Emond et 
al. 2004), suggesting an important physiological role for PG production prior to 
implantation. 
  The effects of IFNT on PG production remain controversial.  Using an in vitro 
model with bovine endometrial cells, IFNT was found to decrease PTGS2 mRNA and 
protein (Xiao et al. 1999, Binelli et al. 2000).  Conversely, Krishnaswamy and 
colleagues (Krishnaswamy et al. 2009) demonstrated that IFNT increased PTGS2 and 
PG production in bovine endometrial stromal cells in a dose-dependent manner, and that 
inhibition of the p38 MAPK pathway abolished IFNT action on PG production.  
Moreover, PTGS2 is upregulated by IFNT in endometria of early pregnant cattle (Arosh 
et al. 2004b, Emond et al. 2004).  IFNT can also affect PGE2 synthesis directly via 
stimulation of PGES and even increase PGE2 receptors, particularly PTGER2, in 
endometria and myometria of cattle (Arosh et al. 2004b). 
 
PTGS1 and 2 Knockout Models 
  Knockout studies in mice have demonstrated the importance of PTGS1 and 
PTGS2 in reproduction.  Compared to their wild-type counterparts, mice deficient in 
Ptgs1 exhibit prolonged gestation periods, protracted parturition and deliver fewer live 
young.  However, conception and conceptus development are unaffected in Ptgs1 null 
mice, indicating that Ptgs1 is not critical for ovulation, fertilization, or implantation, but 
is required for induction of labor (Langenbach et al. 1995, Gross et al. 1998).  However, 
Ptgs2 knockout mice exhibit multiple reproductive failures, including ovulation, 
fertilization, implantation and decidualization defects (Dinchuk et al. 1995, Lim et al. 
1997, Langenbach et al. 1999a, Langenbach et al. 1999b). 
  These findings suggest that while PTGS enzymes catalyze the same reaction, 
they differ in their tissue-specific distribution in the reproductive tract and, therefore, 
serve very different functions.  In addition, Ptgs2 expressed in Ptgs1 knockout mice 
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partially compensates for the PG deficiency (Reese et al. 1999).  Ptgs1 and Ptgs2 double 
knockouts result in death of pups soon after birth, indicating that PGs play a more 
significant role in survival than previously anticipated (Reese et al. 2000, Loftin et al. 
2001). 
 
Inhibition of PG Synthesis 
  Various inhibitors of both PTGS1 and PTGS2 have been tested in animal models.  
As early as 1982, LaCroix and Kann reported that pregnant ewes receiving either 
indomethacin (300 mg subcutaneous daily) or acetylsalicylic acid (aspirin) (1 g 
intravenous daily) from Days 7 to 22 experienced normal pregnancies (Lacroix & Kann 
1982).  While their experiments resulted in a sharp decline in concentrations of PGs in 
endometria and conceptuses on Day 23, an apparently normal conceptus was present in 
the uterus.  Thus, they surmised that PGs were not involved during early pregnancy in 
sheep (Lacroix & Kann 1982).  The dose of indomethacin and aspirin, both non-selective 
PTGS inhibitors, should have resulted in circulating levels that exceeded the half 
maximal inhibitory concentration (IC50) for each compound; however, it was not 
determined if those compounds gained entry into the uterine lumen or if treatment 
inhibited PTGS2 in the conceptus. 
  These results highlight the importance of choosing a proper PTGS inhibitor and 
dosage, but more importantly, an effective mode of entry.  The inhibitors used by 
LaCroix and Kann (Lacroix & Kann 1982) were likely administered in insufficient 
amounts or were not able to access the uterine lumen, thus leading to questionable 
results.  Alzet osmotic pumps provide a unique way to manipulate the uterine 
environment because they deliver constant rates of a chosen compound directly into the 
uterus via a catheter.  These pumps have been used successfully in pigs to study effects 
of various compounds on endometrial gene expression without interrupting pregnancy 
(Joyce et al. 2007).   
  Since many PTGS inhibitors are available, choosing an effective agent is 
important.  Numerous inhibitors have been studied with a wide range of effects on 
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PTGS1, PTGS2, and PG production.  A major area of concern is the specificity of the 
inhibitor; while some compounds can target PTGS1 or PTGS2 specifically, others are 
considered non-selective and inhibit both PTGS isoforms (Landa et al. 2009).  
Moreover, many of these agents have only been tested in vitro (Hood et al. 2003, Uddin 
et al. 2005) and their in vivo effects are unknown.  Several inhibitors have proven 
effective in sheep, including the selective PTGS2 inhibitors meloxicam (Rac et al. 2006, 
Rac et al. 2007, Shukla et al. 2007) and methanesulfonamide (NS-398) (Mertz et al. 
2003), and non-selective PTGS inhibitors indomethacin and acetylsalicylic acid (Lacroix 
& Kann 1982, Weems et al. 2007).  Of these inhibitors, NS-398 is relatively new to 
animal experimentation, while indomethacin and meloxicam have been used extensively 
in sheep (Lees et al. 2004).  Importantly, indomethacin has non-specific effects on 
PTGS-induced PG synthesis.  However, meloxicam specifically targets PTGS2, the 
inducible isoform responsible for reproductive functions, making it a prime candidate for 
studying PG production during early pregnancy in sheep. 
  Experiments with meloxicam have been shown to decrease PG production and 
uterine activity in sheep (McKeown et al. 2000, Rac et al. 2006).  The effects of 
meloxicam treatment on PTGS1 and PTGS2 protein expression, as well as PTGS2 
localization, were evaluated in the ovine endometria, myometria, amnions, placentae, 
and fetal tissues in a model of RU486-induced preterm labor (Rac et al. 2007).  Pregnant 
ewes received an intravenous infusion of a high-maintenance-dose meloxicam, graded-
maintenance-dose of meloxicam, or saline after induction of labor.  All regimens of 
meloxicam treatment decreased PTGS2 proteins significantly in endometria, myometria, 
and amnions compared to saline treated ewes, but did not affect PTGS2 in placental or 
fetal tissues.  Not only did PTGS1 remain constitutively expressed, but PGDH levels 
were also unaffected, confirming the specificity of meloxicam for PTGS2 (Rac et al. 
2007).  PTGS2 staining was strong in the cytoplasm of the uterine LE and weak in the 
GE and stroma in ewes receiving saline; however, after meloxicam treatment, strong 
staining was present in uterine LE but staining in the GE and stroma was not detectable 
(Rac et al. 2007). 
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  In a similar sheep study, levels of meloxicam in fetal plasma were much lower 
than in maternal plasma (Rurak et al. 2001), probably due to the high polarity and low 
solubility of meloxicam and/or the permeability characteristics of the epitheliochorial 
placenta.  Administration of meloxicam to ewes is associated with decreased levels of 
PGs such as fetal PGE2 and maternal PGFM, as well as cortisol and ACTH (McKeown 
et al. 2000).  Collectively, available results indicate that meloxicam affects PTGS2 
activity and decreases PTGS2 protein in a dose- and time-dependent manner, but does 
not influence the PG catabolic pathway (Rac et al. 2007). 
 
Summary 
 Proper communication between the conceptus and the endometrium is required 
for successful establishment and maintenance of pregnancy.  As the fertilized blastocyst 
enters into the uterus, hatches from the zona pellucida and elongates, the mononuclear 
cells of the trophectoderm produce large amounts of IFNT, the ruminant pregnancy 
recognition signal.  IFNT not only blocks the luteolytic mechanism to allow continued 
production of P4 from the CL, but P4 also induces and IFNT further stimulates key 
genes that encode for secreted factors released into uterine histotroph that support 
conceptus development.  The nutrient composition of histotroph is clearly important for 
conceptus elongation and pregnancy maintenance; therefore, genes that encode for 
secreted growth factors, binding proteins, enzymes, and adhesion proteins require further 
evaluation. 
 A family of binding proteins regulates the actions of IGFs, two of which have 
been implicated in development of ovine conceptuses during the peri-implantation 
implantation period.  IGFBP1 is unique among its family members because its RGD 
binding sequence allows it to bind the α5β1 integrin heterodimer expressed 
constitutively by the conceptus trophectoderm and uterine LE to stimulate migration of 
trophectoderm cells.  IGFBP3 has a high affinity for IGFs which extends the half-lives 
of IGFs in blood and alters IGF interactions with cell surface receptors to prevent 
apoptosis.  Expression of both IGFBP1 and IGFBP3 expression is common to most 
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mammals, but IGFBP1 expression is undetectable in uteri of pigs.  Because both 
IGFBP1 and IGFBP3 are specific to endometrial LE/sGE in sheep and are induced by 
P4, it is hypothesized that these binding proteins stimulate elongation of ovine 
conceptuses. 
 Additional studies identified HSD11B1, another P4-responsive gene, expressed 
in ovine uterine GE during the estrous cycle and early pregnancy.  HSD11B1 is one of 
two isoforms of 11β-hydroxysteroid dehydrogenase that modulate the actions of GCs by 
converting inactive cortisone to active cortisol (humans) or corticosterone (rodents).  
While HSD11B2 protects the fetus from excess GCs by generating inactive 
corticosterone from active cortisol, HSD11B1 found throughout the body acts primarily 
as a reductase to produce active cortisol.  HSD11B1 is often localized to the uterus 
during early pregnancy and both expression and reductase activity can be stimulated by 
P4, IFNT, and PGs in many species.  Thus, HSD11B1, through cortisol production and 
regulation, may modulate the uterine environment to ensure a receptive environment for 
implantation and conceptus development, including elongation.  Although HSD11B1 has 
been studied extensively in sheep and humans for its contributions to the induction of 
parturition, the importance of this enzyme in early pregnancy is unknown.  Since cortisol 
influences both embryonic and postnatal development, interpreting expression patterns 
and activity of HSD11B1 may provide important insights into endometrial gene 
regulation, as well as growth and development of the conceptus. 
  GCs, such as cortisol and corticosterone, regulate a myriad of events required for 
successful implantation, followed by growth and development of the fetus and placenta.  
While increased levels of GCs induce maturational changes in the fetal organs and, in 
some species, stimulate labor during the peri-parturient period, GCs can also have 
adverse effects during the latter stages of pregnancy.  Elevated cortisol levels, resulting 
from improper HSD11B activity or maternal stress, can lead to a variety of postnatal 
problems in both humans and farm animals.  Furthermore, the presence of MR and/or 
NR3C1 affects tissue response to circulating GCs.  Spatial and temporal expression of 
MR and NR3C1 mRNA varies among species and is often tissue- and cell- specific.  
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While NR3C1 is common in uteri of most species evaluated, the role(s) of MR has not 
been established.  Because either NR3C1 or MR have been identified in early pregnancy 
in several species, their response to cortisol may be more important than previously 
anticipated.  GCs are known to influence uterine receptivity and can improve pregnancy 
rates in women undergoing assisted reproduction.  Therefore, understanding effects of 
GCs, location and timing of receptor expression, and differences among species will 
contribute to understanding early pregnancy and means to improve pregnancy rates in 
both humans and animals.   
 PGs, particularly PGE2, PGF2α and PGI2, are hypothesized to influence events 
of early pregnancy.  Three isoforms of the PTGS enzyme may be involved in synthesis 
of PGs from arachidonic acid, i.e., PTGS1, PTGS2 and PTGS3.  While PTGS1 is 
constitutively expressed in a variety of cell types, PTGS2 is an inducible enzyme that is 
most often associated with reproduction.  PTGS3 is a variant of PTGS1 and has no 
known function in reproduction.  During early pregnancy in sheep, both PTGS1 and 
PTGS2 are expressed in the conceptus and endometrium, with PTGS1 being expressed 
constitutively.  Further, PG secretion in sheep is coincident with elongation of conceptus 
trophectoderm.  PGs regulate IGFPB1 in human and rodent decidua and HSD11B1 in 
the ovine placenta; thus, it is hypothesized that PGs stimulate these and possibly other 
implantation and conceptus elongation-related genes during early pregnancy.  Review of 
current literature provides ample evidence for endometrial genes that likely support 
growth and development of the conceptus, including elongation of conceptus 
trophectoderm, and for effects of P4, IFNT, and/or PGs in regulation of key genes 
required for establishment and maintenance of pregnancy. 
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CHAPTER III 
INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN ONE IN THE 
RUMINANT UTERUS: POTENTIAL ENDOMETRIAL MARKER AND 
REGULATOR OF CONCEPTUS ELONGATION* 
 
 
 
Introduction 
Maternal support of blastocyst growth and development into an elongated 
conceptus is critical for pregnancy recognition signaling and implantation in ruminants 
(Spencer & Bazer 2004, Spencer et al. 2007).  After hatching from the zona pellucida on 
Day 8 (sheep) or Days 9 to 10 (cattle), the blastocyst develops into an ovoid form by 
Day 11 (sheep) or Day 13 (cattle) and is termed a conceptus (Betteridge & Flechon 
1988, Guillomot 1995, Spencer et al. 2004a).  The ovoid conceptus begins to elongate to 
a tubular form on Day 12 (sheep) or Day 14 (cattle) and a filamentous conceptus of 14 
cm or more in length by Day 16 (sheep) or Day 19 (cattle).  Conceptus elongation 
involves exponential increases in length and weight and decrease in diameter of the 
trophectoderm, as well as differentiation of the extraembryonic membranes (Wales & 
Cuneo 1989), and requires substances secreted from the endometrial LE and GE 
(Flechon et al. 1986, Gray 2002).  During early pregnancy in ruminants, endometrial 
functions are regulated primarily by P4 from the corpus luteum and secreted cytokines 
and hormones from the trophectoderm/chorion including IFNT (Bazer et al. 1979, 
Spencer et al. 2004a, Spencer et al. 2008).  IFNT, produced during conceptus 
elongation, exerts antiluteolytic effects on the endometrium to maintain CL function and 
its production of P4 that, in turn, stimulates and maintains uterine endometrial functions 
necessary for conceptus growth, implantation, placentation and successful development  
 
 
*Reprinted with permission from “Insulin-like growth factor binding protein-1 in the 
ruminant uterus: potential endometrial marker and regulator of conceptus elongation” by 
Simmons RM, Erikson DW, Kim J, Burghardt RC, Bazer FW, Johnson GA, Spencer TE. 
Endocrinology, 150(9), 4295-305, © 2009 The Endocrine Society. 
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of the fetus to term (Spencer et al. 2004b).  Additionally, IFNT acts on the endometrium 
to induce or increase expression of many genes that potentially regulate conceptus 
growth and development (see (Spencer 2007, Bauersachs et al. 2008, Spencer et al. 
2008) for review). 
We recently reported results from an ovine model of accelerated blastocyst 
growth and conceptus development elicited by advancing the post-ovulatory rise in 
circulating levels of P4 during metestrus (Satterfield et al. 2006).  That model was used 
to identify a number of candidate P4-regulated genes encoding secreted proteins 
(LGALS15, GRP, IGFBP1, and IGFBP3) implicated in peri-implantation conceptus 
elongation (Satterfield et al. 2006, Satterfield et al. 2008, Song et al. 2008).  IGFBP1 is 
expressed exclusively in the LE/sGE of the endometrium of both sheep and cattle 
(Osgerby et al. 1999, Robinson et al. 2000).  IGFBP3 is expressed predominantly in the 
LE/sGE of sheep endometria (Reynolds et al. 1997), but in stroma and GE of bovine 
endometria (Robinson et al. 2000).  Limited or no information is available on effects of 
the conceptus, P4, or IFNT on IGFBP1 and IGFBP3 expression in endometria of sheep 
and cattle.  IGFBP1 and IGFBP3 are among the 16 known members of the IGFBP 
superfamily that regulate IGF bioavailability and cellular actions (for reviews see (Wang 
& Chard 1999, Firth & Baxter 2002, Nayak & Giudice 2003, Holly & Perks 2006)).  
IGF1 and IGF2 possess both mitogenic and differentiative properties and are implicated 
in early embryonic and placental development in many species including sheep and 
cattle (Wathes et al. 1998, Irwin et al. 1999, Watson et al. 1999).  IGFBPs can both 
enhance and retard IGF actions (Jones & Clemmons 1995, Clemmons 1997).  IGFBP1 is 
a unique IGFBP as it contains a functional RGD integrin recognition domain (Irwin & 
Giudice 1998).  Integrins expressed constitutively on both the conceptus trophectoderm 
and endometrial LE in sheep and cattle (Johnson et al. 2001, MacIntyre et al. 2002) are 
essential for blastocyst implantation, but require functional binding and cross-linking to 
regulate implantation (Burghardt et al. 2002, Armant 2005).  The biological functions of 
IGFBP1 include stimulation of trophoblast cell migration (Irving & Lala 1995, Gleeson 
et al. 2001) and inhibition of trophoblast invasiveness (Irwin & Giudice 1998).  IGFBP3 
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has a very high affinity for IGF1 and IGF2, prolongs their half-life in serum, alters their 
interaction with cell surface receptors, and may have IGF-independent actions to control 
the cell cycle and apoptosis (Rajaram et al. 1997, Lee & Cohen 2002).   
The reported biological roles for IGFBP1 and IGFBP3 make these molecules 
excellent candidates to influence trophectoderm proliferation, migration and attachment 
to uterine LE that are essential processes modulating peri-implantation ruminant 
conceptus growth and development (Guillomot 1995, Spencer et al. 2004a, Spencer 
2007).  Thus, the working hypothesis for the present study is that IGFBP1 and IGFBP3 
have biological roles in peri-implantation conceptus growth and development in 
ruminants.  As a first step in testing this hypothesis, these studies determined: (1) effects 
of the estrous cycle and early pregnancy on IGFBP1 and IGFBP3 expression in ovine 
and bovine uteri; (2) effects of P4 and IFNT on IGFBP1 and IGFBP3 expression in the 
ovine uterus; and (3) effects of IGFBP1 on ovine trophectoderm cell proliferation, 
migration, and attachment.   
 
Materials and Methods 
Experimental Design 
All experimental and surgical procedures were in compliance with the Guide for 
the Care and Use of Agriculture Animals in Research and Teaching and approved by the 
Institutional Animal Care and Use Committee of Texas A&M University. 
 
Study One 
At onset of estrus (Day 0), ewes were mated to either an intact or vasectomized 
ram and then hysterectomized (n=5 ewes/day) on either Day 3, 6, 10, 12, 14 or 16 of the 
estrous cycle or Day 10, 12, 14, 16, 18 or 20 of pregnancy.  Uterine and/or conceptus 
tissues were processed as described previously (Spencer et al. 1999).  At hysterectomy, 
several sections (~0.5 cm) from the mid-portion of each uterine horn ipsilateral to the CL 
were fixed in fresh 4% paraformaldehyde in PBS (pH 7.2).  After 24 h, fixed tissues 
were changed to 70% ethanol for 24 h and then dehydrated and embedded in Paraplast-
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Plus (Oxford Labware, St. Louis, MO).  The remaining endometrium was physically 
dissected from myometrium, frozen in liquid nitrogen, and stored at -80°C for 
subsequent RNA extraction.  In monovulatory pregnant ewes, uterine tissue samples 
were only from the ipsilateral uterine horn to the ovary bearing the CL.  The uterine 
lumen was flushed with 20 ml of sterile 10 mM Tris buffer (pH 7.2) on Days 10 to 16 of 
pregnancy and the estrous cycle and, in pregnant ewes, the flushing was examined for 
the presence of a morphologically normal conceptus. 
 
Study Two 
Crossbred nulliparous heifers were artificially inseminated (AI) with semen from 
a single bull following a timed AI synchronization protocol (Bridges et al. 2008) and 
then slaughtered on either Day 10, 13, 16 or 19 post-mating.  The uterus was flushed 
with 20 ml of sterile 10 mM Tris buffer (pH 7.2).  Heifers were classified as pregnant if 
the uterine flush contained a blastocyst/conceptus of the correct morphology and size or 
nonpregnant if the uterine flush did not contain a blastocyst/conceptus.  The uterine horn 
ipsilateral to the CL was processed as described for Study One.  Uterine tissues were 
collected from nonpregnant heifers on Days 10, 13, 16 and 19 (n=6 per day) and 
pregnant heifers on Days 13, 16 and 19 (n=6 per day). 
 
Study Three 
Cyclic ewes (n=20) were checked daily for estrus and then ovariectomized and 
fitted with indwelling uterine catheters on Day 5.  Ewes were then assigned randomly 
(n=5 per treatment) to receive daily intramuscular (i.m.) injections of P4 and/or a PGR 
antagonist (RU486; Sigma Chemical Company) and intrauterine (i.u.) infusions of either 
control (CX) serum proteins and/or recombinant ovine IFNT as follows: (1) 50 mg P4 
(Days 5 to 16) and 200 μg serum proteins (Days 11 to 16) [P4+CX]; (2) P4 and 75 mg 
RU486 (Days 11 to 16) and serum proteins [P4+RU+CX]; (3) P4 and IFNT (2 x 107 
antiviral units, Days 11 to 16) [P4+IFN]; or (4) P4 and RU and IFNT [P4+RU+IFN].  
Steroids were administered i.m. daily in corn oil vehicle.  Both uterine horns of each ewe 
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received twice daily injections of either CX serum proteins (50μg/horn/injection) or 
recombinant IFNT (5x106 antiviral units/horn/injection).  Recombinant ovine IFNT was 
produced in Pichia pastoris and purified as described previously (Van Heeke et al. 
1996).  Serum proteins and IFNT were prepared for intrauterine injections as described 
previously (Spencer & Bazer 1995).  This regimen of P4 and IFNT mimics the effects of 
P4 and IFNT from the CL and conceptus, respectively, on endometrial expression of 
hormone receptors and IFNT-stimulated genes during early pregnancy in ewes (Bazer & 
Spencer 2006).  All ewes were hysterectomized on Day 17, and uteri processed as 
described for Study One. 
 
Slot Blot Hybridization Analysis 
 Total cellular RNA was isolated from frozen ipsilateral endometrium (Studies 
One and Two) using Trizol reagent (Gibco-BRL, Bethesda, MD) according to 
manufacturer’s instructions.  The quantity and quality of total RNA was determined by 
spectrometry and denaturing agarose gel electrophoresis, respectively.  Steady-state 
levels of IGFBP1 and IGFBP3 mRNAs in endometria were assessed by slot blot 
hybridization using radiolabeled antisense IGFBP1, IGFBP3 or 18S cRNA probes as 
described previously (Spencer et al. 1999, Satterfield et al. 2008).  Radioactivity 
associated with slots was quantified using a Typhoon 8600 MultiImager (Molecular 
Dynamics, Piscataway, NJ).  Data are expressed as relative units (RU). 
 
In Situ Hybridization Analysis 
 Cell-specific expression of IGFBP1 and IGFBP3 mRNAs in ovine and bovine 
uteri was determined using radioactive in situ hybridization analysis methods as 
described previously (Spencer et al. 1999, Satterfield et al. 2008).  All slides for each 
respective gene were exposed to photographic emulsion for the same period of time.  
Images of representative fields were recorded under brightfield or darkfield illumination 
using a Nikon Eclipse 1000 photomicroscope (Nikon Instruments Inc., Lewisville, TX) 
fitted with a Nikon DXM1200 digital camera. 
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Cell Proliferation Assay 
An ovine trophectoderm cell line (oTr1) from a Day 15 conceptus reported 
previously (Farmer et al. 2008) was used to conduct proliferation assays as described 
previously (Dunlap et al. 2006, Farmer et al. 2008).  Briefly, oTr1 cells were subcultured 
into 12-well plates (Corning Costar #3513, Corning, NY) to about 50% confluency in 
trophoblast growth medium for 6 to 8 h and then switched to serum and insulin-free 
DMEM for 24 h.  In some experiments, cells were cultured under low serum (1%) or full 
serum (10%).  After 24 h, the wells (n=4 per treatment) were treated with either 
increasing amounts of purified human IGFBP1 (Catalog 8-IGFBP; Advanced 
Immunochemical Inc., Long Beach, CA) in serum and insulin-free DMEM, trophoblast 
growth medium containing serum and insulin as a positive control, or DMEM alone as a 
negative control.  After 48 h of culture, cell numbers were determined as described 
previously (Raspotnig et al. 1999).  The entire experiment was repeated at least three 
times with different passages of oTr1 cells.   
 
Cell Migration Assay 
The oTr1 cells (100,000 per 100 µl serum-free DMEM) were seeded in a 
confluent layer on 8 µm pore transwell inserts (Corning-Costar, Corning, NY).  Purified 
human IGFBP1 (Advanced Immunochemical Inc.) or bovine serum albumin (BSA; 
Sigma Chemical Company) was then added to separate wells in serum-free DMEM-F12 
at either 1, 10, 100 or 1000 ng/ml (n=3 replicates/treatment).  After 12 h, cells remaining 
on the top portion of the membrane were removed by scraping with a cotton swab and 
membranes were fixed in -20oC methanol for 10 min.  Membranes were removed, placed 
on slides and stained with 4’,6’-diamidino-2-phenylindole (DAPI) (Invitrogen, Hercules, 
CA).  Cells that migrated to the bottom surface of the membrane were counted in five 
non-overlapping sections of each membrane, which accounted for approximately 70% of 
the membrane area, using a Zeiss Axioplan 2 fluorescence microscope with an Axiocam 
HR digital camera and Axiovision 4.3 software.  Cells incubated in DMEM-F12 
containing 10% fetal bovine serum served as a positive control for migration. 
     
 
80
Cell Attachment Assay 
Cell attachment assays were conducted with oTr1 cells as described previously 
(Bayless & Davis 2001).  Polystyrene microwells (Corning-Costar) were coated 
overnight at 4°C with two-fold serial dilutions (10 µg/ml to 20 ng/ml) of the following 
proteins (50 µl) in phosphate-buffered saline (PBS) (n=3 replicates/treatment): full-
length recombinant human fibronectin (hFN; Sigma), purified human IGFBP1 
(Advanced Immunchemical Inc.); or bovine serum albumin (BSA; Sigma).  After 
blocking each well with 10 mg/ml BSA in PBS (100 µl), oTr1 cells (n=50,000) were 
added to the well and allowed to attach for 1 h (37°C, 5% CO2).  Nonadherent cells were 
removed by washing in isotonic saline, and attached cells were fixed using 10% 
formalin.  Plates were stained with 0.1% Amido black for 15 min, rinsed and solubilized 
with 2 N NaOH to obtain an absorbance reading at 595 nm which directly correlated 
with the number of cells stained in each well (Davis & Camarillo 1993). 
 
Statistical Analyses 
 Data from slot blot hybridization analyses were subjected to least-squares 
analysis of variance using the General Linear Models procedures of the Statistical 
Analysis System (SAS Institute Inc., Cary, NC).  Slot blot hybridization data were 
corrected for differences in sample loading by using the 18S rRNA mRNA data as a 
covariate.  In Study 3, preplanned orthogonal contrasts were used to determine effects of 
treatment (P4+CX vs P4+RU+CX, P4+CX vs P4+IFNT, and P4+RU+CX vs 
P4+RU+IFNT).  In all analyses, error terms used in tests of significance were identified 
according to the expectation of the mean squares for error.  Significance (P<0.05) was 
determined by probability differences of least squares means.  Data are presented as 
least-squares means (LSM) with overall standard error (SE). 
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Results 
IGFBP1 and IGFBP3 in the Ovine Uterus 
 Steady-state levels of IGFBP1 mRNA in ovine uterine endometria are presented 
in Fig. 3.1A.  In cyclic ewes, endometrial IGFBP1 mRNA levels were low to 
undetectable on Days 3, 6 and 10, but increased 29-fold on Day 12 and then declined to 
Day 16 (cubic effect of day, P<0.01).  Between Days 12 and 16, endometrial IGFBP1 
mRNA levels were greater in pregnant than cyclic ewes (day x status, P<0.01).  Indeed, 
IGFBP1 mRNA levels were about 4-fold higher on Day 12 and about 50-fold higher on 
Day 16 of pregnancy than for the same days of the estrous cycle.  In pregnant ewes, 
endometrial IGFBP1 mRNA levels increased from Days 12 to 16 and declined 
substantially to Days 18 and 20 (quadratic effect of day, P<0.01).  In situ hybridization 
analysis found that IGFBP1 mRNA was present specifically in endometrial LE and sGE 
of both cyclic and pregnant ewes and in the Day 18 embryo (Fig. 3.2).  Interestingly, 
IGFBP1 mRNA appeared to be more abundant in the intercaruncular endometrial LE 
and sGE as compared to LE covering the caruncles. 
 Steady-state levels of IGFBP3 mRNA in ovine endometria are illustrated in Fig. 
3.1B.  In cyclic ewes, endometrial IGFBP3 mRNA levels were lowest on Days 3 to 10, 
increased ~2.5-fold on Day 12 and increased further between Days 14 and 16 (cubic 
effect of day, P<0.01).  On Days 12 to 16, endometrial IGFBP1 mRNA levels were not 
different between cyclic and pregnant ewes (day x status, P<0.10).  In pregnant ewes, 
endometrial IGFBP3 mRNA levels were highest between Days 12 and 16 and then 
declined substantially to Day 20 (quadratic effect of day, P<0.05).  In situ hybridization 
analysis found that IGFBP3 mRNA was most abundant in the endometrial LE and sGE 
of both cyclic and pregnant ewes and was also present in the endothelium of blood 
vessels (Fig. 3.3). 
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[A] 
 
[B] 
 
Fig. 3.1. Steady-state levels of IGFBP1 [A] and IGFBP3 [B] mRNAs in endometria of cyclic 
and pregnant ewes.  Endometrial mRNA abundance was determined by slot blot hybridization 
analyses (see Materials and Methods).  Data are presented as LSM with SE.   
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Fig. 3.2. In situ hybridization analysis of IGFBP1 mRNA in uteri of cyclic and pregnant 
ewes.  Cross-sections of the uterine wall from cyclic (C) and pregnant (P) ewes were 
hybridized with radiolabeled antisense or sense ovine IGFBP1 cRNAs.  Note that 
IGFBP1 mRNA is most abundant in the endometrial LE and sGE.  Legend: Car, 
caruncle; Em, embryo; LE, luminal epithelium; sGE, superficial glandular epithelium; 
GE, middle to deep glandular epithelium; Mel, melanocyte; S, stroma.  All 
photomicrographs are displayed at the same width of field (560 μm). 
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Fig. 3.3. In situ hybridization analysis of IGFBP3 mRNA in uteri of cyclic and pregnant ewes.  
Cross-sections of the uterine wall from cyclic (C) and pregnant (P) ewes were hybridized with 
radiolabeled antisense or sense ovine IGFBP3 cRNAs.  Note that IGFBP3 mRNA is most 
abundant in endometrial LE and sGE.  Legend: LE, luminal epithelium; sGE, superficial 
glandular epithelium; GE, middle to deep glandular epithelium; S, stroma; Tr, trophectoderm; V, 
blood vessel.  All photomicrographs are displayed at the same width of field (560 μm). 
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IGFBP1 and IGFBP3 in the Bovine Uterus 
Steady-state levels of IGFBP1 mRNA in bovine endometria are illustrated in Fig. 
3.4A.  In nonpregnant heifers, endometrial IGFBP1 mRNA levels were very low or 
undetectable on Day 10, but increased about 228-fold on Day 13 and then declined about 
5-fold to Day 19 (cubic effect of day, P<0.01).  Between Days 13 and 19, endometrial 
IGFBP1 mRNA levels were affected by pregnancy (day x status, P<0.01) in that they 
were not different on Day 13, but were 3.3-fold higher on Day 16 in pregnant than 
nonpregnant heifers.  In pregnant heifers, IGFBP1 mRNA levels increased between 
Days 13 and 16, were maximal on Day 16, and then declined substantially to Day 19 
(cubic effect of day, P<0.01).  In situ hybridization analysis found that IGFBP1 mRNA 
was present specifically in the endometrial LE and sGE of both nonpregnant and 
pregnant heifers on Days 13 and 16 and also in the middle GE on Day 19 in pregnant 
heifers (Fig. 3.5). 
Steady-state levels of IGFBP3 mRNA in bovine endometria are illustrated in Fig. 
3.4B.  In nonpregnant heifers, endometrial IGFBP3 mRNA levels did not change 
(P>0.10) between Days 10 and 19.  Between Days 13 and 19, endometrial IGFBP3 
mRNA levels were not affected by pregnancy (day x status, P<0.10).  Moreover, 
IGFBP3 mRNA levels were not different (P>0.10) between Days 13 and 19 in pregnant 
heifers.  In situ hybridization analysis was not conducted due to the lack of effects of day 
and pregnancy status on endometrial IGFBP3 expression in heifers. 
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 [A] 
 
[B] 
 
Fig. 3.4. Steady-state levels of IGFBP1 [A] and IGFBP3 [B] mRNAs in endometria of 
nonpregnant and pregnant heifers.  Endometrial mRNA abundance was determined by slot blot 
hybridization analysis (see Materials and Methods).  Data are presented as LSM with SE.  
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Fig. 3.5. In situ hybridization analysis of IGFBP1 mRNA in uteri of nonpregnant and pregnant 
heifers.  Cross-sections of the uterine wall from nonpregnant (NP) and pregnant (P) heifers were 
hybridized with radiolabeled antisense or sense ovine IGFBP1 cRNAs.  Note that IGFBP1 
mRNA is most abundant in the endometrial LE.  Legend: LE, luminal epithelium; GE, middle to 
deep glandular epithelium; S, stroma.  All photomicrographs are displayed at the same width of 
field (560 μm). 
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IGFBP1 is Induced by P4 and Stimulated by IFNT 
 The temporal changes in endometrial IGFBP1 and IGFBP3 mRNAs in uterine 
LE/sGE of cyclic ewes suggested that the IGFBP1 and IGFBP3 genes are regulated by 
ovarian P4, whereas the pregnancy-specific increase in endometrial IGFBP1 mRNA in 
ovine and bovine uteri suggested regulation by a factor from the conceptus such as 
IFNT.  Therefore, the effects of P4, RU486 and IFNT on endometrial IGFBP1 and 
IGFBP3 expression were studied in the ovine uterus (Study Three).  As illustrated in 
Fig. 3.6A, treatment of ovariectomized ewes with P4 for 12 days increased endometrial 
IGFBP1 mRNA abundance about 38-fold (P<0.01, P4+CX vs P4+RU+CX).  
Intrauterine infusions of IFNT increased endometrial IGFBP1 mRNA levels about 2-
fold in P4-treated ewes (P<0.01, P4+CX vs P4+IFNT), but had no effect in ewes 
receiving RU486 (P>0.10, P4+RU+CX vs P4+RU+IFNT).  In situ hybridization analysis 
revealed that effects of P4 to induce and IFNT to stimulate IGFBP1 expression in the 
endometrium were confined to the endometrial LE/sGE and GE (Fig. 3.7). 
As illustrated in Fig. 3.6B, treatment with RU486 increased endometrial IGFBP3 
mRNA abundance about 3-fold (P<0.01, P4+CX vs P4+RU+CX).  Intrauterine infusion 
of IFNT did not affect endometrial IGFBP3 mRNA levels in P4-treated ewes (P<0.01, 
P4+CX vs P4+IFNT), whereas IFNT decreased IGFBP3 mRNA abundance by about 2-
fold in ewes receiving P4 and RU486 (P<0.05, P4+RU+CX vs P4+RU+IFNT).  In situ 
hybridization analyses were not conducted given that IFNT is not produced in the 
absence of P4 action and RU486 is abortifacient in sheep as in other mammals.  
 
IGFBP1 Stimulates Trophectoderm Cell Migration and Mediates Their Attachment 
But Does Not Affect Proliferation 
 The effect of IGFBP1 on trophectoderm migration was determined using oTr1 
cells (Fig. 3.7A) that are mostly mononuclear and express IFNT (Dunlap et al. 2006, 
Hayashi et al. 2007).  IGFBP1 stimulated migration of oTr1 cells in serum- and insulin-
free medium compared to the BSA control.  Relative to the BSA control, as little as 1 
ng/ml IGFBP1 stimulated (P<0.01) oTr1 cell migration, but effects were maximal at 10  
     
 
89
 
Fig. 3.6. Effects of progesterone and IFNT on IGFBP1 and IGFBP3 mRNA in the ovine uterus. 
[A] Steady-state levels of IGFBP1 mRNA in endometria were determined by slot blot 
hybridization analysis.  Treatment of ewes with progesterone (P4) increased (*, P<0.01) 
endometrial IGFBP1 mRNA abundance as compared to ewes receiving P4 and the antiprogestin 
RU486.  Intrauterine IFNT increased IGFBP1 mRNA (P<0.01) in P4-treated ewes, but not in 
P4+RU486-treated ewes.  [B] Steady-state levels of IGFBP3 mRNA in endometria were 
determined by slot blot hybridization analysis.  Treatment of ewes with progesterone (P4) and 
RU486 increased (*, P<0.01) endometrial IGFBP3 mRNA abundance as compared to ewes 
receiving P4 alone.  In ewes receiving P4+RU486, intrauterine IFNT decreased IGFBP3 mRNA 
(P<0.01), but not in P4-treated ewes.  [C] In situ hybridization analyses of IGFBP1 mRNA in the 
ovine uterus.  Cross-sections of the uterine wall from treated-ewes were hybridized with 
radiolabeled antisense or sense ovine IGFBP1 cRNA probes.  Note that the effects of P4 and 
IFNT on IGFBP1 expression were manifest on the endometrial LE and upper GE.  Legend: LE, 
luminal epithelium; GE, middle to deep glandular epithelium; S, stroma.  All photomicrographs 
are displayed at the same width of field (560 μm). 
[A]          [B] 
 
 
 
 
 
 
 
 
 
 
 
    [C] 
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and 100 ng/ml and then decreased at 1,000 ng/ml (quadratic effect of dose, P<0.01).  
IGFBP1 and fibronectin (FN) stimulated attachment of oTr1 cells in a dose-dependent 
manner (Fig. 3.7B) compared to BSA control wells.  An increase in oTr1 cell attachment 
occurred in wells with as little as 80 ng/ml IGFBP1 and the effect of IGFBP1 was dose-
dependent (cubic effect of dose, P<0.01).  The attachment elicited by IGFBP1 was 
consistently greater (dose x treatment, P<0.01) than that elicited by similar 
concentrations of FN.  In contrast, IGFBP1 (0.01-10 μg/ml) had no effect (P>0.10) on 
proliferation of oTr1 cells in insulin-free medium containing 0, 1 or 10% serum (data not 
shown).  
 
Discussion 
Results of the present study support previously published results for IGFBP1 in 
LE and sGE of sheep (Osgerby et al. 1999) and cattle (Reynolds et al. 1997), and 
suggest that IGFBP1 is a common endometrial marker of conceptus elongation and 
implantation in sheep and cattle that is regulated by ovarian P4 and a conceptus-derived 
factor.  In contrast, expression of IGFBP3 is different between sheep and cattle.  
IGFBP3 is expressed by ovine endometrial LE/sGE (Fig. 3.3) (Reynolds et al. 1997), but 
predominantly by subepithelial stromal cells in bovine uteri (Robinson et al. 2000).  
These results agree with emerging evidence to indicate that, although both sheep and 
cattle are ruminants with considerable similarities in conceptus growth, development and 
implantation during early pregnancy, substantial differences exist in endometrial gene 
expression between these species.  For instance, LGALS15, a member of the galectin 
superfamily, is one of the most abundant mRNAs present in ovine endometria during 
early pregnancy (Gray et al. 2004, Gray et al. 2006), but the LGALS15 gene present in 
the bovine genome is not expressed in cattle (Lewis et al. 2007).  These results highlight 
the importance of caution in translating research findings in sheep directly to cattle when 
seeking to identify common mediators of endometrial function and conceptus 
development in ruminants (Spencer et al. 2008). 
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Fig. 3.7. Effects of IGFBP1 on migration and attachment of ovine trophectoderm cells.  [A] Cell 
migration.  Ovine trophectoderm cells (oTr1) were cultured in a Transwell plate in serum- and 
insulin-free medium and treated with IGFBP1 purified from human amniotic fluid or with 
bovine serum albumin (BSA) as a control.  The number of cells that migrated was determined 
after 12 h of treatment.  IGFBP1 increased (*, P<0.01) oTr1 cell migration relative to the BSA 
control.  The graph is a compilation of three independent experiments with three replicates per 
treatment in each experiment.  Data are presented as LSM with SE.  [B] Cell attachment.  Wells 
of suspension culture plates were pre-coated overnight with increasing amounts of either human 
IGFBP1, BSA (negative control) or human fibronectin (FN; positive control).  Equal numbers of 
oTr1 cells were added to each well, and the number of attached cells determined after 1 h.  A 
dose-dependent increase (P<0.01) in cell attachment was induced by both IGFBP1 and FN, but 
not BSA.  The graph is a compilation of three independent experiments with three replicates per 
treatment in each experiment.  Data are presented as LSM with SE. 
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In sheep, the induction in IGFBP1 and increase in IGFBP3 expression in 
endometrial LE/sGE between Days 10 and 12 of the estrous cycle and pregnancy is 
temporally associated with loss of PGR expression in these epithelia (Spencer & Bazer 
1995).  Similarly, the induction of IGFBP1 expression in endometrial LE/sGE between 
Days 10 and 13 in nonpregnant and pregnant heifers is also associated with loss of PGR 
in those epithelia (Robinson et al. 1999, Kimmins & MacLaren 2001).  Likewise, the 
decrease in IGFBP1 mRNA in LE/sGE between Days 14 and 16 of the estrous cycle in 
sheep and Days 16 and 19 in cattle is coincident with the subsequent reappearance of 
PGR expression in those epithelia (Wathes & Hamon 1993, Spencer & Bazer 1995, 
Robinson et al. 2001).  Although the cellular and molecular mechanism(s) are not clear, 
continuous exposure of the sheep uterus to P4 for 8 to 10 days is required for loss of 
PGR mRNA and PGR protein in endometrial LE and sGE, but not stroma or 
myometrium (Spencer & Bazer 1995, Johnson et al. 2000).  Indeed, PGR expression 
remains undetectable in ovine endometrial epithelia throughout pregnancy (Spencer et 
al. 2004b).  In the present Study Three, IGFBP1 mRNA was induced by P4 in 
endometrial LE/sGE, but this effect was blocked by administration of the antiprogestin 
RU486.  Treatment of ewes with antiprogestins results in reappearance of PGR in 
endometrial epithelia (Johnson et al. 2000, Satterfield et al. 2006), because they prevent 
P4 actions to down-regulate PGR expression and production of stromal-derived growth 
factors (Satterfield et al. 2008).  In addition to being an antiprogestin, RU486 is a high 
affinity antagonist of the glucocorticoid receptor (Baulieu 1989), but little is known of 
glucocorticoid receptor expression and glucocorticoid effects within the ovine uterus 
during either the estrous cycle or pregnancy.  IGFBP3 expression in endometrial 
LE/sGE did not decline between Days 14 and 16 of the estrous cycle and increased in 
uteri of ewes treated with RU486 in Study Three, suggesting that IGFBP3 expression is 
regulated by a different mechanism than IGFBP1.     
In addition to induction by ovarian P4 during the estrous cycle and pregnancy, 
IGFBP1 expression in endometrial LE/sGE was also increased by the presence of a 
conceptus in both sheep and cattle.  During early pregnancy, the ruminant conceptus 
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synthesizes and secretes a number of different factors, but IFNT is the most abundant 
protein produced by the elongating ruminant conceptus (Roberts 2007).  Indeed, infusion 
of recombinant ovine IFNT into uteri of P4-treated ewes increased IGFBP1 mRNA 
abundance by almost two-fold.  However, this stimulation by IFNT was rather modest 
and did not mimic the approximately 5- and 29-fold increases in endometrial IGFBP1 
expression observed on Days 12 and 16, respectively, in pregnant as compared to cyclic 
ewes.  In bovine uteri, endometrial IGFBP1 mRNA abundance was over 3-fold higher 
for Day 16 pregnant compared to nonpregnant heifers.  Indeed, the spherical Day 12 
conceptus of sheep produces little IFNT compared to large amounts produced by the 
elongating conceptus that is maximal on Days 15-16 (Ashworth & Bazer 1989).  These 
results strongly suggest that another factor produced by the conceptus regulates 
endometrial IGFBP1 expression in sheep and perhaps cattle, with prostaglandins being 
strong candidates. 
Despite markedly different implantation schemes among primates, rodents, and 
ruminants, IGFBP1 is upregulated in endometria of each of these species during early 
pregnancy and implicated as a regulator of blastocyst implantation and placental growth 
and development (Giudice & Saleh 1995, Fowler et al. 2000).  In humans, IGFBP1 is a 
highly up-regulated gene in the human secretory endometrium during the period of 
receptivity to implantation (Kao et al. 2002) and localized to endometrial LE, a 
subpopulation of stromal cells, and the decidua (Zhou et al. 1994, Han et al. 1996).  
Similarly, IGFBP1 is the primary secretory product of baboon decidua that is stimulated 
by hCG, the pregnancy recognition signal produced by primate conceptuses (Fazleabas 
et al. 1993).  In the present study, IGFBP1 stimulated migration and mediated 
attachment of oTr1 cells, which are required for elongation and implantation of ruminant 
conceptuses (Guillomot 1995, Spencer et al. 2004a); however, IGFBP1 did not stimulate 
oTr1 cell proliferation, suggesting that the purified IGFBP1 used in the present studies 
was not contaminated with IGF1 or another mitogen.  In addition to IGF ligand binding, 
IGFBP1 contains a conserved RGD sequence that can act as a ligand for the integrin 
heterodimer α5β1 (Irwin & Giudice 1998, Gleeson et al. 2001).  Blocking antibodies 
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against the α5β1 integrin subunits inhibit trophoblast cell migration (Irving & Lala 
1995), and IGFBP1 stimulated migration of trophoblast cells is attenuated by mutation 
of the RGD integrin binding sequence to WGD or pretreatment with an inhibitory 
peptide (Gleeson et al. 2001).  In sheep, the α5 and β1 integrin subunits are 
constitutively expressed on the surface of uterine LE/sGE and conceptus trophectoderm 
(Johnson et al. 2001), which supports the hypothesis that IGFBP1 from uterine LE/sGE 
can stimulate migration and adhesion of trophectoderm cells to the uterine LE during the 
attachment phase of implantation.  Indeed, the transient nature of IGFBP1 expression in 
uterine LE/sGE is correlated with elongation of conceptuses of both sheep and cattle 
(Guillomot 1995, Spencer et al. 2004a, Satterfield et al. 2006, Spencer 2007).   In the 
present studies, IGFBP1 mediated attachment of oTr1 cells, which is an essential 
element of blastocyst implantation and trophoblast differentiation in many species 
(Burghardt et al. 2002, Armant 2005).  Indeed, integrins are proposed to be the dominant 
glycoproteins that regulate trophectoderm adhesion to endometrial LE during 
implantation in mammals (Aplin 1997, Armant 2005).  During the peri-implantation 
period of pregnancy in sheep, integrin subunits αv, α4, α5, β1, β3 and β5 are 
constitutively expressed on apical surfaces of the conceptus trophectoderm and 
endometrial LE (Johnson et al. 2001).  Thus, conceptus implantation in sheep does not 
appear to involve temporal or spatial changes in patterns of integrin expression (Johnson 
et al. 2001), but may depend primarily on changes in secreted integrin ligands, such as 
IGFBP1, LGALS15 and secreted phosphoprotein one (SPP1 or osteopontin) (Johnson et 
al. 2003, Spencer et al. 2004a, Joyce et al. 2005, Farmer et al. 2008).  Adhesive LE 
ligands, normally masked by mucins, become exposed during the receptive period, and 
various adhesion molecules then function sequentially, or in parallel, to stabilize 
adhesion of the trophectoderm to the endometrial LE (Johnson et al. 2001, Burghardt et 
al. 2002, Johnson et al. 2003, Burghardt et al. 2009). 
Although endometrial IGFBP3 expression differed between sheep and cattle, its 
expression did increase in endometrial LE/sGE of both cyclic and pregnant ewes after 
Day 10 and was consistently detected in the bovine endometria during early pregnancy.  
     
 
95
In sheep, the increase and decrease in endometrial IGFBP3 expression was correlated 
with the period of rapid elongation of the conceptus.  Although distinct differences exist 
between the cell types expressing IGFBP3 in bovine and ovine uteri, IGFBP3 is the 
predominant IGFBP in the uterine lumen during early pregnancy in both sheep and cattle 
(Keller et al. 1998, Peterson et al. 1998b).  Indeed, substances present in the uterus are 
derived from synthesis and secretions of the endometrium as well as selective transport 
of serum components (Bazer & Roberts 1983), and IGFBP3 is the most abundant 
circulating IGFBP in serum.  In serum, IGFBP3 regulates IGF bioavailability by 
sequestering IGFs in circulating ternary complexes, and it also competitively inhibits 
IGF action at the cellular level (Burger et al. 2005).  IGFBP3 also has IGF-independent 
actions that appear to be mediated by a cell surface receptor and/or by direct nuclear 
action (Burger et al. 2005).  Thus, IGFBP3 may have IGF-dependent and -independent 
activities that modulate conceptus growth and development during early pregnancy in 
ruminants. 
IGF1 and IGF2 possess both mitogenic and differentiative properties and are 
components of uterine luminal histotroph in sheep and cattle (Ko et al. 1991, Keller et 
al. 1998, Kim et al. 2008).  Both ovine and bovine pre-implantation embryos (Watson et 
al. 1999), as well as Day 15 elongated bovine conceptuses express IGF1R (Sawai et al. 
2007).  Indeed, IGF1 stimulates proliferation and inhibits apoptosis in cultured bovine 
embryos (Jousan & Hansen 2004), and IGF2 stimulates oTr cell migration (Kim et al. 
2008).  Thus, access of the blastocyst to IGF1 and IGF2 in the uterine lumen could be 
mitigated by upregulation of IGFBP3 and perhaps IGFBP1 in uterine LE/sGE between 
Days 10 and 12 of pregnancy.  IGF-dependent and -independent activities of IGFBP3 
are regulated by deactivation via several proteases (Burger et al. 2005).  Indeed, 
treatment of ovariectomized ewes with P4 for 10 days resulted in the proteolysis of 
IGFBP3 in the uterine lumen which would theoretically increase bioactive IGF available 
to the blastocyst (Peterson et al. 1998b).  Of particular interest, CTSL1 is a P4- and 
IFNT-stimulated protease expressed by ovine endometrial LE and sGE during early 
pregnancy that may act as an IGFBP protease (Song et al. 2005).  Further, MMP2 and 
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MMP9 are secretory products of ovine endometria that increase from Days 12 to 20 of 
pregnancy and may regulate IGFBP cleavage and thus IGF bioavailability (Fowlkes et 
al. 1995, Bunn & Fowlkes 2003).  The IGF-dependent and -independent effects of 
IGFBP3 on trophectoderm functions need to be investigated in order to understand the 
biological role(s) of this IGFBP in the uterine lumen. 
In summary, the spatiotemporal alterations in IGFBP1 mRNA in ovine and 
bovine uterine LE/sGE during pregnancy, combined with the functional aspects of 
IGFBP1 discovered in the present studies and in published results, support the 
hypothesis that IGFBP1 functions as a heterotypic cell adhesion molecule bridging 
integrins in the endometrial LE and conceptus trophectoderm, which stimulates 
trophectoderm migration and adhesion required for conceptus growth and elongation in 
ruminants prior to implantation in utero.  Future experiments will be directed toward 
discerning the biological role(s) of conceptus-derived prostaglandins on expression of 
IGFBP1 as well as other genes in the endometrium that are important for conceptus 
elongation and development as well as endometrial receptivity to implantation of the 
conceptus.
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CHAPTER IV 
HSD11B1, HSD11B2, PTGS2 AND NR3C1 EXPRESSION IN THE PERI-
IMPLANTATION OVINE UTERUS: EFFECTS OF PREGNANCY, 
PROGESTERONE AND INTERFERON TAU 
 
 
 
Introduction 
Maternal support of blastocyst growth and development into an elongated 
conceptus is critical for pregnancy recognition signaling and implantation in ruminants 
(Spencer et al. 2004a, Spencer 2007).  After hatching from the zona pellucida on Day 8, 
the blastocyst develops into an ovoid form by Day 11 and is then termed a conceptus 
(Guillomot 1995, Spencer et al. 2004a).  The conceptus begins to elongate on Day 12 to 
form a tubular and then filamentous conceptus of 14 cm or more in length by Day 16.  
Conceptus elongation requires substances secreted from the endometrial LE and GE 
(Flechon et al. 1986, Gray 2002).  During early pregnancy in ruminants, endometrial 
epithelia functions are regulated primarily by P4 from the CL and secreted factors from 
the trophectoderm/chorion such as IFNT (Bazer et al. 1979, Spencer et al. 2004b, 
Spencer et al. 2008).  IFNT, produced by the mononuclear trophectoderm cells of the 
conceptus during elongation, exerts antiluteolytic effects on the endometrium to inhibit 
production of luteolytic pulses of PGF2α, thereby maintaining CL function for 
production of P4 that, in turn, stimulates and maintains uterine endometrial functions 
necessary for conceptus growth, implantation, placentation and successful development 
of the conceptus to term (Spencer et al. 2004b).  In addition to antiluteolytic effects, 
IFNT induces or increases expression of many genes in the endometrial epithelia that 
regulate conceptus growth and development during the peri-implantation period of 
pregnancy (see (Spencer 2007, Bauersachs et al. 2008, Spencer et al. 2008) for review).   
We recently reported results from an ovine model of accelerated blastocyst 
growth and conceptus development elicited by advancing the post-ovulatory rise in 
circulating levels of P4 during metestrus (Satterfield et al. 2006).  That model was used 
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to identify a number of P4-regulated genes that are expressed in the endometrial 
epithelia (LE, sGE and/or GE) and encode secreted proteins (LGALS15, GRP, IGFBP1, 
and IGFBP3) which are hypothesized to regulate conceptus elongation via effects on 
trophectoderm proliferation, migration and/or attachment (see CHAPTER III and 
(Satterfield et al. 2006, Farmer et al. 2008, Satterfield et al. 2008, Song et al. 2008)).  In 
addition to genes encoding secreted proteins, our microarray analysis identified 
HSD11B1 as a candidate P4-regulated gene (Satterfield MC et al., submitted).  
HSD11B1 is one of two isoforms of 11β-hydroxysteroid dehydrogenase that modulate 
the actions of GCs within potential target cells (see (Michael et al. 2003) for review).  
HSD11B1 acts predominantly as an NADP(H)-dependent reductase to generate active 
cortisol from inactive corticosterone, whereas HSD11B2 acts predominantly to generate 
inactive corticosterone from active cortisol.  Cortisol can activate both the NR3C1 and 
the MR.  Although the NR3C1 and NR3C2 expression has not been investigated in the 
ovine uterus during early pregnancy, HSD11B1 was previously found to be expressed in 
the endometrial LE and upper GE of the ovine uterus during the estrous cycle and early 
pregnancy (Yang et al. 1996).  In fact, the pattern of expression during the estrous cycle 
and pregnancy led those investigators to conclude that HSD11B1 expression was 
regulated by P4, although experiments were not presented to test that hypothesis.  In the 
ovine placenta, PGs can stimulate HSD11B1 activity and GCs increase PG synthesis by 
up-regulating expression and activities PLA2 and PTGS2 (see (Michael & 
Papageorghiou 2008)), thereby establishing a positive feed-forward loop implicated in 
the timing of parturition (Challis et al. 2000).   Recent studies found that prostaglandins 
regulate HSD11B1 activity in the bovine uterus (Lee et al. 2009).  In sheep, elongation 
of the conceptus is coordinate with PTGS2 expression in the endometrial epithelia and 
prostaglandin production by the conceptus (Lewis & Waterman 1985, Charpigny et al. 
1997a, Charpigny et al. 1997b).       
Therefore, available evidence supports the working hypotheses that ovarian P4 
and prostaglandins control HSD11B1 expression in endometrial epithelia and that 
regenerated cortisol produced by HSD11B1 acts via NR3C1 to regulate endometrial 
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functions important for conceptus elongation and implantation during the peri-
implantation period of pregnancy.  As a first step in testing these hypotheses, the present 
studies determined effects of pregnancy, P4 and IFNT on HSD11B1, HSD11B2, PTGS2, 
and NR3C1 expression in the ovine uterus.   
   
Materials and Methods 
Experimental Design  
All experimental and surgical procedures were in compliance with the Guide for 
the Care and Use of Agriculture Animals in Research and Teaching and approved by the 
Institutional Animal Care and Use Committee of Texas A&M University. 
 
Study One 
The experimental design and methods for Study One are the same as those 
described in Chapter III. 
 
Study Two 
In order to determine circulating levels of cortisol in blood during early 
pregnancy, cyclic ewes (n=4) were mated at estrus (Day 0) to a fertile ram.  Blood 
samples were taken daily by jugular venipuncture until Day 20 post-mating.  Serum was 
collected after clotting at 4oC for 4 h and clarified by centrifugation (3000 x g for 30 min 
at 4oC) before storage at -20oC.  All ewes were confirmed pregnant by transrectal 
ultrasonography. 
 
Study Three  
 The effects of early administration of P4 on blastocyst development and uterine 
endometrial gene expression were evaluated using the following experimental design.  
As described previously (Satterfield et al. 2006), ewes were mated at estrus (Day 0) to 
intact rams and then assigned randomly to receive daily i.m. injections from Days 1.5 to 
9 of either corn oil vehicle (CO; n=6) or 25 mg progesterone (P4; n=6); all ewes were 
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hysterectomized on Day 9.  An additional group of ewes were mated and assigned 
randomly to receive daily intramuscular (i.m.) injections of either: (a) CO (n=8); (b) 25 
mg P4 (Sigma Chemical Co., St. Louis, MO) from Days 1.5 to 12 (n=7); or (c) 25 mg P4 
(from days 1.5 to 8, n=5) and 75 mg of RU486 (Sigma-Aldrich, Inc., St. Louis, MO), a 
PGR and NR3C1 antagonist (Baulieu 1989), from Days 8 to 12 (P4+RU486); all ewes 
were hysterectomized on Day 12.  Uteri were processed as described for Study One.  
Pregnancy was confirmed by the recovery of a morphologically normal blastocyst or 
conceptus in the uterine flushing. 
 
Study Four 
The purpose, details of experimental design, tissue collection and analyses for 
Study Four are the same as described for Study Three in Chapter III. 
 
Cortisol Radioimmunoassay 
  Concentrations of cortisol in serum were measured in samples from Study Two 
by solid phase radioimmunoassay (RIA) as per manufacturer’s instructions (TKC02, 
Siemens Diagnostic Products Corporation; Deerfield, IL).  The minimum detectable 
concentration of cortisol was 1.2 ng/ml and the intra-assay coefficient of variation was 
3.75%.  Standards, controls, and samples (25 μl each of standards and controls) were 
added to appropriately labeled coated tubes, followed by the addition of I125-labeled 
cortisol (1 ml/tube).  Tubes were incubated for 45 minutes in a 37°C water bath, after 
which supernatants were decanted, and tubes dried for at least 5 minutes.  Tubes were 
placed in Packard Cobra II auto gamma counter to determine counts per minute (i.e., 
CPM bound).  Concentrations of cortisol in serum were determined by comparison to a 
standard curve generated with known concentrations of cortisol (Assay Zap, Biosoft, 
Cambridge, United Kingdom).  Data are presented as ng/ml cortisol in serum. 
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RT-PCR of Ovine HSD11B1 and HSD11B2 cDNAs  
Partial cDNAs for ovine HSD11B1 and HSD11B2 mRNAs were amplified by 
RT-PCR using total RNA isolated from Day 18 pregnant ewes as described previously 
(Song et al. 2008).  For HSD11B1, the sense primer (5'- CAT TCT GGG GAT CTT 
CTT GG -3') and antisense primer (5'- GAA TAG GCA GCA GCA AGT GG -3') were 
derived from the Ovis aries HSD11B1 mRNA coding sequence (GenBank accession no. 
NM_001009395) and amplified a 534 bp product.  For HSD11B2, the sense primer (5'- 
AGT TCA CCA AGG TCC ACA CC -3') and antisense primer (5'- TGC TCG ATG 
TAG TCC TCA CC -3') were derived from the Ovis aries HSD11B2 mRNA coding 
sequence (GenBank accession no. NM_001009460) and amplified a 457 bp product.  
Partial ovine cDNAs were cloned into pCRII using a T/A Cloning Kit (Invitrogen), and 
sequences verified using an ABI PRISM Dye Terminator Cycle Sequencing Kit and ABI 
PRISM automated DNA sequencer (Perkin-Elmer Applied Biosystems).  
 
Slot Blot Hybridization Analysis 
 Total cellular RNA was isolated from frozen endometria using Trizol reagent 
(Gibco-BRL, Bethesda, MD) according to manufacturer’s instructions.  The quantity and 
quality of total RNA was determined by spectrometry and denaturing agarose gel 
electrophoresis, respectively.  Steady-state levels of HSD11B1 mRNA were assessed by 
slot blot hybridization using radiolabeled antisense HSD11B1 and 18S cRNA probes as 
described previously (Spencer et al. 1999).  Radiolabeled antisense cRNA probes were 
generated by in vitro transcription using linearized partial plasmid cDNA templates, 
RNA polymerases, and [α-32P]-UTP.  Radioactivity associated with slots was quantified 
using a Typhoon 8600 MultiImager (Molecular Dynamics, Piscataway, NJ).  Data are 
expressed as relative units (RU). 
  
In Situ Hybridization Analysis 
 Cell-specific expression of HSD11B1 and HSD11B2 mRNAs in ovine uteri was 
determined using radioactive in situ hybridization analysis as described previously 
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(Spencer et al. 1999, Satterfield et al. 2008).  Radiolabeled antisense and sense cRNA 
probes were generated by in vitro transcription using linearized partial plasmid cDNA 
templates, RNA polymerases, and [α-35S]-UTP.  All slides for each respective gene were 
exposed to photographic emulsion for the same period of time.  Images of representative 
fields were recorded under brightfield or darkfield illumination using a Nikon Eclipse 
1000 photomicroscope (Nikon Instruments Inc., Lewisville, TX) fitted with a Nikon 
DXM1200 digital camera. 
 
Immunohistochemical Analyses 
Immunoreactive PTGS2 and NR3C1 proteins were localized in ovine uteri as 
described previously using a rabbit anti-murine PTGS2 polyclonal antibody (Catalog 
160106; Cayman Chemical) at a 1:250 final dilution, and a mouse anti-rat NR3C1 
monoclonal antibody (Catalog MA1-510; Affinity Bioreagents) at 5 μg/ml final dilution.  
Antigen retrieval for both PTGS2 and NR3C1 was performed using the boiling citrate 
method.  Negative controls included substitution of the primary antibody with purified 
non-immune rabbit IgG at the same final concentration.  Sections were not 
counterstained prior to affixing coverslips. 
 
Statistical Analyses 
 All quantitative data were subjected to least-squares analyses of variance 
(ANOVA) using the Statistical Analysis System (SAS Institute, Cary, NC).  Slot blot 
hybridization data were corrected for differences in sample loading using the 18S rRNA 
data as a covariate.  Data from ewes between Days 12 and 16 (Study One) were analyzed 
for effects of day, pregnancy status (cyclic or pregnant), and their interaction.  Data from 
Study Two were analyzed for effects of day of pregnancy using regression analysis.  
Data from Studies Three and Four were analyzed using orthogonal contrasts (Day 9: CO 
vs P4, Day 12: CO vs P4, and Day 12: P4 vs P4+RU486 for Study Two; and P4+CX vs 
P4+IFN, P4+RU+CX vs P4+RU+IFN, P4+CX vs P4+RU+CX for Study Three) to 
elucidate effects of treatment.  All tests of significance were performed using the 
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appropriate error terms according to the expectation of the mean squares for error.  A P-
value of 0.05 or less was considered significant.  Data are presented as least-square 
means (LSM) with standard errors (SE). 
 
Results 
HSD11B1, HSD11B2, PTGS2 and NR3C1 in the Ovine Uterus During the Cycle and 
Early Pregnancy 
 HSD11B1. As illustrated in Fig. 4.1, endometrial HSD11B1 mRNA levels were 
low to undetectable on Days 3, 6 and 10, increased 7.3-fold between Days 10 and 12, 
increased another 10.8-fold from Days 12 to 14, and remained elevated to Day 16 in 
cyclic ewes (cubic effect of day, P<0.01).  Between Days 12 and 16, endometrial 
HSD11B1 mRNA levels were greater in pregnant than cyclic ewes (day x status, 
P<0.01).  As compared to cyclic ewes, HSD11B1 mRNA levels were 11.3-fold higher on 
Day 12, 2.0-fold higher on Day 14, and 2.4-fold higher on Day 16 of pregnancy.  In 
pregnant ewes, endometrial HSD11B1 mRNA levels increased from Days 12 to 14, were 
maximal on Days 14 and 16, and then declined to Day 20 (quadratic effect of day, 
P<0.01). 
 In situ hybridization analysis revealed that HSD11B1 mRNA was most abundant 
in the LE, superficial GE (sGE) and upper GE of endometria, although mRNA was 
observed at much lower abundance in the middle to deep GE, stroma and myometrium 
(Fig. 4.2A).  Consistently, HSD11B1 mRNA appeared to be more abundant in the 
uterine intercaruncular LE/sGE than the caruncular LE.  In Day 18 and 20 conceptuses, 
HSD11B1 mRNA was detected, but very low in abundance.   
 HSD11B2. In situ hybridization analysis found that HSD11B2 mRNA was 
present at very low levels in all cell types of uteri from both cyclic and pregnant ewes 
(Fig. 4.2B); therefore, steady-state levels of HSD11B2 mRNA in the endometria were 
not measured.  In contrast to the uterus, HSD11B2 mRNA was readily detected in the 
trophectoderm and endoderm of conceptuses on Days 18 and 20 of pregnancy. 
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PTGS2. In the uterus, immunoreactive PTGS2 protein was observed only in the 
LE/sGE and upper GE and distributed throughout the cytoplasm (Fig. 4.3).  In cyclic 
ewes, PTGS2 was low in the endometrial LE/sGE on Day 10, increased to maximal 
abundance on Day 12, and then declined to Day 16.  In uteri from pregnant ewes, 
PTGS2 was also low in the endometrial LE/sGE on Day 10, increased to maximal 
abundance on Day 14, and then steadily declined to nearly undetectable levels on Day 
20.  On both Days 14 and 16, PTGS2 was consistently more abundant in the endometrial 
LE/sGE and upper GE of pregnant as compared to matched cyclic ewes.  In Day 18 and 
20 conceptuses, PTGS2 was detected in the trophectoderm and was particularly 
abundant in the inner cell mass.   
 NR3C1. Immunoreactive NR3C1 (glucocorticoid receptor) protein was detected 
in the nuclei of most, if not all, cell types in the endometrium and myometrium (Fig. 
4.3).  In cyclic ewes, NR3C1 protein was most abundant on Days 10 and 12 in the 
endometrial epithelia.  After Day 12, NR3C1 protein abundance decreased in the 
endometrium, particularly in the epithelia.  In pregnant ewes, NR3C1 protein was most 
abundant on Day 10 in the endometrial epithelia.  After Day 12, NR3C1 was most 
abundant in the middle to deep GE, stroma and myometrium and present at low 
abundance in the LE, sGE and upper GE of the endometrium.  In Day 18 and 20 
conceptuses, NR3C1 was also detected in the nuclei of trophectoderm cells. 
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Fig. 4.1. Steady-state levels of HSD11B1 mRNA in endometria of cyclic and pregnant ewes.  
Endometrial HSD11B1 mRNA abundance was determined by slot blot hybridization analyses 
(see Materials and Methods).  Between Days 12 and 16, endometrial HSD11B1 mRNA levels 
were greater in pregnant than cyclic ewes (day x status, P<0.01). 
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Fig. 4.2. In situ hybridization analysis of HSD11B1 [A] and HSD11B2 [B] mRNAs in uteri of 
cyclic and pregnant ewes.  Cross-sections of the uterine wall from cyclic (C) and pregnant (P) 
ewes were hybridized with radiolabeled antisense or sense ovine cRNAs.  Note that HSD11B1 
mRNA is most abundant in the endometrial LE and sGE, whereas HSD11B2 mRNA is most 
abundant in the conceptus during early pregnancy.  Legend: C, caruncle; LE, luminal epithelium; 
sGE, superficial glandular epithelium; GE, middle to deep glandular epithelium; S, stroma; Tr, 
trophectoderm.  All photomicrographs are displayed at the same width of field (560 μm). 
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Fig. 4.3. Immunohistochemical analysis of PTGS2 and NR3C1 proteins in uteri of cyclic and 
pregnant ewes.  Cross-sections of the uterine wall from cyclic (C) and pregnant (P) ewes were 
used for immunohistochemical using specific antibodies or non-immune IgG as a control (see 
Materials and Methods).  Sections were not counterstained.  Legend: LE, luminal epithelium; 
sGE, superficial glandular epithelium; GE, middle to deep glandular epithelium; ICM, inner cell 
mass; M, myometrium; S, stroma; Tr, trophectoderm.  All photomicrographs are displayed at the 
same width of field (280 μm). 
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Circulating Levels of Cortisol During Early Pregnancy 
 As illustrated in Fig. 4.4, circulating levels of cortisol in serum were highest on 
Day 1 (~27 ng/ml) and then declined to between 5 and 15 ng/ml from Days 5 to 20 of 
pregnancy (quadratic effect of day, P<0.01).   
 
HSD11B1 is Induced by P4 and Stimulated by IFNT 
 The temporal changes in endometrial HSD11B1 mRNA in uterine epithelia of 
cyclic and early pregnant ewes observed in Study One supported the idea that its 
expression was regulated by ovarian P4 and a factor from the conceptus.  Study Three 
utilized a sheep model in which circulating levels of P4 were prematurely elevated after 
estrus by treatment with exogenous P4 from Day 1.5 post-mating.  This early P4 
treatment is known to increase blastocyst size on Day 9 and conceptus growth into an 
elongated filamentous form on Day 12 that secreted more IFNT (Satterfield et al. 2006).  
As illustrated in Fig. 4.5A, HSD11B1 mRNA abundance was two-fold (CO vs P4, 
P<0.01) greater in early P4-treated ewes on Day 9 and 2.4-fold (CO vs P4, P<0.01) 
greater on Day 12.  Endometrial HSD11B1 mRNA abundance was 23.6-fold (P4 vs 
P4+RU486, P<0.001) lower in P4 than P4+RU486-treated ewes on Day 12.  In situ 
hybridization analysis revealed that HSD11B1 mRNA was expressed most abundantly in 
the endometrial LE/sGE of CO- and P4-treated Day 12 ewes (Fig. 4.5B).  The amount of 
PTGS2 protein in the endometrial LE/sGE was higher in P4-treated ewes on both Days 9 
and 12, higher in Day 12 than Day 9 CO-treated ewes, but much lower to absent in Day 
12 ewes receiving P4 and RU486 and Day 9 ewes receiving CO.  NR3C1 protein was 
detected in all endometrial cell types and was more abundant in the endometrial LE/sGE 
of Day 9 and 12 early P4-treated ewes.  Moreover, NRC3C1 protein was lower in uteri, 
particularly in the endometrial epithelia, of Day 12 ewes treated with P4 and RU486 as 
compared to uteri from Day 12 ewes receiving CO or early P4 treatment (Fig. 4.5B). 
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Fig 4.4. Circulating levels of cortisol in the serum of early pregnant ewes.  Serum levels of 
cortisol were measured using a specific radioimmunoassay (see Materials and Methods) and 
were highest on Day 1, declined to Day 6 and remained constant thereafter (quadratic effect of 
day, P<0.05). 
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Fig. 4.5.  Effects of progesterone during early pregnancy on HSD11B1 mRNA, PTGS2 and 
NR3C1 in the ovine uterus.  [A] Steady-state levels of HSD11B1 mRNA in endometria 
determined by slot blot hybridization analysis.  In ewes treated to Day 9, endometrial HSD11B1 
mRNA abundance was increased 2-fold by P4 (CO vs P4, P<0.01).  In ewes treated to Day 12, 
HSD11B1 mRNA was increased 2.3-fold by P4 (CO vs P4, P<0.01).  Treatment of ewes with the 
anti-progestin RU486 from Days 8 to 12 reduced endometrial HSD11B1 mRNA levels by 23.5-
fold (P4 vs P4+RU486, P<0.01) compared to P4-treated ewes.  The asterisk denotes an effect of 
treatment (*, P < 0.01).  [B] In situ hybridization analysis of HSD11B1 mRNA and 
immunohistochemical analysis of PTGS2 and NR3C1 protein.  Legend: LE, luminal epithelium; 
sGE, superficial glandular epithelium; GE, glandular epithelium; S, stroma.  Photomicrographs 
of in situ hybridization analysis are displayed at the same width of field (560 μm), whereas those 
of the immunohistochemical analysis are at 280 μm. 
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 Study Four utilized a model extensively used by our laboratory to determine if 
genes are regulated by ovarian P4 and conceptus IFNT (Bazer & Spencer 2006).  As 
illustrated in Fig. 4.6A, endometrial HSD11B1 mRNA abundance was 3.3-fold (P<0.01, 
P4+CX vs P4+RU+CX) greater in ovariectomized ewes treated with P4 for 12 days.  
Further, endometrial HSD11B1 mRNA levels were 2.2-fold greater (P<0.01, P4+CX vs 
P4+IFNT) in P4-treated ewes receiving intrauterine infusions of IFNT, but not in ewes 
receiving P4 and RU486 (P>0.10, P4+RU+CX vs P4+RU+IFNT).  In situ hybridization 
analysis revealed that effects of P4 to induce and IFNT to stimulate HSD11B1 
expression in the endometrium were confined to the endometrial LE/sGE and upper GE 
(Fig. 4.6B).  In ewes receiving P4 and RU486, HSD11B1 mRNA observed in the 
subepithelial stroma was localized primarily to immune cells.  
 As observed in Study Three, PTGS2 and NR3C1 abundance paralleled HSD11B1 
mRNA in the endometrial LE/sGE and upper GE of uteri from P4-treated ewes (Fig. 
4.6B).  In P4-treated ewes, PTGS2 protein and NR3C1 protein was more abundant in the 
endometrial LE/sGE of ewes receiving IFNT.  In ewes receiving intrauterine infusion of 
CX proteins, PTGS2 and NR3C1 proteins were much higher in the endometrial LE/sGE 
of ewes receiving P4 than P4 and RU486.   
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Fig. 4.6. Effects of progesterone and IFNT on HSD11B1 mRNA, PTGS2 and NR3C1 in the 
ovine uterus.  [A] Steady-state levels of HSD11B1 mRNA in endometria were determined by 
slot blot hybridization analysis.  Treatment of ewes with progesterone (P4) increased (*, P<0.01) 
endometrial HSD11B1 mRNA abundance as compared to ewes receiving P4 and the 
antiprogestin RU486.  Intrauterine IFNT increased HSD11B1 mRNA (P<0.01) in P4-treated 
ewes, but not in P4+RU486-treated ewes.  [B] In situ hybridization analysis of HSD11B1 mRNA 
and immunohistochemical analysis of PTGS2 and NR3C1 protein.  Legend: LE, luminal 
epithelium; sGE, superficial glandular epithelium; GE, glandular epithelium; S, stroma.  
Photomicrographs of in situ hybridization analysis and PTGS2 Immunolocalization are displayed 
at the same width of field (560 μm), whereas those of NR3C1 Immunolocalization are at 280 
μm. 
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Discussion 
Results of the present studies support the idea that ovarian P4, conceptus IFNT 
and PTGS2-derived prostaglandins regulate HSD11B1 expression in the endometrial 
LE/sGE.  In Studies Three and Four, HSD11B1 mRNA was induced by P4 in 
endometrial LE/sGE, but this effect was blocked by administration of RU486, a PGR 
and NR3C1 antagonist  (Baulieu 1989).  In both studies, HSD11B1 mRNA and PTGS2 
protein were absent from the endometrial epithelia of ewes treated with RU486.  
Progesterone upregulation of PTGS2 expression in the ovine uterine endometrium was 
reported previously (Charpigny et al. 1997b). Although postulated previously (Yang et 
al. 1996), results of the present studies are the first to demonstrate that P4 induces 
HSD11B1 expression in the ovine endometrial LE/sGE.  Paradoxically, the increase in 
HSD11B1 and PTGS2 expression in endometrial LE/sGE between Days 10 and 12 of the 
cycle and pregnancy is temporally associated with loss of PGR expression in the same 
epithelia (Wathes & Hamon 1993, Spencer & Bazer 1995, Satterfield et al. 2006).  
Continuous exposure of the sheep uterus to P4 for 8 to 10 days is required for loss of 
PGR in endometrial epithelia, which does not occur in the stroma or myometrium 
(Spencer & Bazer 1995, Johnson et al. 2000).  Loss of PGR in the endometrial LE/sGE 
between Days 10 and 12 is associated with the onset of expression of HSD11B1 and a 
number of other different genes, including PTGS2, LGALS15, GRP, IGFBP1, SLC2A1, 
SLC5A1, and solute carrier family 7 (cationic amino acid transporter, y+ system), 
member 2 (SLC7A2), that are implicated as regulators of cellular processes involved in 
conceptus elongation (see CHAPTER III and (Charpigny et al. 1997b, Gray et al. 2004, 
Satterfield et al. 2006, Satterfield et al. 2008, Song et al. 2008, Gao et al. 2009a, Gao et 
al. 2009b)).  In addition to being an antiprogestin, RU486 is also a high affinity 
antagonist of NR3C1 (Baulieu 1989), and loss of NR3C1 was observed along with 
HSD11B1 mRNA in endometria of ewes treated with RU486 in both Studies Three and 
Four.  It is possible that effects of P4 on HSD11B1 and PTGS2 expression are mediated 
by NR3C1, because P4 regulates gene expression in human trophoblasts via an 
interaction with NR3C1 (Karalis et al. 1996, Patel et al. 2003).  The effects of a specific 
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NR3C1 antagonist on uterine gene expression and function during early pregnancy has 
not been reported in sheep, although the RU486 treatment used in Study Three elicited 
embryo loss in sheep (Satterfield et al. 2006).   
In Study One, HSD11B1 mRNA and PTGS2 abundance in the endometrial 
LE/sGE was clearly increased by the presence of a conceptus as early as Day 12.  IFNT, 
a novel member of the type I IFN family, is the most abundant protein secreted by the 
elongating conceptus (Roberts 2007).  In Study Three, endometrial HSD11B1 and 
PTGS2 expression was greater in early P4-treated Day 12 ewes that contained an 
elongating, filamentous conceptus producing more IFNT as compared to control ewes 
containing a much smaller ovoid conceptus producing little or no IFNT (Satterfield et al. 
2006).  In Study Four, infusion of recombinant ovine IFNT into uteri of P4-treated ewes 
increased abundance of HSD11B1 mRNA in the endometrial LE/sGE.  Collectively, 
results of the present studies indicate that HSD11B1 is another novel P4-induced and 
IFNT-stimulated gene along with LGALS15, GRP, IGFBP1, SLC2A1, SLC5A1, and 
SLC7A2 (Gray et al. 2004, Song et al. 2008, Gao et al. 2009a, Gao et al. 2009b).  The 
mechanism whereby IFNT stimulates expression of those genes in the LE/sGE and 
upper GE of the endometrium is not known.  The canonical JAK-STAT signaling 
pathway used by type I IFNs is not active in the endometrial LE/sGE and upper GE of 
the ovine uterus during early pregnancy, because several essential transcription factors 
(STAT1, STAT2 and IRF9 that form the ISGF3 transactivator complex) that mediate 
canonical type I IFN signaling are not expressed in those epithelia due to expression of 
IRF2, a potent transcriptional repressor (Choi et al. 2001, Fleming et al. 2009).  Thus, 
IFNT likely regulates gene expression in endometrial LE/sGE using a non-canonical 
signaling pathway, such as MAPK p38 cascade and the phosphatidylinositol 3-kinase 
cascade reported for other IFNs (Platanias 2005). 
When comparing results of Studies One and Four, it was apparent that the two-
fold increase in endometrial HSD11B1 mRNA levels elicited by intrauterine infusions of 
IFNT into uteri of P4-treated ewes was rather modest compared to the 11.3-fold higher 
level of HSD11B1 mRNA observed in the endometria of Day 12 pregnant as compared 
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to Day 12 cyclic ewes.  The ovoid to slightly tubular Day 12 ovine conceptus produces 
little IFNT compared to large amounts produced by the elongating Day 14 and 16 
conceptuses (Ashworth & Bazer 1989).  Thus, another factor produced by the ovine 
conceptus likely regulates endometrial HSD11B1 expression with prostaglandins being a 
strong candidate.  The trophectoderm cells of the ovine conceptus contain abundant 
levels of PTGS2 (Charpigny et al. 1997a) and synthesize and secrete a number of 
different prostaglandins including PGE2 and PGF2α (Lewis & Waterman 1983, Lewis & 
Waterman 1985).  In pregnant ewes, the increase in HSD11B1 expression in endometrial 
LE/sGE between Days 10 and 14 and the subsequent decline in expression between 
Days 16 and 20 is temporally associated with PG production by the ovine conceptus and 
PG levels in the uterine lumen (Marcus 1981, Lewis 1989, Charpigny et al. 1997b).  In 
the endometrial LE/sGE, PTGS2 abundance was coordinate with HSD11B1 expression 
in the present studies and in agreement with other studies (Charpigny et al. 1997b).  In 
the ovine placenta, HSD11B1 expression and/or bioactivity is stimulated by a positive 
feedback loop involving cortisol and prostaglandins as well as proinflammatory 
cytokines (IL1B and TNFA) and P4 (see (Michael et al. 2003, Michael & Papageorghiou 
2008) for review), thereby establishing a positive feed-forward loop implicated in the 
timing of parturition (Challis et al. 2000).  Given that circulating levels of cortisol did 
not increase in ewes during early pregnancy (Study Four), it is unlikely that extrauterine 
cortisol is involved in stimulating endometrial HSD11B1 expression.   Collectively, 
available results support the idea that HSD11B1 expression in ovine endometrial LE/sGE 
and upper GE during early pregnancy is regulated by IFNT and prostaglandins from the 
elongating conceptus and HSD11B1-regenerated cortisol within the endometrial 
epithelia.  
In addition to conceptus-derived prostaglandins, it is plausible that endometrial-
derived prostaglandins regulate HSD11B1 expression, because changes in HSD11B1 
mRNA and PTGS2 protein were coordinate in the endometrial LE/sGE and upper GE 
during the estrous cycle.  Both pregnant and nonpregnant endometria have similar 
abilities to synthesize prostaglandins (Silvia et al. 1984, Zarco et al. 1988a, Zarco et al. 
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1988b).  In non-pregnant bovine endometria, PGF2α stimulated HSD11B1 activity (Lee 
et al. 2009).  In placentae, cortisol increases prostaglandin synthesis (Sun and Myatt 
2003; Li, Gao et al. 2006) by stimulating PTGS2 transcription (Whittle, Patel et al. 
2001).  Thus, the increased abundance of PTGS2 on Days 12, 14 and 16 of the estrous 
cycle and early pregnancy in endometrial LE/sGE in Study One could be due to higher 
levels of prostaglandins, HSD11B1 and cortisol acting in an autocrine manner on those 
epithelia.  Moreover, active cortisol generated by HSD11B1 in uterine LE/sGE could 
activate NR3C1 and regulate expression of target genes, particularly since PGR are 
absent from the same epithelia.  Future studies should determine the biological roles of 
cortisol and prostaglandins in regulation of HSD11B1 and PTGS2 gene expression and 
bioactivity in the ovine uterus during the estrous cycle and early pregnancy.  Finally, it is 
possible that other factors within the endometrium and from the conceptus regulate 
HSD11B1 and PTGS2 expression in the ovine uterus.   
The present studies established the presence of both HSD11B1 and NR3C1 in the 
ovine uterus during early pregnancy; however, the biological roles of HSD11B1-
regenerated cortisol and NR3C1 mediated actions are unknown.  Despite extensive 
studies of the developmental consequences of increased glucocorticoid exposure in mid- 
to late pregnancy, relatively little is known regarding the significance of HSD11B1 and 
glucocorticoids in early pregnancy in any species (see (Michael et al. 2003, Michael & 
Papageorghiou 2008).  Clear physiological roles for placental HSD11B1 in parturition 
and HSD11B2 in protection of the fetus from excess cortisol have been established (see 
(Michael & Papageorghiou 2008) for review).  Moreover, HSD11B2 is expressed and 
functional in first trimester trophoblasts of the human placenta where it has been 
implicated in successful embryo attachment and implantation (Arcuri et al. 1998).  
Glucocorticoids are hypothesized to exert many actions that could impact both 
negatively and positively on key aspects of early pregnancy (see (Michael & 
Papageorghiou 2008) for review).  The positive effects would promote pregnancy (e.g. 
stimulation of hCG secretion, immunosuppression, promotion of trophoblast 
growth/invasion, and increased amino acid transport), whereas the negative effects 
     
 
117
would compromise the pregnancy (e.g. inhibition of cytokine-prostaglandin signaling, 
restriction of trophoblast invasion, induction of apoptosis, and inhibition of embryonic 
and placental growth).  Of particular interest, pregnancy rates are increased in women 
undergoing standard in vitro fertilization who receive synthetic glucocorticoids prior to 
or immediately after embryo transfer (Boomsma et al. 2007).   
In summary, the present studies established that: HSD11B1 is expressed 
predominantly in ovine uterine epithelia, whereas HSD11B2 is expressed predominantly 
in the conceptus during early pregnancy; HSD11B1 and PTGS2 expression are 
coordinate in the endometrium and during conceptus elongation; P4 induces and IFNT 
modestly stimulates HSD11B1 expression in the endometrium; and NR3C1 is expressed 
in most uterine and conceptus cell types during early pregnancy.  Collectively, these 
results and others support our working hypotheses that ovarian P4 and prostaglandins 
control HSD11B1 expression in endometrial epithelia and cortisol produced by 
HSD11B1 acts via NR3C1 to regulate endometrial functions important for conceptus 
elongation and implantation during the peri-implantation period of pregnancy. 
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CHAPTER V 
INTRAUTERINE INFUSION OF MELOXICAM RETARDS OVINE 
CONCEPTUS ELONGATION AND ALTERS ENDOMETRIAL GENE 
EXPRESSION AND FUNCTION 
 
 
 
Introduction 
In ruminants, pregnancy recognition signaling and implantation is dependent on 
maternal support of blastocyst growth and development into an elongated conceptus 
(embryo/fetus and associated membranes) (Bazer 1992, Spencer et al. 2007).  The ovine 
blastocyst hatches from the zona pellucida on Day 8, develops into an ovoid or tubular 
form by Day 11, and is termed a conceptus.  The conceptus begins to elongate on Day 12 
and becomes filamentous, reaching 14 cm or more in length by Day 16.  Conceptus 
elongation involves exponential increases in length and weight and a decrease in 
diameter of the trophectoderm, differentiation of the extraembryonic membranes (Wales 
& Cuneo 1989), as well as transient attachment of the conceptus trophectoderm to the 
uterine LE for outgrowth and migration.  IFNT, produced by the elongating conceptus, 
exerts antiluteolytic effects on the endometrium to maintain CL function and its 
production of P4.  Progesterone, in turn, stimulates and maintains uterine endometrial 
functions necessary for conceptus growth, implantation, placentation and successful 
development of the fetus to term (Spencer et al. 2004b).  Additionally, IFNT acts on the 
endometrium to induce or increase expression of many genes that potentially regulate 
conceptus growth and development (Spencer et al. 2008, Bazer et al. 2009).  These 
genes encode for various secreted enzymes, binding proteins, and growth factors from 
the endometrial LE and GE that are presumed to support the conceptus throughout early 
development (Bazer 1975, Bazer et al. 1979) and are hypothesized to play a role in 
successful growth of the conceptus to term. 
We recently reported results from an ovine model of accelerated blastocyst 
growth and conceptus development that advanced circulating levels of P4 during 
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metestrus (Satterfield et al. 2006).  That model has been used to identify numerous P4-
regulated genes, many of which are expressed in the endometrial LE/sGE consistent with 
a role in pre-implantation blastocyst growth, development, and conceptus elongation 
(Satterfield et al. 2006, Satterfield et al. 2008, Song et al. 2008).  For example, SLC2A1 
and SLC5A1 mediate the transfer of glucose across the plasma membrane (Pantaleon & 
Kaye 1998).  Glucose has a recognized role in pre-implantation embryonic development 
(Devreker & Englert 2000) and can amplify trophoblast cell growth and proliferation 
during pregnancy (Wen et al. 2005).  Other genes encode for secreted proteins and 
function in cell migration and attachment (IGFBP1 and LGALS15), cell proliferation 
(GRP), or regulate IGFs (IGFBP3).  Enzymes and their inhibitors (CST3 and CTSL) 
process proteins and are perhaps involved in endometrial remodeling and placentation in 
sheep (Song et al. 2007).  Other genes encode enzymes (HSD11B1 and PTGS2) that 
produce factors implicated in endometrial function and/or conceptus development.  
Expression of these endometrial genes is associated with loss of the PGR in the LE/sGE 
between Days 10-11 and the GE between Days 12-13 post-mating (Wathes & Hamon 
1993, Spencer & Bazer 1995).  Exposure of the endometrium to P4 for at least 8 to 10 
days downregulates PGR expression in the endometrial epithelia, but not stroma or 
myometrium (Spencer & Bazer 2002).  IFNT from the elongating conceptus acts on the 
endometrium to induce or enhance expression of a myriad of genes, collectively termed 
ISGs (Hansen et al. 1999, Spencer et al. 2004a, Spencer 2007, Bazer et al. 2008).  Two 
classical ISGs, RSAD2 and ISG15, are hypothesized to regulate conceptus development.  
IFNT enhances expression of a number of the aforementioned genes that encode for 
secreted proteins (IGFBP1, IGFBP3, LGALS15, CST3, CTSL1, GRP), transporters for 
glucose (SLC2A1), or enzymes (HSD11B1, PTGS2), further implicating these genes in 
the events of early pregnancy. 
Effects of P4 and IFNT on endometrial genes in the ovine uterus have been well 
documented (Spencer et al. 2008).  However, recent work in cattle has implicated 
prostaglandins (PGs) in the events of early pregnancy.  In the bovine endometrium, 
IFNT from the conceptus upregulates endometrial PTGS2 gene expression, PTGS2 
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enzymatic activity, and PGE2 production via the p38 MAPK pathway (Asselin et al. 
1997, Arosh et al. 2004b, Emond et al. 2004, Krishnaswamy et al. 2009).  In other 
species, PGs regulate numerous reproductive events including ovulation, implantation, 
parturition, and luteolysis (Poyser 1995, Dubois et al. 1998).  In sheep, it is well 
established that the conceptus and endometria synthesize and secrete PGs during early 
pregnancy, particularly PGE2 and PGF2α (Lewis & Waterman 1985).  PTGS2, the 
predominant enzyme responsible for the production of PGs, is transiently expressed in 
the ovine endometrium from Days 12 to 15 of the estrous cycle and Days 12 to 17 of 
pregnancy (Charpigny et al. 1997b).  Furthermore, PTGS2 mRNA and protein is 
localized to the endometrial LE and GE in cyclic and pregnant ewes (Kim et al. 2003).  
Studies from our lab have further implicated a role for PGs in endometrial gene 
expression (CHAPTERS III and IV).  P4 induced and IFNT stimulated IGFBP1 and 
HSD11B1 mRNA expression in sheep uterine epithelia; however, IFNT stimulation was 
modest in pregnant ewes compared to corresponding day of the estrous cycle.  Further, 
HSD11B1 and PTGS2 expression was coordinate in the endometrial epithelia, and 
NR3C1 was present in all endometrial cell types (CHAPTER IV).  Collectively, these 
results support ideas that IGFBP1 and HSD11B1 expression is regulated by P4, IFNT 
and prostaglandins, and that HSD11B1-regenerated cortisol acts via NR3C1 to regulate 
endometrial functions during early pregnancy in the ovine uterus.  Thus, our working 
hypothesis is that PGs regulate endometrial expression and function of genes associated 
with ovine conceptus growth, development and elongation.  In order to test this 
hypothesis, a study was conducted to determine effects of intrauterine infusion of 
meloxicam, a selective PTGS2 inhibitor, on (1) peri-implantation conceptus 
development and (2) endometrial function in sheep. 
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Materials and Methods 
Experimental Design 
All experimental and surgical procedures were in compliance with the Guide for 
the Care and Use of Agriculture Animals in Research and Teaching and approved by the 
Institutional Animal Care and Use Committee of Texas A&M University. 
 
Study One 
 Ewes (n=10) were mated at estrus (Day 0) to rams of proven fertility.  On Day 8 
post-mating, ewes underwent a mid-ventral laparotomy, and the uterine horn ipsilateral 
to the ovary with a visible corpus luteum received a catheter connected to a preloaded 
and equilibrated Alzet 2ML1 Osmotic Pump (see Fig. 5.1).  The Alzet pump was affixed 
to the intercornual ligament between the uterine horns, oviduct and ovary using medical 
adhesive and then secured using suture.  Ewes (n=5 per treatment) received pumps 
containing either: (1) vehicle control (2 ml of 2% ethanol saline); or (2) meloxicam 
(1225 ng in 2 ml vehicle; Boehringer Ingelheim Pharmaceuticals), a partially selective 
PTGS2 inhibitor (13.1 times more inhibitory for PTGS2 than PTGS1) (Pairet et al. 
1998) that is effective in sheep (Rac et al. 2007, Shukla et al. 2007).  The Alzet 2ML1 
Osmotic Pump delivers 10 μl/h (240 μl/day) for 7 days.  All ewes were necropsied on 
Day 14 post-mating.  The uterine lumen was flushed with 20 ml sterile 10 mM Tris 
buffer (pH 7.2) on Day 14 of pregnancy and the flushing was examined for the presence 
of a morphologically normal conceptus.  At hysterectomy, several sections (~0.5 cm) 
from the mid-portion of each uterine horn ipsilateral to the CL were fixed in fresh 4% 
paraformaldehyde in PBS (pH 7.2).  After 24 h, fixed tissues were changed to 70% 
ethanol for 24 h and then dehydrated and embedded in Paraplast-Plus (Oxford Labware, 
St. Louis, MO).  The remaining endometrium was physically dissected from 
myometrium, frozen in liquid nitrogen, and stored at -80°C for subsequent RNA 
extraction.  In monovulatory pregnant ewes, uterine tissue samples were only from the 
ipsilateral uterine horn to the ovary bearing the CL.  
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Fig. 5.1. Implantation of an Alzet osmotic pump and placement of catheter into the uterine 
lumen of a ewe.  The Alzet osmotic pump was affixed to the intercornual ligament between the 
uterine horns, oviduct and ovary using medical adhesive.  The catheter and pump were then 
secured using suture. 
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Slot Blot Hybridization Analysis 
 Total cellular RNA was isolated from frozen ipsilateral endometrium using 
Trizol reagent (Gibco-BRL, Bethesda, MD) according to manufacturer’s instructions.  
The quantity and quality of total RNA was determined by spectrometry and denaturing 
agarose gel electrophoresis, respectively. Steady-state levels of IGFBP1, IGFBP3, 
LGALS15, HSD11B1, SLC2A1, SLC5A1, RSAD2, ISG15, GRP, CST3, and CTSL 
mRNAs and 18S cRNA in endometria were assessed by slot blot hybridization as 
described previously (Spencer et al. 1999, Satterfield et al. 2008).  Radioactivity 
associated with slots was quantified using a Typhoon 8600 MultiImager (Molecular 
Dynamics, Piscataway, NJ).  Data are expressed as relative units (RU). 
 
Statistical Analyses 
 Data from slot blot hybridization analyses were subjected to least-squares 
analysis of variance using the General Linear Models procedures of the Statistical 
Analysis System (SAS Institute Inc., Cary, NC).  Slot blot hybridization data were 
corrected for differences in sample loading by using the 18S rRNA mRNA data as a 
covariate.  In all analyses, error terms used in tests of significance were identified 
according to the expectation of the mean squares for error. Data are presented as least-
squares means (LSM) with overall standard error (SE). 
 
Results 
Elongating and filamentous conceptuses (12 to >14 cm) were recovered from all 
5 control ewes implanted with a pump releasing control vehicle.  In contrast, ovoid (~2 
mm; n=3), tubular (~1 cm; n=1), and a very fragmented conceptus (n=1) were recovered 
from the ewes implanted with a pump releasing the PTGS2 inhibitor meloxicam (data 
not shown).   
Steady-state levels of endometrial IGFBP1, IGFBP3, LGALS15, HSD11B1, 
SLC2A1, GRP, and CST3 mRNAs were reduced (P<0.05) in endometria from 
meloxicam-infused compared to vehicle-control ewes (Table 5.1).  Consistent with 
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retarded conceptus elongation, expression of two classical IFNT-stimulated genes 
(RSAD2 and ISG15) were lower (P<0.05) in endometria of meloxicam-infused ewes.  
Interestingly, SLC5A1 mRNA levels were increased (P<0.01) by meloxicam infusion, 
whereas CTSL mRNA levels were not affected (P>0.10). 
 
 
 
 
 Table 5.1. Effect of intrauterine infusion of meloxicam  
 on endometrial mRNA levels in the ovine uterus 
GENE CONTROL TREATMENTa 
IGFBP1 100% 45%+ 
IGFBP3 100% 62%+ 
LGALS15 100% 61%+ 
HSD11B1 100% 61%+ 
SLC2A1 100% 54%+ 
SLC5A1 100% 181%* 
RSAD2 100% 15%* 
ISG15 100% 25%* 
GRP 100% 55%+ 
CST3 100% 55%* 
CTSL 100% 130% 
  aData are shown as percentages of mRNA levels in meloxicam-treated  
  endometria relative to that in endometria of control ewes (designated  
  as 100%). +P<0.05; *P<0.01 
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Discussion 
 The present study supports our working hypothesis that PTGS2-derived PGs 
regulate conceptus elongation and influence endometrial gene expression during early 
pregnancy.  In 1982, LaCroix and Kann (Lacroix & Kann 1982) reported that treatment 
of pregnant ewes from Days 7 to 22 post-mating with two non-selective PTGS 
inhibitors, indomethacin (300 mg subcutaneous daily) and aspirin (1 g intravenous 
daily), decreased endometrial and conceptus production of PGs as assessed on Day 23.  
Pregnancy was not affected by those treatments, because a morphologically normal 
conceptus was present on Day 23.  Thus, they concluded ovine blastocyst implantation 
and establishment of pregnancy were not dependent upon PGs as had been demonstrated 
in the rodent model.  While the levels of indomethacin and aspirin used should have 
exceeded the half maximal inhibitory concentration (IC50) for each compound, it was not 
determined if these compounds were able to access the uterine lumen and effectively 
inhibit the high levels of PTGS2 in trophectoderm of the elongating conceptus.  From 
Days 12-13, blood flow to the uterus is relatively low (Reynolds et al. 1984) and the 
endometrial LE is intact, whereas blood flow is higher on Day 23 and much of the LE 
has been removed by fusion with trophoblast giant binucleate cells (BNC) (Wooding 
1984).  Thus, results of the LaCroix and Kann (Lacroix & Kann 1982) experiment could 
be due to inadequate levels of the inhibitors within the lumen during early pregnancy. 
IGFBP1, IGFBP3, HSD11B1, LGALS15, and GRP are P4-regulated genes 
implicated in peri-implantation conceptus elongation (Satterfield et al. 2006, Song et al. 
2008).  We have previously determined IGFBP1 to be a marker of conceptus elongation 
in ruminants (CHAPTER III) while IGFBP3 expression was only coordinate with 
elongation in sheep but not in cattle.  HSD11B1 provides a source of active cortisol 
(Stewart & Krozowski 1999) to bind its nuclear receptor subfamily 3, group C, member 
1 (glucocorticoid receptor) (NR3C1) and regulate gene expression in the ovine 
endometrium.  Previous studies from our laboratory have shown IGFBP1, HSD11B1 and 
PTGS2 expression are coordinate in the endometrial epithelia during early pregnancy 
(CHAPTER IV), further supporting a role for PGs during conceptus elongation.  Both 
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LGALS15 and GRP encode for secreted proteins that, collectively, regulate 
trophectoderm proliferation, migration, and adhesion (Patel et al. 2006, Farmer et al. 
2008).  Thus, IGFBP1, IGFBP3, LGALS15, HSD11B1 and GRP may all contribute to 
conceptus elongation during early pregnancy.  Interference with PG production reduced 
gene expression and function, contributing to failed conceptus elongation. 
Endometrial genes, such as RSAD2 and ISG15, are classical IFNT-stimulated 
genes implicated in the events of implantation and/or conceptus elongation.  RSAD2 is 
an antiviral protein produced in response to Type I Interferons that may modulate local 
immune cells to ensure acceptance of the allogenic conceptus and stimulate cytokine 
production (Hansen 1995, Croy et al. 2003).  ISG15 is expressed in uteri of ruminants in 
response to IFNT and its activity increases during pregnancy, making it another 
candidate gene for regulating peri-implantation (Joyce et al. 2005).  As expected, 
expression of these genes was lower in endometria of meloxicam-infused ewes, 
consistent with retarded conceptus elongation.  All of the conceptuses in the meloxicam-
treated ewes failed to elongate properly, indicating reduced IFNT production since the 
spherical Day 12 conceptus produces little IFNT (Ashworth & Bazer 1989).  These 
results imply indirect effects on endometrial genes, since lack of PGs alter gene 
expression imperative for conceptus elongation and subsequent IFNT production, which 
then affects genes classically stimulated by IFNT.  
Both SLC2A1 and SLC5A1 mRNA and proteins are abundant in the ovine LE, 
sGE, and conceptus (Gao et al. 2009a).  While SLC2A1 is a P4 induced and IFNT 
stimulated gene, SLC5A1 is induced by P4 but not further stimulated by IFNT (Gao et 
al. 2009a).  In the present experiment, PG inhibition decreased SLC2A1, but increased 
endometrial SLC5A1 levels.  Both genes are localized to the same cell types, but clearly 
each responds differently to the hormones of pregnancy.  Because SLC2A1 expression is 
dependent on IFNT, conceptuses from ewes receiving meloxicam infusion failed to 
elongate properly and, thus, produced less IFNT.  Lack of IFNT, caused by reduced PG 
production, explains decreased endometrial SLC2A1 mRNA.  The increase in SLC5A1 
mRNA can be rationalized in at least two ways.  Perhaps IFNT and/or PGs inhibit 
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SLC5A1 which peaks on Day 12 of pregnancy (Gao et al. 2009a), i.e., before significant 
amounts of IFNT are being produced (Ashworth & Bazer 1989) and declines thereafter.  
In addition, large amounts of PGs are being produced by both the endometrium and 
conceptus during this period (Lewis & Waterman 1985, Lewis 1989).  Thus, a 
combination of increasing IFNT and PGs may contribute to declining levels of SLC5A1 
during normal pregnancy.  The disruption of IFNT and PG production in the present 
experiment may account for the increase in SLC5A1 mRNA levels.  Alternatively, other 
transporters not dependent on IFNT or PG stimulation may be upregulated to 
compensate for decreased glucose transport. 
While CST3 levels decreased in meloxicam-infused ewes, CTSL mRNA levels 
did not change.  Because CST3 is an inhibitor of CTSL (Charpigny et al. 1997a, 
Charpigny et al. 1997b, Spencer et al. 2008), downregulation of endometrial CST3 
mRNA may have permitted unregulated expression of CTSL.  Both genes are induced in 
the presence of P4 and further stimulated by IFNT (Song et al. 2005, Song et al. 2006).  
Why expression of CST3 is reduced, but CTSL expression is unaffected remains unclear.  
It is possible that the decrease in production of PGs in meloxicam-treated ewes fails to 
adequately stimulate CST3 mRNA expression.  However, CTSL remains constitutively 
expressed in uterine endometria, suggesting that CTSL regulation is more complex than 
other genes evaluated. 
While many endometrial genes were downregulated from meloxicam treatment, 
no gene expression was completely ablated.  It is important to note that meloxicam 
preferentially inhibits PTGS2 within the endometrium and conceptus; however, PTGS1 
is constitutively expressed in the ovine endometrium during early pregnancy (Charpigny 
et al. 1997a, Charpigny et al. 1997b).  Therefore, while meloxicam infusion decreased 
PG production by PTGS2, the uterine endometrium could still produce moderate levels 
of PGs via PTGS1, thus maintaining low levels of endometrial gene expression.  
Moreover, different tissues throughout the body express varying levels of PTGS1 and 
PTGS2 (Sales & Jabbour 2003).  Meloxicam infusion targeted locally produced PGs 
within the uterus, but circulating PGs may have also influenced endometrial gene 
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expression.  Thus, PGs may be derived from the endometrium, conceptus, circulation, or 
perhaps a combination of all three sources.  While results from this experiment 
demonstrate the importance of PGs for ovine conceptus elongation, the source of these 
PGs remains to be determined. 
 In summary, PG production stimulates endometrial gene expression and 
promotes proper conceptus elongation.  Conceptuses that fail to elongate produce little 
IFNT, which further impacts gene expression of classical ISGs.  The effects of PTGS2 
inhibition and subsequent decline in PG production on conceptus elongation and 
endometrial gene expression support the hypothesis that PGs are important regulators of 
peri-implantation development in sheep.  Both conceptuses and endometria of sheep and 
cattle synthesize and secrete a variety of PGs during early pregnancy (Lewis & 
Waterman 1985, Lewis 1989).  While PGF2α and PGE2 are well studied, little 
information exists to define the roles of other PGs in early pregnancy.  Moreover, 
identifying the source of PGs as conceptus and/or endometrial in origin may also provide 
valuable insight into gene regulation and elongation.  It is probable that additional genes 
are involved in conceptus elongation and are perhaps regulated, in part, by PGs.  
Identifying novel genes or better characterizing existing ones would greatly improve the 
existing knowledge of conceptus elongation.  Understanding the biological function of 
PGs and their interactions with endometrial genes may further our understanding of 
early pregnancy events and perhaps contribute to solutions for early pregnancy loss. 
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CHAPTER VI 
CONCLUSIONS 
 
 
 
 Conceptus elongation and implantation require effective cross-talk between the 
uterus and developing conceptus.  This is a complex process which involves a myriad of 
endocrine cues and subsequent gene responses, both by the uterine endometrium and/or 
conceptus trophectoderm.  While certain aspects of regulatory pathways governing 
changes in gene expression have been well characterized, little work has been done to 
explore novel methods of gene regulation and how affected genes influence conceptus 
elongation.  Results discussed in this thesis are the first to provide evidence for the 
involvement of PGs in conceptus elongation via regulation of endometrial gene 
expression. 
Among factors hypothesized to regulate ovine endometrial gene expression and 
subsequent conceptus elongation and implantation, ovarian P4 and conceptus-derived 
IFNT have been well described in the literature (see (Spencer & Bazer 2002, Spencer et 
al. 2008) for reviews).  The objective of the present study was to enhance the body of 
knowledge regarding conceptus elongation through identification and evaluation of 
genes that may be influenced by P4 and IFNT.  In fact, P4 induced and IFNT further 
stimulated expression of genes specific to the LE and sGE, including IGFBP1 and 
HSD11B1 (CHAPTERS III and IV).  It is important to note that the upregulation in gene 
expression following stimulation by IFNT in experimentally manipulated ewes was only 
modest compared to the greater degree of upregulation detected in pregnant vs. cyclic 
ewes on the same day after onset of estrous.  These results provide a rationale for the 
hypothesis that factors other than IFNT upregulate endometrial genes during the period 
of conceptus elongation. 
The coordinate expression of PTGS2, IGFBP1 and HSD11B1 in the ovine 
endometrium during early pregnancy also implicates PGs in gene regulation.  To better 
characterize the effects of PGs in vivo, ewes were fitted with indwelling Alzet osmotic 
pumps which provided intrauterine infusion of either meloxicam, a selective PTGS2 
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inhibitor, or vehicle control.  Ewes with less access to PGs, due to the meloxicam 
exposure, had reduced expression of many genes hypothesized to be important for 
conceptus implantation and elongation, including IGFBP1, IGFBP3, and HSD11B1.  
Importantly, all conceptuses recovered from ewes treated with meloxicam failed to 
elongate properly (CHAPTER V).  These results suggest that PGs are required for 
upregulation of IGFBP1, IGFBP3, and HSD11B1 as well as conceptus elongation.  
However, determining a functional role for those genes in early pregnancy and their 
involvement in conceptus elongation is an important area of investigation that remains to 
be addressed. 
The biological significance of IGFBP1 and IGFBP3 in ruminant conceptus 
elongation was evaluated in this study because expression of both IGFBP1 and IGFBP3 
is concomitant with conceptus elongation; however, only IGFBP1 expression is 
coincident with the period of conceptus elongation in cattle.  Furthermore, IGFBP3 
expression was downregulated in the presence of P4 and did not change with the 
addition of IFNT, indicating its expression is regulated in an alternate fashion 
(CHAPTER III).  Therefore, IGFBP1, but not IGFBP3, may be a marker of conceptus 
elongation in ruminants.  Similar to sheep and cattle, IGFBP1 is upregulated in 
endometria of both primates and rodents during early pregnancy, and is implicated as a 
regulator of blastocyst implantation and placental growth and development (Giudice & 
Saleh 1995, Fowler et al. 2000).  Thus, despite differences in implantation schemes, 
IGFBP1 is likely imperative for success in early pregnancy and may serve as a universal 
requirement for pregnancy. 
The prevalence of research involving IGFBP1 within the literature begs the 
question of what is known about IGFBP1 in reproductive biology across species, and 
how does that relate to our working knowledge of IGFBP1 in regulating implantation in 
sheep?  Molecularly, IGFBP1 is unique within the family of IGFBPs as it contains a 
functional RGD integrin recognition domain that specifically binds the α5β1 integrin 
heterodimer (Irwin & Giudice 1998).  This distinction is of particular importance as 
integrins are proposed to be the dominant glycoproteins regulating trophectoderm 
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adhesion to endometrial LE during implantation in mammals (Aplin 1997, Armant 
2005).  Functional studies have demonstrated that blocking antibodies against the α5β1 
integrin subunits (Irving & Lala 1995) or mutation of the RGD integrin binding 
sequence (Gleeson et al. 2001) inhibit human trophoblast cell migration.  In sheep, a 
variety of integrin subunits, including α5 and β1, are constitutively expressed on apical 
surfaces of the conceptus trophectoderm and endometrial LE during the peri-
implantation period (Johnson et al. 2001) and similar to humans, IGFBP1 stimulates 
migration and mediates attachment of ovine trophectoderm cells (CHAPTER III).  This 
affect may be due to the interaction of the internal RGD site with integrins (such as 
α5β1) expressed by the conceptus trophectoderm cells and LE (Fig. 6.1).  However, 
additional experiments using ovine cells are required to confirm if IGFBP1 binds the 
α5β1 integrin specifically, and if mutation of the RGD site negates trophectoderm cell 
migration.  This information will provide valuable insight into the similarities and/or 
differences in IGFBP1 functionality across species. 
 In humans, other primates, and rodents, IGFBP1 levels can influence conceptus 
invasion.  Excess IGFBP1 is often detected in cases of shallow trophoblast invasion 
which leads to pre-eclampsia and intra-uterine growth restriction of offspring (Giudice et 
al. 1997).  In rodents, overexpression of Igfbp1 in transgenic animals may result in 
impaired fertility and implantation, interrupted or prolonged labor, and fetal or neonatal 
death (Gay et al. 1997).  While decreased endometrial IGFBP1 expression contributed to 
failed conceptus elongation in sheep (CHAPTER V), an excess of IGFBP1 may also be 
detrimental to establishment of pregnancy in ruminants.  The infusion of excess levels of 
IGFBP1 into the ovine uterine lumen via Alzet osmotic pumps may further elucidate its 
effects during early pregnancy.  Realizing that sheep embryos utilize a process of 
elongation as opposed to invasion for establishment of pregnancy and a large surface 
area for uptake of nutrients and gases, it is still likely that in ruminants, as in other 
species, IGFBP1 levels must be closely regulated for successful implantation.   
In comparison to the relatively clear influence of IGFBP1 on conceptus 
elongation, the role(s) of IGFBP3 remain largely undefined.  Despite the relative paucity  
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Fig. 6.1. Schematic illustration of the proposed roles of IGFBP1 and IGFBP3 during ovine 
conceptus elongation.  IGFBP1 and IGFBP3 are produced by the endometrial epithelia and 
secreted into the uterine lumen.  IGFBP1 can bind α5β1 integrin heterodimers expressed by the 
conceptus trophectoderm to promote cell migration and adhesion, or to α5β1 integrin 
heterodimers expressed by the uterine LE, resulting in integrin activation and the formation of 
focal adhesions. Within the uterine lumen, both IGFBP1 and IGFBP3 regulate the bioavailability 
of IGFs. IGFPB3, however, is the most abundant binding protein in the uterine lumen, making it 
more influential in controlling IGF levels than IGFBP1. 
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of information available, it is important not to dismiss IGFBP3s importance during early 
pregnancy due to its high affinity for IGF1 and IGF2.  Expression patterns of IGFBP3 
are very different between sheep and cattle.  Relative changes in expression of IGFBP3 
in cyclic and pregnant ewes are equivalent (CHAPTER III).  Conversely, there is 
elevated expression of IGFBP3 in non-pregnant as compared to pregnant heifers.  It is 
interesting to note that the overall levels of IGFBP3 were much lower in non-pregnant 
and early pregnant heifers as compared to sheep (CHAPTER III).  Thereby in sheep and 
cattle, it is possible that levels of IGFBP3 increase, even in cyclic animals, to prepare for 
a potential pregnancy by sequestering IGFs within the uterine lumen. 
 In terms of conceptus elongation, IGFBP3 expression increased coincidentally 
with that event in sheep, but IGFBP3 expression did not increase after Day 10 of 
pregnancy in cattle.  Moreover, IGFBP3 is expressed in the endometrial LE and sGE in 
the ovine uterus, but is predominant in the subepithelial stroma in the bovine uterus 
(CHAPTER III).  Perhaps less IGFBP3 allows greater utilization of IGFs by the bovine 
conceptus.  Although proteolysis of IGFBP3 has not been studied in the bovine uterine 
lumen, IGFBP3 exists primarily in a fragmented form between Days 12 to 15 of 
pregnancy in sheep, purportedly to increase availability of IGFs for the elongating 
conceptus (Peterson et al. 1998b).  Because IGFBP3 is known to inhibit IGF-induced 
mitogenesis, it has also been hypothesized that reduced IGFBP3 expression may 
increase the stimulatory effects of IGFs on the endometrial stroma and influence 
caruncular development (Cerro & Pintar 1997, Robinson et al. 2000).  IGFPB3 may also 
be important for conceptus elongation in sheep, as there was decreased endometrial 
IGFBP3 mRNA detected in ewes with conceptuses that failed to elongate (CHAPTER 
V). 
 In addition to IGFPB1 and IGFBP3, the enzyme HSD11B1 is an attractive 
candidate for influencing pregnancy.  HSD11B1 primarily converts inactive 
corticosterone to active cortisol which serves as a ligand for two nuclear receptors, MR 
and NR3C1.  The binding of cortisol to activate NR3C1 leads to transactivation of 
numerous genes implicated in the events of implantation and conceptus elongation.  
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Treating ewes with RU486, a high affinity antagonist of both PGR and NR3C1 (Baulieu 
1989), decreased NR3C1 protein and HSD11B1 mRNA in the endometrium (CHAPTER 
IV).  Similarly, P4 regulates gene expression via an interaction with NR3C1 in human 
trophoblast cells (Karalis et al. 1996, Patel et al. 2003).  Thus, many P4-induced and 
IFNT stimulated genes may also be regulated by cortisol.  The relative binding affinity 
of RU486 to PGR is more than twice that of P4 and its relative binding affinity for 
NR3C1 is more than 10 times that of cortisol (Heikinheimo et al. 2003).  Because 
RU486 can influence the effects of both P4 and cortisol, it cannot be determined from 
these studies whether the decreases in IGFBP1, IGFBP3, and HSD11B1 mRNAs 
(CHAPTERS III and IV) were the result of RU486 antagonizing PGR, NR3C1 or both.  
However, the increase in IGFBP1, IGFBP3, and HSD11B1 mRNA expression in the 
endometrial LE and GE between Days 10 and 12 of the cycle and pregnancy is 
temporally associated with loss of PGR expression (Wathes & Hamon 1993, Spencer & 
Bazer 1995, Satterfield et al. 2006).  Thus, cortisol activation of NR3C1 may be 
regulating expression of target genes since PGR are absent from the same epithelia.  
Development of a specific antagonist for the PGR and NR3C1 would clarify the precise 
effects of P4 and cortisol on endometrial gene expression. 
 Extensive studies document the developmental consequences of increased GC 
exposure in mid- to late pregnancy, including intra-uterine growth restriction, increased 
risk of pre-term labor, and adverse effects on fetal brain development (see (Michael et 
al. 2003, Michael & Papageorghiou 2008) for reviews).  Thus, cortisol production by 
placental HSD11B1 and cortisol inactivation by placental HSD11B2 is highly regulated 
in late pregnancy.  However, HSD11B1, HSD11B2, and GCs in early pregnancy are a 
more recent area of interest since GCs can benefit pregnancy.  Positive effects of GCs 
include stimulation of hCG secretion, immunosuppression for maternal acceptance of the 
conceptus allograft, promotion of trophoblast growth/invasion, and increased amino acid 
transport (see (Michael & Papageorghiou 2008) for review).  Interestingly, pregnancy 
rates are increased in women undergoing standard in vitro fertilization who receive 
synthetic GCs prior to or immediately after embryo transfer (Boomsma et al. 2007).  Our 
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sheep model utilizing meloxicam treatment further supports the need for GCs during the 
peri-implantation period, since uteri of treated ewes expressed less HSD11B1 mRNA 
(CHAPTER V), which likely resulted in decreased intrauterine cortisol production. 
 While these results suggest biological roles for GCs in early pregnancy, the 
source of cortisol remains questionable.  Cortisol is the most potent GC produced by the 
adrenal cortex and is often released in response to physical or psychological stress 
(Weber 1998).  However, circulating levels of cortisol did not increase in ewes during 
early pregnancy (CHAPTER IV); therefore, intrauterine production of cortisol by 
HSD11B1 is likely responsible for regulating endometrial gene expression, and 
subsequent conceptus elongation. 
 As previously mentioned, stimulation of IGFBP1 and HSD11B1 in ovine 
endometria by IFNT was modest compared to the much larger increase in expression 
noted in Day 12 pregnant compared to Day 12 cyclic ewes (CHAPTERS III and IV).  
Because relatively little IFNT is produce by the spherical Day 12 ovine conceptuses 
(Ashworth & Bazer 1989), we hypothesized that another conceptus-derived factor must 
be important for the regulation of gene expression.  In rodents PGs are critical for 
successful pregnancies as they regulate blastocyst implantation, decidualization, and 
uterine angiogenesis (Dey et al. 2004, Wang & Dey 2006, Kennedy et al. 2007).  While 
it is well established that conceptuses and endometria of sheep and cattle synthesize and 
secrete various PGs during early pregnancy (Ellinwood et al. 1979, Marcus 1981, Lewis 
et al. 1982, Lewis & Waterman 1985), production of PGF2α is more closely associated 
with luteolysis (McCracken et al. 1999) than regulation of conceptus elongation.  
However, the coordinate expression of IGFBP1 and HSD11B1 in ovine endometrial 
LE/sGE with PTGS2 (CHAPTERS III and IV) suggests that PGs may be biologically 
relevant to the process of implantation and conceptus elongation in ruminants (Kraeling 
et al. 1985, Harney & Bazer 1989).  Previous research has shown IFNT stimulates PGE2 
production via the p38 MAPK pathway in bovine uterine endometria (Krishnaswamy et 
al. 2009) and that PGF2α can stimulate HSD11B1 enzyme bioactivity and protein 
expression in bovine endometrial stromal cells (Lee et al. 2009).  PGs also serve to 
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regulate HSD11B1 in the ovine placenta (Strakova et al. 2000, Michael & 
Papageorghiou 2008). 
 Our studies also found that interruption of PG synthesis via PTGS2 inhibition is 
detrimental for implantation and expression of elongation-related genes such as: 
IGFBP1, IGFBP3, LGALS15, HSD11B1, ISG15, RSAD2, GRP, SLC5A1, and CST3 
(CHAPTER V).  In addition to playing a role in conceptus elongation, many of those PG 
regulated genes are hypothesized to be involved in the cascade of events which occur 
during early pregnancy.  Specifically, endometrial receptivity for implantation (ISG15), 
contribution to conceptus elongation by nutrient transport (SLC5A1), or encoding 
enzymes producing factors implicated in endometrial function and/or conceptus 
development (HSD11B1).  Other genes affected by PGs are known to encode secreted 
proteins that function as trophectoderm migration and attachment factors (IGFBP1, 
LGALS15), regulate cell proliferation (GRP) or IGF bioavailability (IGFBP3), and 
process proteins that regulate conceptus invasion (CST3, CTSL). 
 While PGs are undoubtedly important during peri-implantation, the source of 
these PGs remains to be determined.  The ovine blastocyst and endometrium both 
express PTGS2 (Charpigny et al. 1997a, Charpigny et al. 1997b), thereby meloxicam 
infusion likely targeted both sources of the enzyme.  This poses a question as to whether 
the source of PGs necessary for regulation of gene expression and subsequent conceptus 
elongation are of conceptus or endometrial origin.  Upregulation of IGFPB1, HSD11B1, 
and numerous other genes during pregnancy supports the hypothesis that PGs are 
derived from the conceptus.  However, expression of IGFBP1 and HSD11B1 are 
coordinate with PTGS2 protein in endometrial LE/sGE and upper GE during the estrous 
cycle, suggesting that presence of a conceptus is not required, ergo the endometrium is 
the source of PGs.  Moreover, both pregnant and nonpregnant endometria can synthesize 
PGs (Silvia et al. 1984, Zarco et al. 1988a, Zarco et al. 1988b).  At the onset of 
parturition, cortisol increases PG synthesis (Sun & Myatt 2003) by stimulating PTGS2 
transcription in the placenta (Whittle et al. 2001); thus, the increased abundance of 
PTGS2 in endometrial LE/sGE observed in the estrous cycle and early pregnancy 
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(CHAPTER IV) could be due to higher levels of HSD11B1, cortisol, and upregulation of 
PTGS2 mRNA in those same tissues. 
 Summarily, our working hypothesis implicates both endometrial and conceptus-
derived factors in the regulation of gene expression to facilitate conceptus elongation 
(Fig. 6.2).  We propose that ovarian P4 and endometrial and/or conceptus-derived PGs 
can stimulate the activity of HSD11B1, leading to an increase in levels of active cortisol 
that can then bind either MR to stimulate ion and water transport, or NR3C1 to activate 
genes containing a GRE or PRE.  Potentially activated genes include LGALS15, 
IGFBP1, PTGS2, SLC5A1, and many others.  The stimulation of PTGS2 expression is 
notable, as that would allow for enhanced PG synthesis from arachidonic acid and 
increased HSD11B1 activity, thus propagating a feed forward loop that is important for 
the events of early pregnancy, specifically the process of conceptus elongation. 
 Based on the results presented in this thesis as well as established information in 
the literature, we propose the central hypothesis that peri-implantation conceptus growth 
and development in ruminants is modulated by secretions of the endometrium that are 
regulated by factors produced by the ovary (P4), the conceptus (IFNT and PGs), and the 
endometrium itself (PGs) (Fig. 6.3).  In the conceptus trophectoderm and uterine 
LE/sGE, arachidonic acid is liberated from the cell membrane by PLA2 and then 
converted into PGH2 by PTGS2.  PGH2 is then converted into different primary PGs by 
cell-specific isomerases and synthases.  Two PGs, PGI2 and a variant of PGJ2, 15-Δ-
PGJ2, can activate nuclear PPARs (PPARD and PPARG), which can then dimerize with 
retinoid X receptors and regulate transcription of genes.  PGs can also be transported 
into the uterine lumen by PG transporters (SLC20A1 and MRP4) where they can interact 
with their G protein-coupled receptors expressed by the LE/sGE and stimulate the 
release of intracellular calcium (Ca2+) or increase cAMP production.  These messengers 
activate the cAMP response element binding (CREB) protein, leading to regulation of 
elongation- and implantation-related genes.  IFNT produced be the elongating conceptus 
can bind its receptor (IFNAR) on the LE/sGE and upregulate PTGS2, and thus PG pro- 
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Fig. 6.2. Proposed model for the interactions of prostaglandins, HSD11B1, and cortisol during 
elongation in sheep.  Ovarian P4 and endometrial and/or conceptus-derived PGs can stimulate 
the activity of HSD11B1 to increase production of active cortisol.  Cortisol can then bind nuclear 
MR or NR3C1, leading to ion and water transport or activation of genes, respectively.  
Stimulation of PTGS2 increases PG synthesis from arachidonic acid (AA), increasing HSD11B1 
to propagate a feed-forward mechanism that contributes to conceptus elongation. 
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Fig. 6.3. Schematic of central hypothesis.  In the conceptus trophectoderm and uterine LE/sGE, 
arachidonic acid is liberated from the cell membrane by phospholipase A2 (PLA2) and then 
converted into PGH2 by prostaglandin-endoperoxide synthase 2 (PTGS2).  PGH2 is then 
converted into different primary PGs by cell-specific isomerases and synthases.  Two PGs, 
prostacyclin (PGI2) and PGJ2 can activate nuclear peroxisome proliferator-activating receptors 
(PPARs), which can then dimerize with retinoid X receptors (RXRs) and regulate transcription 
of genes.  PGs can also be transported into the uterine lumen by PG transporters (SLC20A1 and 
MRP4) where they can interact with their G protein-coupled receptors expressed by the LE/sGE 
and stimulate inositol triphosphate (IP3) and the release of intracellular calcium (Ca2+), or 
increase cyclic adenosine monophosphate (cAMP).  These messengers activate the cAMP 
response element binding (CREB) protein, leading to regulation of elongation- and implantation-
related genes.  Interferon tau (IFNT) produced be the elongating conceptus can bind its receptor 
(IFNAR) on the LE/sGE and upregulate PTGS2, and thus PG production by uterine endometria. 
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duction by uterine endometria.  PGs produced in uterine LE/sGE can also be transported 
throughout the body to regulate gene expression and function in the stroma and glands, 
immune response, blood vessel formation, or development of the CL. 
 Experiments in this thesis have contributed toward the body of knowledge 
regarding regulation of ruminant endometrial gene expression and the roles of PGs 
during conceptus elongation.  These analyses have also determined that the utilization of 
Alzet osmotic pumps is a viable method for administration of pharmacological reagents 
to the ovine uterine lumen during gestation without interrupting pregnancy, as control 
samples were undisturbed.  These findings suggest that this technology would be 
suitable for use in investigation of other relevant signaling pathways within the uterus of 
sheep or potentially in other animals.  Importantly, these analyses have also determined 
that IGFBP1, IGFPB3, and HSD11B1 are implantation and elongation-related genes that 
are regulated by PGs, in addition to P4 and IFNT.  Future experiments are needed to 
determine the relative importance of individual PGs and endometrial genes on conceptus 
elongation in sheep, as well as in other ruminants.  Such experiments should include (1) 
characterization of the spatial and temporal expression of additional genes that may be 
important during conceptus elongation, as identified by microarray analysis; (2) 
determination of the regulatory effects of P4, IFNT, and PGs on individual gene 
expression and localization; and (3) utilization of osmotic pumps to deliver reagents 
targeting individual PGs for inhibition, thus allowing elucidation of roles for specific 
PGs on conceptus elongation.  Such experiments will expand the body of knowledge 
associated with the onset and regulation of events in early pregnancy and subsequent 
conceptus elongation in sheep, perhaps providing a comparative model for evaluation of 
the implantation process among other species. 
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